<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-22T18:58:35Z</responseDate><request verb="ListRecords" metadataPrefix="oai_capes">https://api.arca.fiocruz.br/oai/request</request><ListRecords><record><header><identifier>oai:arca.fiocruz.br:icict/61151</identifier><datestamp>2026-10-20T13:36:05Z</datestamp><setSpec>com_icict_44671</setSpec><setSpec>com_icict_1707</setSpec><setSpec>col_icict_44677</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>doctoral thesis</dcterms:type>
   <dcterms:title language="pt-BR">Monitoramento e avaliação ecotoxicológica de níveis ambientais de cocaína e benzoilecgonina em águas fluviais no Rio de Janeiro</dcterms:title>
   <dcterms:alternative language="en">Monitoring and ecotoxicological assessment of environmental levels of cocaine and benzoylecgonine in river waters in Rio de Janeiro</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Cocaína (COC) e benzoilecgonina (BE), seu principal metabólito, vêm sendo detectadas em corpos hídricos. A literatura relacionada a efeitos de concentrações ambientais de COC e BE (µg e ng L⁻¹) sobre organismos aquáticos não-alvo é escassa, sobretudo no modelo Danio rerio (zebrafish). Neste estudo, concentrações de COC e BE foram investigadas em cinco rios urbanos na cidade do Rio de Janeiro em campanhas de monitoramento nas estações seca e chuvosa. O espectrômetro de massas Q-Exactive Plus (Thermo Scientific) com ionização electrospray (ESI) foi utilizado na detecção de COC e BE nas amostras de água a partir de extração em fase sólida e análise em sistema Dionex 3000 UHPLC (Thermo Scientific). Embriões de zebrafish foram expostos à COC e BE por 96 h (50-5000 ng L⁻¹), utilizando o OECD Fish Embryo Toxicity Test adaptado em placas de 24 poços, verificando-se efeitos morfológicos e teratogênicos. Zebrafish adultos foram expostos por 21 dias à COC (10-1000 ng L⁻¹), BE (10-1000 ng L⁻¹) e sua combinação (COC+BE 10+1000 ng L⁻¹ e COC+BE 1000+10 ng L⁻¹), analisando-se biomarcadores antioxidantes e oxidativos. Cocaína e BE foram quantificadas (&amp;gt; LQ) com 100 % de frequência em todas as campanhas e pontos de coleta, indicando a contaminação potencial desses ambientes e sugerindo a exposição ininterrupta de organismos não-alvo. Maiores níveis médios de COC (383,68 ± 269,57 ng L⁻¹) e BE (1022,16 ± 535,04 ng L⁻¹) foram observados na estação chuvosa comparados à estação seca (COC 192,27 ± 127,23 ng L⁻¹; BE 504,30 ± 382,28 ng L⁻¹), contrastando com os maiores resultados de NNH3 e DQO observados nesta estação (estação seca), sugerindo a influência do comportamento de consumo de COC associado à primavera/verão (estação chuvosa). Alterações morfológicas e teratogênicas foram observadas nos embriões expostos, com efeitos acima do observado no controle já a partir da menor concentração de BE (50 ng L⁻¹) testada, a qual correspondeu à menos de 10 % da concentração média de BE monitorada. Modulações de biomarcadores de estresse oxidativo (principalmente no cérebro) foram observadas nos peixes adultos expostos, bem como estresse oxidativo associado à peroxidação lipídica e carbonilação de proteínas. Os resultados alertam para a presença de COC e BE em rios do Rio de Janeiro em níveis capazes de causar efeitos deletérios em organismo não-alvo, deflagrando um alarmante problema de saúde pública e meio ambiente.</dcterms:abstract>
   <dcterms:abstract language="en">Cocaine (COC) and benzoylecgonine (BE) (main metabolite) have been detected in water sources. The literature on the effects of COC and BE environmental concentrations (µg and ng L⁻¹) in non-target aquatic organisms is scarce, especially in the Danio rerio model (zebrafish). In this study, COC and BE concentrations were investigated in five urban rivers in Rio de Janeiro City, in monitoring campaigns in the dry and rainy seasons. The Q-Exactive Plus mass spectrometer (Thermo Scientific) with electrospray ionization (ESI) was used to detect COC and BE in water samples after solid phase extraction and analysis in a Dionex 3000 UHPLC system (Thermo Scientific). Zebrafish embryos were exposed to COC and BE for 96 h (50-5000 ng L⁻¹), using the OECD Fish Embryo Toxicity Test adapted in 24-well plates, verifying morphological and teratogenic effects. Adult zebrafish were exposed for 21 days to COC (10-1000 ng L⁻¹), BE (10-1000 ng L⁻¹) and their combination (COC+BE 10+1000 ng L⁻¹ and COC+BE 1000+ 10 ng L⁻¹), analyzing antioxidant and oxidative biomarkers. Cocaine and BE were quantified (&amp;gt; LQ) with 100% frequency in all campaigns and sampled rivers, indicating the potential contamination of these environments and suggesting the uninterrupted exposure of non-target organisms. Higher average levels of COC (383.68 ± 269.57 ng L⁻¹) and BE (1022.16 ± 535.04 ng L⁻¹) were observed in the rainy season compared to the dry season (COC 192.27 ± 127, 23 ng L⁻¹; BE 504.30 ± 382.28 ng L⁻¹), contrasting with the higher N-NH3 and COD results observed in this season (dry season), suggesting the influence of COC consumption behavior associated with spring/summer (rainy season). Morphological and teratogenic alterations were observed in the exposed embryos, with effects above those observed in the control already from the lowest BE tested concentration (50 ng L⁻¹), which corresponded to less than 10% of the average concentration of monitored BE. Modulations of oxidative stress biomarkers (mainly in the brain) were observed in exposed adult fish, as well as oxidative stress associated with lipid peroxidation and protein carbonylation. The results alert to the COC and BE presence in Rio de Janeiro rivers at levels capable of causing deleterious effects in non-target organisms, triggering an alarming public health and environmental problem.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Contaminantes emergentes</dcterms:subject>
   <dcterms:subject language="pt-BR">Ecotoxicologia aquática</dcterms:subject>
   <dcterms:subject language="pt-BR">Estresse oxidativo</dcterms:subject>
   <dcterms:subject language="pt-BR">Drogas de abuso</dcterms:subject>
   <dcterms:subject language="pt-BR">Detecção do Abuso de Substâncias</dcterms:subject>
   <dcterms:subject language="pt-BR">Drogas Ilícitas</dcterms:subject>
   <dcterms:subject language="pt-BR">Bacias Fluviais</dcterms:subject>
   <dcterms:subject language="pt-BR">Biomarcadores</dcterms:subject>
   <dcterms:subject language="pt-BR">Cocaína</dcterms:subject>
   <dcterms:subject language="pt-BR">Qualidade da Água</dcterms:subject>
   <dcterms:subject language="pt-BR">Ecotoxicologia</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/61151</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde Pública e Meio Ambiente</capes:hasProgram>
   <capes:programCode>31010016015P0</capes:programCode>
   <bibo:numPages>220</bibo:numPages>
   <capes:defenseDate>2023-05-31</capes:defenseDate>
   <creator>
      <dcterms:creator>Araujo, Gabriel de Farias</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Correia, Fábio Veríssimo</capes:advisor>
   </advisor>
   <coAdvisor>
      <capes:coAdvisor>Saggioro, Enrico Mendes</capes:coAdvisor>
   </coAdvisor>
   <committeeMember>
      <capes:committeeMember>Pereira, Henrique Marcelo Gualberto</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Gomes, Márcia Marques</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Sodré, Fernando Fabriz</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Medeiros, Renata Jurema</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Saggioro, Enrico Mendes</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Correia, Fábio Veríssimo</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/6813</identifier><datestamp>2026-07-24T18:50:22Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Chagasic Patients with Indeterminate Clinical Form of the Disease have High Frequencies of Circulating CD3 Þ CD16 –CD56 þNatural Killer T Cells and CD4 þ CD25 High Regulatory T Lymphocytes</dcterms:title>
   <dcterms:abstract language="en">Several studies have demonstrated that different clinical manifestations of human Chagas&amp;apos; disease are associated with distinct and complex host–parasite relationships directly involving the immune system. In this context, it has been proposed that tissue damage might be more severe in the absence of regulatory mechanisms that involve both innate and adaptive immune responses. Herein, we describe a descriptive phenotypic profile focusing on the frequency of major regulatory T cells [CD4 þ CD25 high and natural killer T (NKT) lymphocytes] in different clinical forms of Chagas&amp;apos; disease. Ex vivo immunophenotyping of whole blood demonstrated that the indeterminate clinical form displays a higher frequency of both CD4 þ CD25 high and NKT regulatory cells (CD3 þ CD16 – CD56 þ ), associated with increased levels of circulating cytotoxic NK cells (CD3 – CD16 þ CD56 þ and CD3 – CD16 þ CD56 dim NK cells). By con-trast, the increased percentage of activated CD8 þ HLA-DR þ T-cell subset was exclusively associated with severe clinical forms of Chagas&amp;apos; disease. We hypothe-size that regulatory T cells may be able to control the deleterious cytotoxic activity in the indeterminate clinical form by inhibiting the activation of CD8 þ HLA-DR þ T cells. The lack of regulated populations in cardiac and digestive clinical forms could account for impaired immune response that culminates in strong cytotoxic activity and tissue damage.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/6813</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Avelar, Danielle Marquete Vitelli</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Avelar, Renato Sathler</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dias, João Carlos Pinto</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pascoal, Vanessa Peruhype Magalhães</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Andréa Teixeira de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lage, Paula Souza</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santos, Silvana Maria Elói</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Rodrigo Corrêa de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martins Filho, Olindo Assis</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/73215</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_1745</setSpec><setSpec>com_icict_3802</setSpec><setSpec>col_icict_1747</setSpec><setSpec>col_icict_9180</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Pandemia da COVID-19: revelando interfaces entre saúde, ambiente e desenvolvimento</dcterms:title>
   <dcterms:alternative language="en">Pandemic of the COVID-19: revealing interfaces between health, environment and development</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O ensaio analisou a situação da pandemia da COVID-19, apresentando as interfaces existentes entre o ambiente, o modelo de desenvolvimento econômico e a saúde pública. Como ponto de partida, considerou a compreensão da pandemia da COVID-19 como um problema complexo e propôs uma modelagem explicativa, aqui denominada ecossistêmica, para auxiliar as necessárias ações integradas em seu enfrentamento. Com base no conceito de reprodução social, foram analisados em sua determinação os condicionantes nos níveis de macro e micro contexto que estão em interação nos distintos planos &amp;quot;biocomunal&amp;quot;, da &amp;quot;autoconsciência e da conduta&amp;quot;, &amp;quot;tecno-econômica&amp;quot; e &amp;quot;ecológico-política&amp;quot;. A identificação deste conjunto de condicionantes interdependentes permitiu caracterizar as vulnerabilidades socioambientais que devem ser consideradas na tomada de decisões no âmbito das políticas públicas.</dcterms:abstract>
   <dcterms:abstract language="en">The essay analyzed the situation of the pandemic of COVID-19, presenting the existing interfaces between the environment, the economic development model and public health. As a starting point, it considered the understanding of the pandemic of COVID-19 as a complex problem and proposed an explanatory modeling, here called ecosystemic, to help the necessary integrated actions in its confrontation. Based on the concept of social reproduction, we have analyzed the determinants at the macro and micro contexts, that are in interaction at the different levels of &amp;quot;biocommunal&amp;quot;, &amp;quot;self-awareness and conduct&amp;quot;, &amp;quot;techno-economic&amp;quot;, and &amp;quot;ecological-political&amp;quot;. The identification of this set of interdependent conditioning factors has made it possible to characterize the socio-environmental vulnerabilities that must be considered when making public policies decisions.</dcterms:abstract>
   <dcterms:subject language="pt-BR">SARS-CoV-2</dcterms:subject>
   <dcterms:subject language="pt-BR">Pandemia</dcterms:subject>
   <dcterms:subject language="pt-BR">Complexidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde Pública</dcterms:subject>
   <dcterms:subject language="pt-BR">Desenvolvimento econômico</dcterms:subject>
   <dcterms:subject language="pt-BR">Pandemias</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/73215</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Santos, Solange Laurentino dos</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Augusto, Lia Giraldo da Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Medeiros, Marcilio Sandro de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Costa, André Monteiro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mertens, Frederic Adelin Georges</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/23637</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_3802</setSpec><setSpec>col_icict_9180</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Epidemiological assessment of neglected diseases in children: lymphatic filariasis and soil-transmitted helminthiasis</dcterms:title>
   <dcterms:alternative language="pt-BR">Prevalência de doenças negligenciadas em escolares: filariose linfática e parasitoses intestinais</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Descrever a prevalência de infecção filarial e de parasitoses intestinais em escolares numa área endêmica de filariose e refletir sobre a opção terapêutica utilizada no Brasil no tratamento coletivo para filariose.</dcterms:abstract>
   <dcterms:abstract language="en">To report the prevalence of lymphatic filariasis and intestinal parasitic infections in school-aged children living in a filariasis endemic area and discuss about the therapeutic regimen adopted in Brazil for the large-scale treatment of filariasis.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Filariose linfática</dcterms:subject>
   <dcterms:subject language="pt-BR">Helmintíase</dcterms:subject>
   <dcterms:subject language="pt-BR">Doenças negligenciadas</dcterms:subject>
   <dcterms:subject language="pt-BR">Enteropatias parasitárias</dcterms:subject>
   <dcterms:subject language="pt-BR">Prevenção e controle</dcterms:subject>
   <dcterms:subject language="pt-BR">Adolescente</dcterms:subject>
   <dcterms:subject language="pt-BR">Animais</dcterms:subject>
   <dcterms:subject language="pt-BR">Criança</dcterms:subject>
   <dcterms:subject language="pt-BR">Pré-Escolar</dcterms:subject>
   <dcterms:subject language="pt-BR">Humanos</dcterms:subject>
   <dcterms:subject language="pt-BR">Estudos Transversais</dcterms:subject>
   <dcterms:subject language="pt-BR">Epidemiologia</dcterms:subject>
   <dcterms:subject language="pt-BR">Fezes</dcterms:subject>
   <dcterms:subject language="pt-BR">Parasitologia</dcterms:subject>
   <dcterms:subject language="pt-BR">Solo</dcterms:subject>
   <dcterms:subject language="pt-BR">Anti-Helmínticos</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">Quimioterapia Combinada</dcterms:subject>
   <dcterms:subject language="pt-BR">Métodos</dcterms:subject>
   <dcterms:subject language="pt-BR">Filtração</dcterms:subject>
   <dcterms:subject language="pt-BR">Cromatografia de Afinidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Membranas Artificiais</dcterms:subject>
   <dcterms:subject language="pt-BR">Prevalência</dcterms:subject>
   <dcterms:subject language="pt-BR">Microfilárias</dcterms:subject>
   <dcterms:subject language="pt-BR">Estudantes</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/23637</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Aguiar-Santos, Ana Maria</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Medeiros, Zulma</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bonfim, Cristine</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rocha, Abraham C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Brandão, Eduardo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Miranda, Tereza</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Paula</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sarinho, Emanuel S. C.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/74740</identifier><datestamp>2026-10-19T21:52:23Z</datestamp><setSpec>com_icict_3790</setSpec><setSpec>col_icict_9624</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>editorial</dcterms:type>
   <dcterms:title language="en">Editorial: Immune response in tuberculosis with comorbidities or coinfections</dcterms:title>
   <dcterms:subject language="en">Coinfection</dcterms:subject>
   <dcterms:subject language="en">Comorbidities</dcterms:subject>
   <dcterms:subject language="en">Helminth</dcterms:subject>
   <dcterms:subject language="en">Immune response</dcterms:subject>
   <dcterms:subject language="en">Tuberculosis</dcterms:subject>
   <dcterms:subject language="pt-BR">Infecções</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/74740</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Gomes-Silva, Adriano</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Babu, Subash</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rolla, Valeria Cavalcanti</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/8869</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_3808</setSpec><setSpec>col_icict_8470</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Panorama da ocorrência de resíduos de medicamentos veterinários em leite no Brasil</dcterms:title>
   <dcterms:alternative language="en">Overview on veterinary drug residues ocurrence in milk in Brazil</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O objetivo deste trabalho foi elaborar um panorama sobre a ocorrência de resíduos de medicamentos veterinários em leite no Brasil, compilando tanto os publicados por autoridades governamentais quanto por instituições acadêmicas. Os dados foram obtidos por meio de pesquisa bibliográfica. Esta pesquisa identificou 35 publicações sobre monitoramentos de resíduos de medicamentos veterinários em leite no país, das quais 34 apresentaram dados sobre o monitoramento de resíduos de antimicrobianos e 10 sobre a ocorrência de resíduos de antiparasitários. Quanto ao número de ocorrências de resíduos de antimicrobianos no leite, os beta-lactâmicos e as tetraciclinas foram os responsáveis pela maior incidência de amostras com resultados acima dos limites de detecção dos métodos empregados. 4 das 9 referências encontradas sobre monitoramentos de anfenicóis apresentaram a ocorrência de cloranfenicol e florfenicol. Apenas três referências apresentaram a ocorrência de amostras com teores acima do Limite Máximo de Resíduos (LMR), cujos analitos foram a benzilpenicilina, da classe dos beta-lactâmicos e o aminoglicosídeo estreptomicina/diidroestreptomicina. Apenas 7 (20,0%) das referências avaliadas apresentaram resultados insatisfatórios para antimicrobianos com relação à legislação brasileira. Com relação aos antiparasitários, 5 de 10 referências (50,0%) apresentaram resultados acima do LMR.</dcterms:abstract>
   <dcterms:abstract language="en">The objective of this work is an overview on the occurrence of veterinary drugs residues in milk in Brazil, gathering as much data as from those published by governmental authority and by academic institutions. Data were obtained through literature search. This search found 35 publications on monitoring of residues of veterinary drugs in milk in the country, 34 out of the total presented data on the monitoring of antimicrobial residues and 10 on the occurrence of residues of antiparasitics. Regarding the number of occurrences of residues of antimicrobials in milk, the beta-lactams and the tetracyclines were responsible for the higher incidence of samples with results above the detection limits of the employed methods. 4 of 9 references found on the amphenicols monitoring showed the presence of chloramphenicol and florphenicol. Only three showed the occurrence of samples with levels above the Maximum Residue Limit (MRL), which analyte was benzylpenicillin, from the class of beta-lactam antibiotics and the aminoglycoside streptomycin/dihydrostreptomycin. Only 7 (20.0%) of the evaluated references showed unsatisfactory results for antimicrobials with respect to Brazilian legislation. Regarding antiparasitics, 5 of 10 references (50.0%) showed results above the MRL.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Resíduos de Medicamentos Veterinários</dcterms:subject>
   <dcterms:subject language="pt-BR">Leite</dcterms:subject>
   <dcterms:subject language="pt-BR">Ocorrência de Resíduos</dcterms:subject>
   <dcterms:subject language="pt-BR">Resíduos de Drogas</dcterms:subject>
   <dcterms:subject language="pt-BR">Contaminação de Alimentos</dcterms:subject>
   <dcterms:subject language="pt-BR">Vigilância Sanitária</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/8869</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Ferreira, Rosana Gomes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Spisso, Bernardete Ferraz</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Hora, Iracema Maria de Carvalho da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Monteiro, Mychelle Alves</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pereira, Mararlene Ulberg</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Costa, Rafaela Pinto da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carlos, Betânia de Souza</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/37263</identifier><datestamp>2026-10-20T21:42:59Z</datestamp><setSpec>com_123456789_1</setSpec><setSpec>col_icict_844</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="pt-BR">AIDS, homossexualidade e estigma social nos anos 1980: as vozes da mídia nos jornais brasileiros da Coleção ABIA</dcterms:title>
   <dcterms:abstract language="pt-BR">Apresenta a relevância e a importância histórico-patrimonial da Coleção ABIA. Expõe o acervo de clippings da coleção como uma significativa fonte de informação histórico-científica em AIDS no Brasil. Analisa as notícias de jornais brasileiros publicadas no início da década 1980. Identifica discursos discriminatórios por parte da mídia impressa nacional em relação à população homossexual. Através das notícias, expõe como a falta de conhecimento sobre a doença contribuiu para a disseminação do preconceito contra a população homossexual.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Coleção ABIA</dcterms:subject>
   <dcterms:subject language="pt-BR">Homossexualidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Aids</dcterms:subject>
   <dcterms:subject language="pt-BR">Notícias</dcterms:subject>
   <dcterms:subject language="pt-BR">Estigma social</dcterms:subject>
   <dcterms:subject language="pt-BR">Síndrome da Imunodeficiência Adquirida</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/37263</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Lima, Igor Falce Dias de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Almeida, Fátima Duarte de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Risi, Maria Tereza</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/16107</identifier><datestamp>2026-07-24T18:50:26Z</datestamp><setSpec>com_icict_3790</setSpec><setSpec>com_icict_8371</setSpec><setSpec>col_icict_9624</setSpec><setSpec>col_icict_8372</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Synthesis and Antibacterial Activity of Alkylated Diamines and Amphiphilic Amides of Quinic Acid Derivatives</dcterms:title>
   <dcterms:abstract language="en">Different series of N-alkylated diamines and their derivatives condensed to quinic acid were synthesized and tested for antibacterial properties against Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Mycobacterium tuberculosis. The lipophilic chain and carbohydrate moiety modulate the antibacterial activity and the compounds showed a structure-activity relationship. Overall, 11 compounds displayed better activity than chloramphenicol against Gram-positive and Gram-negative bacteria. Monoalkylated amines 2a-h displayed an activity similar to that of ethambutol against Mycobacterium tuberculosis.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/16107</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Rezende Júnior, Celso de Oliveira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Larissa A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Bruno A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Almeida, Camila G.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ferreira, Bianca S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>le Hyaric, Mireille</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Guilherme S. L.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lourenço, Maria Cristina S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Batista, Michel</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Marchini, Fabrício Klerynton</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Vania L.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Diniz, Claudio G.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Almeida, Mauro Vieira de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/74707</identifier><datestamp>2026-10-17T19:21:41Z</datestamp><setSpec>com_icict_3802</setSpec><setSpec>col_icict_9180</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Comparison of DNA extraction methods for COVID-19 host genetics studies</dcterms:title>
   <dcterms:abstract language="en">The coronavirus disease 2019 (COVID-19) pandemic has resulted in global shortages in supplies for diagnostic tests, especially in the developing world. Risk factors for COVID-19 severity include pre-existing comorbidities, older age and male sex, but other variables are likely play a role in disease outcome. There is indeed increasing evidence that supports the role of host genetics in the predisposition to COVID-19 outcomes. The identification of genetic factors associated with the course of SARS-CoV-2 infections relies on DNA extraction methods. This study compared three DNA extraction methods (Chelex®100 resin, phenol-chloroform and the QIAamp DNA extraction kit) for COVID-19 host genetic studies using nasopharyngeal samples from patients. The methods were compared regarding number of required steps for execution, sample handling time, quality and quantity of the extracted material and application in genetic studies. The Chelex®100 method was found to be cheapest (33 and 13 times cheaper than the commercial kit and phenol-chloroform, respectively), give the highest DNA yield (306 and 69 times higher than the commercial kit and phenol-chloroform, respectively), with the least handling steps while providing adequate DNA quality for downstream applications. Together, our results show that the Chelex®100 resin is an inexpensive, safe, simple, fast, and suitable method for DNA extraction of nasopharyngeal samples from COVID-19 patients for genetics studies. This is particularly relevant in developing countries where cost and handling are critical steps in material processing.</dcterms:abstract>
   <dcterms:subject language="en">DNA</dcterms:subject>
   <dcterms:subject language="en">COVID-19</dcterms:subject>
   <dcterms:subject language="en">Genetics Sudies</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/74707</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Ronaldo Celerino da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lima, Suelen Cristina de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Reis, Wendell Palôma Maria dos Santos</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Magalhães, Jurandy Júnior Ferraz de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Ronaldo Nascimento de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rathi, Brijesh</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Kohl, Alain</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bezerra, Marcos André Cavalcanti</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pena, Lindomar</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/34905</identifier><datestamp>2026-10-20T14:14:53Z</datestamp><setSpec>com_icict_61036</setSpec><setSpec>com_icict_3802</setSpec><setSpec>col_icict_61037</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Conhecimentos e práticas dos profissionais da estratégia de saúde da família no município de Recife-PE sobre diabetes mellitus e doenças bucais</dcterms:title>
   <dcterms:alternative language="en">Knowledge and practices of professionals of the family health strategy in the municipality of Recife, Brazil, on diabetes mellitus and oral diseases</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O Diabetes Mellitus (DM) se destaca como uma das principais doenças crônicas no mundo e é responsável por um número elevado de mortes prematuras e perda da qualidade de vida. Diante disso, a atenção integral ao paciente portador dessa condição é uma necessidade constante e é fundamental que os profissionais de saúde de diferentes áreas de atuação tenham conhecimentos sobre as relações que envolvem o diabetes mellitus e as doenças bucais. Esse estudo tem por objetivo analisar os conhecimentos e as práticas dos profissionais de saúde da estratégia de saúde da família do município de Recife/PE em relação ao diabetes mellitus e às doenças bucais. Trata-se de um estudo exploratório, descritivo e com abordagem quantitativa. A amostra foi composta por 35 equipes de saúde da família distribuídas nos oito Distritos Sanitários de Saúde da cidade. Os dados foram coletados através de dois instrumentos: um questionário aplicado aos profissionais das equipes sobre conhecimentos e práticas e um outro que abordou as características gerais da unidade de saúde e da equipe. Os dados foram tabulados para o cálculo de suas frequências e analisados através dos testes Qui-quadrado, Kruskal-Wallis e Wilcoxon para um nível de significância de 5%. A maioria das equipes entrevistadas (77,1%) informou que possuía grupo de educação em saúde para pacientes diabéticos e, apesar do cirurgião dentista participar dos grupos em 91,4% das equipes da amostra, a relação entre doenças bucais e DM não era abordada em todos os grupos. A maioria dos profissionais entrevistados afirmou saber que existe relação entre DM e doenças bucais, porém mais de 50% deles relatou não saber que as doenças bucais podem afetar o controle glicêmico do paciente diabético. Somente 19,7% dos entrevistados realizavam exame da cavidade bucal, 36,4% realizavam estratificação de risco e 41,4% acompanhavam a hemoglobina glicada dos pacientes. De forma geral, os profissionais apresentaram maior nível de conhecimento da relação entre doenças bucais e DM, porém, menor nível de prática sugerindo-se maior investimento na motivação profissional e troca de saberes visando à integralidade do cuidado do paciente diabético.</dcterms:abstract>
   <dcterms:abstract language="en">Diabetes Mellitus (DM) stands out as one of the leading chronic diseases in the world and it is responsible for a high number of premature deaths and loss of quality of life. Therefore, the integral attention to the patient with that condition is a constant necessity and it is fundamental that the health professionals of different areas have knowledge about the relationships between DM and the oral diseases wich are one of its risk factors. This study aims to verify the knowledge and practices of health professionals of the Family Health Strategy in Recife/PE in relation to DM and Oral Diseases. This is an exploratory and a descriptive study with a quantitative approach. The sample consisted of 35 family health teams distributed in the eight Health Districts of the city. The data were collected through two instruments: a questionnaire applied to the professionals of the teams about knowledge and practices and another one that addressed the general characteristics of the health unit and the teams. Data were tabulated for the calculation of their frequencies and analyzed using the Chi-square, Kruskal-Wallis and Wilcoxon tests at a 5% significance level. Most of the interviewed teams (77.1%) reported they had a health education group for diabetic patients, and although the dentists have participated in 91.4% of the groups in the sample teams, the relationship between oral diseases and DM was not addressed in all groups. Most of the professionals interviewed knew that there is a relationship between DM and oral diseases, but more than 50% of them reported not knowing that oral diseases could affect the glycemic control of the diabetic patient. Only 19.7% of the interviewees underwent oral cavity examination, 36.4% performed risk stratification and 41.4% followed the patients&amp;apos; glycated hemoglobin. In general, the professionals presented a higher level of knowledge of the relationship between oral diseases and DM, but a lower level of practice suggesting greater investment in professional motivation and knowledge exchange aiming the integral care of diabetic patients.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Doença Crônica</dcterms:subject>
   <dcterms:subject language="pt-BR">Diabetes Mellitus</dcterms:subject>
   <dcterms:subject language="pt-BR">Doenças da Boca</dcterms:subject>
   <dcterms:subject language="pt-BR">Conhecimentos, Atitudes e Prática em Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção básica</dcterms:subject>
   <dcterms:subject language="en">Chronic diseases</dcterms:subject>
   <dcterms:subject language="en">Diabetes Melittus</dcterms:subject>
   <dcterms:subject language="en">Oral diseases</dcterms:subject>
   <dcterms:subject language="en">Knowledge, Attitude and practices in health</dcterms:subject>
   <dcterms:subject language="en">Primary attention</dcterms:subject>
   <dcterms:subject language="pt-BR">Estratégias de Saúde Nacionais</dcterms:subject>
   <dcterms:subject language="pt-BR">Pessoal de Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção Primária à Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde da Família</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/34905</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde Pública</capes:hasProgram>
   <capes:programCode>25007017002P1</capes:programCode>
   <bibo:numPages>116</bibo:numPages>
   <capes:defenseDate>2019-03-25</capes:defenseDate>
   <creator>
      <dcterms:creator>Lima, Flávia Inojosa Coutinho de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Cesse, Eduarda Ângela Pessoa</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Cesse, Eduarda Ângela Pessoa</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Silva, Amanda Priscila de Santana Cabral</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Jamelli, Silvia Regina</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/51180</identifier><datestamp>2026-10-20T13:51:13Z</datestamp><setSpec>com_icict_27163</setSpec><setSpec>com_icict_3790</setSpec><setSpec>col_icict_27164</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Avaliação comparativa de fenótipos associados à virulência de isolados clínicos da família Trichosporonaceae</dcterms:title>
   <dcterms:abstract language="pt-BR">A Família Trichosporonaceae compreende um grande número de basidiomicetos leveduriformes que estão amplamente distribuídos na natureza. Algumas dessas espécies, em especial Trichosporon asahii, Trichosporon asteroides e Trichosporon inkin, possuem a capacidade de causar infecções em humanos. A habilidade das espécies da Família Trichosporonaceae em causar infecções invasivas está relacionada a uma série de fatores de virulência apresentados por elas, os quais são a produção de enzimas líticas, formação de biofilme, resistência a agentes oxidantes, plasticidade metabólica, mudanças fenotípicas e a presença de determinadas moléculas na parede celular do fungo. Enquanto os três primeiros fatores são bastante descritos na literatura científica, os demais são pouco estudados em isolados clínicos. Desta forma, o objetivo desse estudo foi avaliar os diferentes fenótipos de virulência de isolados clínicos da Família Trichosporonaceae. Foram incluídos 79 isolados clínicos identificados fenotipicamente como Trichosporon spp. e identificados à nível de espécie molecularmente através do sequenciamento da subunidade D1/D2 da região 28S do DNA ribossomal. A plasticidade metabólica foi avaliada através do crescimento do fungo utilizando lactato e N-acetilglicosamina. Curvas de crescimento dos isolados frente a essas duas fontes de carbono foram construídas utilizando espectrofotometria e comparadas com o crescimento do fungo na presença de glicose Mudanças fenotípicas foram avaliadas através da observação e contagem de colônias com morfologia rapidamente alterada em comparação com a colônia mãe após repique e incubação a 37 ºC. As moléculas associadas à parede celular analisadas foram melanina e glucuronoxilomanana. A produção de melanina foi analisada espectrofotometricamente após crescimento do fungo em meio de cultura contendo L-dihidroxifenilalanina. A quantificação de carboidratos secretados foi avaliada utilizando a metodologia de dosagem pelo método de ácido-sulfúrico e fenol em microplacas. A espécie predominante foi T. asahii (n=65), seguida de T. inkin (n=4), Apiotrichum montevideense (n=3), Trichosporon japonicum (n = 2), Trichosporon faecale (n=2), Cutaneotrichosporon debeurmannianum (n=1), Trichosporon ovoides (n=1) e Cutaneotrichosporon arboriformis (n=1). Os isolados de T. asahii tiveram melhor crescimento durante os 7 dias em lactato e N-acetilglicosamina. Quanto ao crescimento em glicose, T. asahii cresceu melhor durante as primeiras 72 horas. Somente T. asahii, T. inkin e T. japonicum apresentaram mudanças fenotípicas. Todos os isolados foram produtores de melanina e glucuronoxilomanana, sem diferenças estatisticamente significativas entre as espécies. Esses resultados permitem ampliar os conhecimentos relativos à virulência da Família Trichosporonaceae, consequentemente expandindo o entendimento dos mecanismos de interação patógeno-hospedeiro e suas implicações na tricosporonose invasiva</dcterms:abstract>
   <dcterms:abstract language="en">The Trichosporonaceae family comprises a large number of yeast-like basidiomycetes that are widely distributed in nature. Some of these species, especially Trichosporon asahii, Trichosporon asteroides, and Trichosporon inkin, have the ability to cause infections in humans. The ability of Trichosporonaceae species to cause invasive infections is related to a series of virulence factors presented by them, which are the production of lytic enzymes, biofilm formation, resistance to oxidizing agents, metabolic plasticity, phenotypic switching, and the presence of certain molecules in the fungal cell wall. While the first three factors are widely described in the scientific literature, the others are poorly studied in clinical isolates. Thus, the aim of this study was to evaluate the different virulence phenotypes of drugs of the Trichosporonaceae Family. We included 79 clinical isolates phenotypically identified as Trichosporon spp. and identified at the species level molecularly by sequencing of the D1/D2 subunit of the 28S region of ribosomal DNA. Metabolic plasticity was evaluated by fungal growth using lactate and N-acetyl glucosamine. Growth curves were constructed, using spectrophotometric methodology, in the presence of these two carbon sources and compared with the growth of the fungi in the presence of glucose. Phenotypic switching was evaluated through the observation and counting of rapidly morphology altered colonies compared to the mother colony after subcultures and incubation at 37 ºC The cell wall associated molecules analyzed were melanin and glucuronoxylomannan. Melanin production was analyzed spectrophotometrically after fungus growth in culture medium containing L-dihydroxyphenylalanine. The quantification of secreted carbohydrates was assessed using the dosing methodology using the sulfuric acid and phenol method in microplates. The predominant species was T. asahii (n = 65), followed by T. inkin (n = 4), Apiotrichum montevideense (n = 3), Trichosporon japonicum (n = 2), Trichosporon faecale (n = 2), Cutaneotrichosporon debeurmannianum (n=1), Trichosporon ovoides (n=1), and Cutaneotrichosporon arboriformis (n = 1). T. asahii isolates had better growth during the 7 days on lactate and N-acetylglucosamine. As for glucose, T. asahii had better growth during the first 72 hours. Only T. asahii, T. inkin, and T. japonicum isolates were able to phenotypic switch. All isolates were melanin and glucuronoxylomannan producers, without statistically significant differences between species. The results of this study expand the knowledge regarding the virulence of members of the Trichosporonaceae family, consequently expanding the understanding of the pathogen-host interaction mechanisms and their implications for invasive tricosporonosis</dcterms:abstract>
   <dcterms:subject language="pt-BR">Trichosporon</dcterms:subject>
   <dcterms:subject language="pt-BR">Plasticidade metabólica</dcterms:subject>
   <dcterms:subject language="pt-BR">Melanina</dcterms:subject>
   <dcterms:subject language="pt-BR">Virulência</dcterms:subject>
   <dcterms:subject language="en">Metabolic plasticity</dcterms:subject>
   <dcterms:subject language="en">Melanin</dcterms:subject>
   <dcterms:subject language="en">Virulence</dcterms:subject>
   <dcterms:subject language="pt-BR">Adaptação Fisiológica</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/51180</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Pesquisa Clínica em Doenças Infecciosas</capes:hasProgram>
   <capes:programCode>31010016008P4</capes:programCode>
   <bibo:numPages>99</bibo:numPages>
   <capes:defenseDate>2020</capes:defenseDate>
   <creator>
      <dcterms:creator>Andrade, Iara Bastos de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Paes, Rodrigo de Almeida</capes:advisor>
   </advisor>
   <advisor>
      <capes:advisor>Santos, Fábio Brito dos</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Trilles, Luciana</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Carvajal, Susana Frases</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Carvalho, Maria Helena Galdino Figueiredo de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Magalhães, Alba Regina de</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/39218</identifier><datestamp>2026-10-21T00:06:04Z</datestamp><setSpec>com_icict_28198</setSpec><setSpec>com_icict_13554</setSpec><setSpec>col_icict_28200</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>video</dcterms:type>
   <dcterms:title language="pt-BR">Conselhos de participação social: ameaça e resistência</dcterms:title>
   <dcterms:abstract language="pt-BR">O Decreto Federal nº 9.759, de abril de 2019, que extingue ou altera os canais de participação social nas políticas públicas, representa ataque frontal à democracia. Esse entendimento orientou a análise de três especialistas, sobre as consequências da medida, ao blog do CEE-Fiocruz. Eles abordaram os conselhos nacionais de alimentação, meio ambiente e drogas, afetados pelas mudanças, ao lado de outros tantos, como os conselhos de Direitos à Pessoa com Deficiência, das Florestas, dos Direitos dos Idosos, além de entidades representativas como a Comissão Nacional de Política Indigenista e o Comitê Gestor de Internet no Brasil. Os especialistas falaram ao blog após o seminário Participação popular na construção de políticas públicas, por ocasião dos 34 anos da Escola Politécnica de Saúde Joaquim Venâncio (EPSJV/Fiocruz), em 20/8. &amp;quot;O Consea foi decisivo no avanço do combate à fome e no incentivo a uma alimentação mais adequada e saudável para população&amp;quot;, destaca Francisco Menezes, ex-presidente do Conselho Nacional de Segurança Alimentar e Nutricional. &amp;quot;O Brasil que tem seis biomas distintos, é um país diverso, mas não conta mais com uma representação diversificada dos estados&amp;quot;, observa o analista ambiental Rogério Rocco, do Instituto Chico Mendes de Conservação da Biodiversidade (ICMBio), sobre as mudanças na composição do Conselho Nacional do Meio Ambiente (Conama). &amp;quot;Hoje não temos representante da sociedade civil participando&amp;quot;, aponta o pesquisador Dênis Petuco, da EPSJV, a respeito do Conselho Nacional de Políticas sobre Drogas, um dos mais antigos do país, criado em 1936. &amp;quot;Vivemos sob ataque às instituições democráticas, mas a eliminação da participação social desses grupos não eliminará essas múltiplas vozes organizadas&amp;quot;, afirma.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Participação Social</dcterms:subject>
   <dcterms:subject language="pt-BR">Democracia</dcterms:subject>
   <dcterms:subject language="pt-BR">Extinção dos Conselhos</dcterms:subject>
   <dcterms:subject language="pt-BR">Consea</dcterms:subject>
   <dcterms:subject language="pt-BR">Conama</dcterms:subject>
   <dcterms:subject language="pt-BR">Conselho Nacional do Meio Ambiente</dcterms:subject>
   <dcterms:subject language="pt-BR">Conselho Nacional de Segurança Alimentar e Nutricional</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/39218</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/36202</identifier><datestamp>2026-07-24T18:50:21Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Immunological biomarkers of subclinical infection in household contacts of leprosy patients</dcterms:title>
   <dcterms:abstract language="en">Hansen&amp;apos;s disease (or leprosy) still persists as a serious public health issue. Its diagnosis is based primarily on the detection of clinical signs that are characteristic of the disease. Studies have pointed to the selection of a set of serological and cellular biomarkers of subclinical infection that result in an efficient diagnosis. The aim of this study was compare index cases and their household contacts to identify differentially expressed biomarkers of immune response in leprosy that could provide reliable evidence of subclinical infection in household contacts. The study population consisted of index cases with multibacillary form (IC, n = 13) and their household contacts (HC, n = 14). Serum cytokines and chemokines were quantified using the cytometric beads array (CBA) system. The humoral response was assessed by ELISA test. Flow cytometry was used to characterize the cellular immune response. Monocyte and CD4 + T lymphocytes frequency was significantly higher in IC. Both CD4+ and CD8 + T lymphocytes had a reduced CD25 expression in HC. The immunoglobulin (Ig)M profile anti- NDO-HSA, LID-1, and NDOLID antigens was significantly higher in IC. This study points to the monocyte and CD4+ lymphocyte frequency, as well as specific IgM profile, as predictors of subclinical infection in the household contacts.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/36202</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Queiroz, Edson A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Medeiros, Nayara Ingrid</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mattos, Rafael Teixeira de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Ana Paula M.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alves, Marina L. Rodrigues</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dutra, Walderez Ornelas</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lana, Francisco Carlos Félix</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gomes, Juliana A. S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Rodrigo Corrêa de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/23693</identifier><datestamp>2026-10-20T21:43:02Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Malária, lactase e adaptações: exemplos de como a espécie humana sofre a ação da seleção natural</dcterms:title>
   <dcterms:subject language="pt-BR">Malária</dcterms:subject>
   <dcterms:subject language="pt-BR">Lactase</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/23693</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Luz, Maurício</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/27728</identifier><datestamp>2026-10-20T21:43:02Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Diagnostic tool based on an HTLV-1-Tax expression system in eukaryotic cells using a poxvirus vector</dcterms:title>
   <dcterms:abstract language="en">Human T-lymphotropic virus 1 (HTLV-1) induces an immune-mediated inflammatory disease affecting the nervous system that eventually is accompanied by ocular, rheumatic and dermatologic manifestations (HTLV-1 associated myelopathy/tropical spastic paraparesis, or HAM/TSP). Proviral load and HTLV-1 protein expression, mainly of Tax, is correlated with disease progression and induction of host–virus equilibrium breakdown that, reportedly, involves the presence of Tax-specific cytotoxic T lymphocytes (CTL), T regulatory cells and anti-Tax antibodies. Based on knowledge of anti-Tax antibodies as markers of disease progression, the objectives of this study were both to design an infection/transfection system using the Vaccinia virus and a tax-encoding plasmid for the expression of Tax protein as well as to use this cell support to evaluate anti-Tax IgG by flow cytometry. The flow cytometry assay was standardized using pooled sera from each test group (negative, asymptomatic and HAM/TSP patients). The HAM/TSP group presented higher IgG anti-Tax reactivity (above 70%) than the asymptomatic group (nearly 40% reactivity). The data indicate that the infection/transfection system is useful for assessing Tax expression. This is a promising assay for use as a diagnostic tool to detect IgG anti-Tax and monitor HTLV-1 infected individuals.</dcterms:abstract>
   <dcterms:subject language="pt-BR">HTLV-1</dcterms:subject>
   <dcterms:subject language="pt-BR">HAM/TSP</dcterms:subject>
   <dcterms:subject language="pt-BR">Vacina</dcterms:subject>
   <dcterms:subject language="pt-BR">Vírus Linfotrópico T Tipo 1 Humano</dcterms:subject>
   <dcterms:subject language="pt-BR">Vacinas</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/27728</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Souza, Jaqueline Gontijo de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Fonseca, Flávio Guimarães da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martins Filho, Olindo Assis</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Andreateixeira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martins, Camila Pacheco Silveira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Luciana Debortoli</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Reis, Jordana Grazziela Alves Coelho dos</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Giph</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Stancioli, Edel Figueiredo Barbosa</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/40900</identifier><datestamp>2026-10-17T18:30:22Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Toll-Like Receptor-2-Mediated C-C Chemokine Receptor 3 and Eotaxin-Driven Eosinophil Influx Induced by Mycobacterium bovis BCG Pleurisy</dcterms:title>
   <dcterms:abstract language="en">An acute and persistent eosinophil infiltration is observed during Mycobacterium bovis BCG pleural infection in mice. Eosinophil accumulation, lipid body formation, and eotaxin production were significantly reduced in BCG-infected Toll-like receptor-2 (TLR2)-deficient mice compared to wild-type mice. Neutralization of eotaxin or CCR3 drastically inhibited BCG-induced eosinophil accumulation and lipid body formation, indicating that BCG-induced eosinophil recruitment and activation is largely dependent of TLR2-mediated eotaxin generation.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Influxo de Eosinófilos</dcterms:subject>
   <dcterms:subject language="pt-BR">Eotaxina</dcterms:subject>
   <dcterms:subject language="pt-BR">Mycobacterium bovis BCG Pleurisia</dcterms:subject>
   <dcterms:subject language="pt-BR">Receptor C-C Mediado por Quimiocina</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/40900</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>D&amp;apos;Avila, Heloisa</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Almeida, Patrícia E.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Roque, Natália R.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Faria Neto, Hugo Caire C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bozza, Patrícia T.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/58328</identifier><datestamp>2026-07-24T18:50:23Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Systemic immune mediators reflect tumor-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast câncer</dcterms:title>
   <dcterms:abstract language="en">Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer. Neoadjuvant chemotherapy has proven efficacy in its treatment, and a pathological complete response (pCR) to therapy is predictive of improved long-term survival. The immune response is key to successful neoadjuvant chemotherapy, as indicated by the relation between the percentage of stromal tumor-infiltrating lymphocytes (TILs) in pre-treated tumor tissue samples and the likelihood of achieving pCR. Here we studied systemic immune mediators from volunteer TNBC patients before undergoing neoadjuvant chemotherapy to determine the systemic response association with TIL intensity, treatment response and survival. Patients were classified into pCR responder or non-responder at time of surgery. We found higher levels of immune mediators before treatment began in patients that went on to be pCR responders vs. non-pCR, with AUC values of 0.64 - 0.80. We also observed a positive correlation between inflammatory systemic immune mediators and the percentage of TILs in pCR responder patients. Combining TILs and systemic immune mediator levels provided stronger AUC values (range of 0.72 - 0.82). Lastly, performing a progression free survival analysis with several of the systemic cytokines that predict pCR, segregated the patients into long and short survival groups based on high and low production of the cytokines, respectively. Our study demonstrates that circulating cytokines, before treatment begins, predict pCR in TNBC patients treated with neoadjuvant chemotherapy. Moreover, they may act as a surrogate marker of high TILs or together with TILs to better predict pCR and survival.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/58328</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Lopes, Ananda D.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Galdino, Nayane A. L.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Figueiredo, Amanda B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Brianese, Rafael C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Morais, Katia L. P.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Brot, Marina de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Osório, Cynthia A. B. T.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Andréa Teixeira de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Calsavara, Vinicius F.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Evangelista, Guilherme F. B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alves, Natalia S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Makdissi, Fabiana B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sanches, Solange M.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lima, Vladmir C. Cordeiro de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carraro, Dirce M.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gollob, Kenneth J.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/11488</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_123456789_2</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_156</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Signal integration duringT lymphocyte activation and function: lessons from the Wiskott–Aldrich syndrome</dcterms:title>
   <dcterms:abstract language="en">Over the last decades, research dedicated to the molecular and cellular mechanisms underlying primary immunodeficiencies (PID) has helped to understand the etiology of many of these diseases and to develop novel therapeutic approaches. Beyond these aspects, PID are also studied because they offer invaluable natural genetic tools to dissect the human immune system. In this review, we highlight the research that has focused over the last 20 years on T lymphocytes fromWiskott–Aldrich syndrome (WAS) patients.WAS T lymphocytes are defective for the WAS protein (WASP), a regulator of actin cytoskeleton remodeling. Therefore, study of WAS T lymphocytes has helped to grasp that many steps of T lymphocyte activation and function depend on the crosstalk between membrane receptors and the actin cytoskeleton. These steps include motility, immunological synapse assembly, and signaling, as well as the implementation of helper, regulatory, or cytotoxic effector functions. The recent concept that WASP also works as a regulator of transcription within the nucleus is an illustration of the complexity of signal integration in T lymphocytes. Finally, this review will discuss howfurther study ofWAS may contribute to solve novel challenges of T lymphocyte biology.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Motilidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Citoesqueleto de Actina</dcterms:subject>
   <dcterms:subject language="pt-BR">Linfócitos T</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/11488</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Almeida, Vinicius Cotta de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dupré, Löic</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Guipouy, Delphine</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Vasconcelos, Zilton Farias Meira de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/39151</identifier><datestamp>2026-10-20T21:43:26Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Behavorial responses to light by the snall Biomphalaria tenagophila (Orbigny, 1835)</dcterms:title>
   <dcterms:abstract language="pt-BR">Em um ambiente de escolha (labirinto em Y) foi estudada a resposta à luz de populações albinas procedentes de Joinvile (SC) e melâncias de São Jose dos Campos (SP) do caramujo Biomphalaria tenagophila. O comportamento foi estimado pela distância (cm) percorrida por hora e a localização (horizontal e vertical) do animal no labirinto. Os dados foram comparados entre as amostras de animais de diâmetro grande e pequeno estudadas em grupos e isoladamente. Todas as amostras responderam positivamente à luz, entretanto, ocorreram diferenças no tempo de aproximação do estímulo, o qual variou com o diâmetro da concha e a condição social dos animais. Os resultados foram comparados aos da espécie B. glabrata e B. straminea estudadas em condições semelhantes e discutidos quanto à relação com a resposta à luz do parasito Schistosoma mansoni.</dcterms:abstract>
   <dcterms:abstract language="en">Biomphalaria tenagophila snails placed in a Y-shaped aquarium were studied in terms of their behavorial response to light. Albino populations from Joinvile (State of Santa Catarina, Brazil) and melanic populations from São José dos Campos (State of São Paulo) were used. Snail behavior was measured by the distance (cm) covered per hour and location of the animal in the aquarium. Data obtained for animals with a small shell diameter were compared to those obtained for animals with a large shell diameter studied both as groups and separately. All samples studied were attracted to light, but differences were observed in time os aproximation to the stimulus, which varied with shell diameter and social condition of the animal. The results were compared to those obtained for B. glabrata and B. straminea in previous studies under similar conditions, and discussed in terms of the resnpondes to light by the parasite Schistosoma mansoni.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Biomphalaria tenagophila</dcterms:subject>
   <dcterms:subject language="pt-BR">Comportamento</dcterms:subject>
   <dcterms:subject language="pt-BR">Luz</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/39151</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Schall, Virgínia Torres</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Jurberg, Pedro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Vasconcellos, Mauricio Carvalho de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/8984</identifier><datestamp>2026-10-20T21:43:27Z</datestamp><setSpec>com_icict_1744</setSpec><setSpec>col_icict_57384</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Transplante de células da medula óssea na insuficiência cardíaca chagásica: relato da primeira experiência humana</dcterms:title>
   <dcterms:abstract language="pt-BR">Fundamento: A insuficiência cardíaca (IC) causada pela Doença de Chagas (DC) é uma cardiomiopatia inflamatória progressiva que afeta milhões de pessoas na América Latina. Estudos com modelos experimentais de IC devido à DC indicam que o transplante de células mononucleares derivadas da medula óssea (TCMO) pode reduzir a inflamação, fibrose e melhorar a função miocárdica. Objetivo: O objetivo desse estudo foi avaliar, pela primeira vez em seres humanos, a segurança e a eficácia do TCMO no miocárdio de pacientes com IC devido à DC. Métodos: Um total de 28 pacientes com IC devido à DC (idade média 52,2 ± 9,9 anos), em classes funcionais III e IV (NYHA) foram submetidos ao TCMO através de injeção coronariana. Foram avaliados os efeitos na fração de ejeção do ventrículo esquerdo (FEVE), capacidade funcional, qualidade de vida, arritmias e parâmetros bioquímicos, imunológicos e neuro-humorais. Resultados: Não houve complicações relacionadas diretamente ao procedimento. A FEVE passou de 20,1 ± 6,8% para 28,3 ± 7,9%, p &amp;lt; 0,03, quando se comparou o período basal e 180 dias após o procedimento, respectivamente. No mesmo período, também foram observadas melhoras na classe funcional NYHA média (3,1 ± 0,3 para 1,8 ± 0,5; p &amp;lt; 0,001), escore de qualidade de vida de Minnesota (50,9 ± 11,7 para 25,1 ± 15,9; p &amp;lt; 0,001), e no teste de caminhada de seis minutos (355 ± 136 m para 437 ± 94 m; p &amp;lt; 0,01). Não houve alterações nos marcadores de ativação inflamatória ou neuro-hormonais. Nenhuma complicação foi registrada. Conclusão: Nossos dados sugerem que a injeção intracoronariana de células derivadas da medula óssea é segura e potencialmente efetiva em pacientes com IC devido à DC. A extensão do benefício, entretanto, parece ser discreta e necessita ser confirmada em ensaios clínicos randomizados, duplo-cegos, controlados com placebo.</dcterms:abstract>
   <dcterms:abstract language="en">Background: Heart failure due to Chagas&amp;apos; disease (HFCD) is a progressive inflammatory cardiomyopathy that affects millions of individuals in Latin America. Studies using mice models of HFCD indicate that bone marrow mononuclear cell transplantation (BMCT) may reduce inflammation, fibrosis, and improve myocardial function. Objective: The purpose of this study was to evaluate, for the first time in humans, the safety and efficacy of BMCT to the myocardium of patients with HFCD. Methods: A total of 28 HFCD patients (mean age 52.2 ± 9.9 years) with NYHA class III and IV were submitted to BMCT through intracoronary injection. Effects on the left ventricle ejection fraction (LVEF), functional capacity, quality-of-life, arrhythmias, biochemical, immunological, and neuro-humoral parameters, were evaluated. Results: There were no complications directly related to the procedure. LVEF was 20.1 ± 6.8% and 28.3 ± 7.9%, p &amp;lt; 0.03 at baseline and 180 days after the procedure, respectively. In the same period, significant improvements were observed in the NYHA class (3.1 ± 0.3 to 1.8 ± 0.5; p &amp;lt; 0.001), quality-of-life (50.9 ± 11.7 to 25.1 ± 15.9; p &amp;lt; 0.001), and in the six-minute walking test (355 ± 136 m to 437 ± 94 m; p &amp;lt; 0,01). There were no changes in markers of immune or neurohormonal activation. No complications were registered. Conclusion: Our data suggest that the intracoronary injection of BMCT is safe and potentially effective in patients with HFCD. The extent of the benefit, however, appears to be small and needs to be confirmed in a larger randomized, double blind, placebo controlled clinical trial</dcterms:abstract>
   <dcterms:subject language="pt-BR">Células-tronco</dcterms:subject>
   <dcterms:subject language="pt-BR">Insuficiência cardíaca</dcterms:subject>
   <dcterms:subject language="pt-BR">Doença de Chagas</dcterms:subject>
   <dcterms:subject language="pt-BR">Terapia celular</dcterms:subject>
   <dcterms:subject language="pt-BR">Cardiomiopatia dilatada</dcterms:subject>
   <dcterms:subject language="pt-BR">Terapia Baseada em Transplante de Células e Tecidos</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/8984</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Vilas-Boas, Fábio</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Feitosa, Gilson Soares</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Soares, Milena Botelho Pereira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pinho Filho, Joel Alves</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mota, Augusto César de Andrade</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gonçalves Almeida, Augusto José</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Andrade, Marcus Vinicius</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Heitor Ghissoni de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Adriano Dourado de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santos, Ricardo Ribeiro dos</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/13311</identifier><datestamp>2026-10-20T14:14:53Z</datestamp><setSpec>com_icict_61036</setSpec><setSpec>com_icict_3802</setSpec><setSpec>col_icict_61037</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Rastreamento e monitoramento de risco para o envelhecimento ativo: avaliação da funcionalidade de idosos da comunidade na Cidade do Recife</dcterms:title>
   <dcterms:alternative language="en">Geriatric assessment for detection and management of risk for active aging: Evaluation of functionality of older adults in Recife</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O Brasil apresenta um acelerado envelhecimento populacional. A transição demográfica alterou o perfil de saúde da população, surgindo um novo conceito de saúde focado na capacidade funcional, com ou sem doença orgânica. Rastrear fatores de risco funcional em uma avaliação multidimensional e proativa, pela atenção primária, é importante estratégia para promoção do envelhecimento ativo. O objetivo do estudo foi validar um protocolo para detectar riscos à funcionalidade em idosos brasileiros, na cidade do Recife/PE. O estudo, descritivo transversal, comparou homens e mulheres, com 60 anos ou mais, de dois grupos: residentes na comunidade do V Distrito Sanitário do Recife e participantes de programa de promoção de saúde, aplicando um protocolo para identificar fatores de risco, composto de um questionário estruturado e instrumentos validados. O tempo médio de aplicação foi de 11.7 ± 4.1 minutos. 57.9 por cento dos idosos eram solteiros, viúvos ou separados, 16.5 por cento moravam sós, 24.9 por cento não tinham assistência da família e 6.8 por cento nenhum tipo de apoio. 55.3 por cento apresentaram quedas nos últimos 2 anos, 62.2 por cento necessitaram de ajuda para levantar e 84.5 por cento tinham medo de cair. 40.9 por cento tinham dificuldade em conter a urina, 35.4 por cento para enxergar e 27.4 por cento para entender a conversa em situações sociais, 32 por cento necessitavam que repetissem o que foi dito. 65.4 por cento tomavam de 1 a 4 comprimidos por dia e 15 por cento usavam 5 ou mais medicamentos. Depressão foi detectada em 35.9 por cento, alteração cognitiva em 42.4 por cento e risco de declínio funcional em 39.3 por cento. O Protocolo de Avaliação do Risco Funcional no Idoso mostrou ser simples e sensível para identificar os fatores que mais comprometem a funcionalidade, não detectáveis na abordagem tradicional focada em queixas ou doenças e oferece uma visão multidimensional do idoso, permitindo programar intervenções individuais ou coletivas para reverter ou minimizar as condições de risco e estabelecer fluxos entre os níveis de atenção, da básica a especializada, promovendo o envelhecimento ativo.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Envelhecimento populacional</dcterms:subject>
   <dcterms:subject language="pt-BR">Idoso</dcterms:subject>
   <dcterms:subject language="pt-BR">Avaliação geriátrica</dcterms:subject>
   <dcterms:subject language="pt-BR">Avaliação em saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde do idoso</dcterms:subject>
   <dcterms:subject language="pt-BR">Prevenção primária</dcterms:subject>
   <dcterms:subject language="pt-BR">Fatores de risco</dcterms:subject>
   <dcterms:subject language="pt-BR">Dinâmica Populacional</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção à Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Idoso Fragilizado</dcterms:subject>
   <dcterms:subject language="pt-BR">Guias como Assunto</dcterms:subject>
   <dcterms:subject language="pt-BR">Estudos Transversais</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/13311</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde Pública</capes:hasProgram>
   <capes:programCode>25007017002P1</capes:programCode>
   <bibo:numPages>72</bibo:numPages>
   <capes:defenseDate>2014-09-29</capes:defenseDate>
   <creator>
      <dcterms:creator>Oliveira, Maria Clécia Lins de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Luna, Carlos Feitosa</capes:advisor>
   </advisor>
   <advisor>
      <capes:advisor>Almeida, Marília Siqueira Campos de</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Almeida, Marília Siqueira Campos de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Lapa, Tiago Maria</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/36926</identifier><datestamp>2026-10-20T21:43:27Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Dinâmica populacional de células mielóides durante o curso de inflamação crônica em camundongos C57BL/6 infectados com Toxoplasma gondii</dcterms:title>
   <dcterms:alternative language="en">Population dynamics of myeloid cells during the course of chronic inflammation in C57 BL/6 mice infected with Toxoplasma gondii</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Fagócitos mononucleares (Mø) e polimorfonucleares neutrófilos (PMN) foram analisados durante o curso da infecção por Toxoplasma gondii em camundongos C57 BL/6, fêmeas, portadores de inflamações crônicas focais induzidas por material inerte. A dinâmica populacional de células mielóides dirigidas ao suporte inerte foi medida a partir do quarto dia após inoculação intraperitonial de 90-100 cistos de T. gondii, ao longo de vinte dias, e comparada com o percentual relativo de leucócitos sangüíneos. Observou-se uma diminuição do percentual de PMN e um aumento significativo de Mø no sangue dos animais infectados. A infecção assintomática por T. gondii em camundongos resultou em um maior esforço do sistema mielóide na produção de células destinadas a combater focos inflamatórios, tornando-as menos aptas a responder adequadamente a diferentes fontes de infecção crônica. A mudança na maturidade e nas proporções normais de células mielóides indicou haver um bloqueio da extrusão de quimiocinas responsáveis pela atração quimiotática de PMN com comprometimento da resolução de focos inflamatórios durante infecções crônicas e assintomáticas por Toxoplasma gondii.</dcterms:abstract>
   <dcterms:abstract language="en">Cells of the mononuclear and polymorphonuclear series were analyzed throughout the course of Toxoplasma gondii infections of C57 BL/6 female mice with chronic inflammatory foci. The animals were inoculated intraperitoneally with 90-100 parasitic cysts followed by subcutaneous implantation of cover glasses (after 4 days). The shift of leukocytes from the blood to the inflammatory focus, corresponding to a prolonged infiltration of myeloid cells, was measured in a time course of 20 days. A significant decline was observed in the mature polymorphonuclear cells in the blood and a concomitant development of a marked monocytosis. Infections with T. gondii in mice with chronic inflammatory foci resulted in dedication of the entire myeloid cells system to the generation of cells that were exported to combat the inflammation, which occurred in those places, and to the chronic infection itself. The shift in the normal proportions of cells and in cells of different degrees of maturity, suggesting that a blockade in the chemokines extruded to attract polimorphonuclear cells, might account to a large extent for the failure of immune responses commonly associated with Toxoplasma subclinical infections.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Toxoplasma gondii</dcterms:subject>
   <dcterms:subject language="pt-BR">Células mielóides</dcterms:subject>
   <dcterms:subject language="pt-BR">Infecção crônica</dcterms:subject>
   <dcterms:subject language="pt-BR">Leucócitos</dcterms:subject>
   <dcterms:subject language="pt-BR">Toxoplasma</dcterms:subject>
   <dcterms:subject language="pt-BR">Células Mieloides</dcterms:subject>
   <dcterms:subject language="pt-BR">Infecção Persistente</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/36926</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Fernandes, Bárbara Cruz Tavares de Macedo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Amendoeira, Maria Regina Reis</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Freire, Ronald Bastos</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/30592</identifier><datestamp>2026-10-21T00:13:47Z</datestamp><setSpec>com_icict_1744</setSpec><setSpec>col_icict_57384</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents</dcterms:title>
   <dcterms:abstract language="en">The development of novel therapeutics is urgently required for diseases where existing treatments are failing due to the emergence of resistance. This is particularly pertinent for parasitic infections of the tropics and sub-tropics, referred to collectively as neglected tropical diseases, where the commercial incentives to develop new drugs are weak. One such disease is schistosomiasis, a highly prevalent acute and chronic condition caused by a parasitic helminth infection, with three species of the genus Schistosoma infecting humans. Currently, a single 40-year old drug, praziquantel, is available to treat all infective species, but its use in mass drug administration is leading to signs of drug-resistance emerging. To meet the challenge of developing new therapeutics against this disease, we developed an innovative computational drug repurposing pipeline supported by phenotypic screening. The approach highlighted several protein kinases as interesting new biological targets for schistosomiasis as they play an essential role in many parasite&amp;apos;s biological processes. Focusing on this target class, we also report the first elucidation of the kinome of Schistosoma japonicum, as well as updated kinomes of S. mansoni and S. haematobium. In comparison with the human kinome, we explored these kinomes to identify potential targets of existing inhibitors which are unique to Schistosoma species, allowing us to identify novel targets and suggest approved drugs that might inhibit them. These include previously suggested schistosomicidal agents such as bosutinib, dasatinib, and imatinib as well as new inhibitors such as vandetanib, saracatinib, tideglusib, alvocidib, dinaciclib, and 22 newly identified targets such as CHK1, CDC2, WEE, PAKA, MEK1. Additionally, the primary and secondary targets in Schistosoma of those approved drugs are also suggested, allowing for the development of novel therapeutics against this important yet neglected disease.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Drogas</dcterms:subject>
   <dcterms:subject language="pt-BR">Quinase</dcterms:subject>
   <dcterms:subject language="pt-BR">Esquistossomicidas</dcterms:subject>
   <dcterms:subject language="pt-BR">Esquistossomose</dcterms:subject>
   <dcterms:subject language="pt-BR">Schistosoma mansoni</dcterms:subject>
   <dcterms:subject language="pt-BR">Resistência a drogas</dcterms:subject>
   <dcterms:subject language="pt-BR">Humanos</dcterms:subject>
   <dcterms:subject language="pt-BR">Fosfotransferases</dcterms:subject>
   <dcterms:subject language="pt-BR">Resistência a Medicamentos</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/30592</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Giuliani, Sandra</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Arthur de Carvalho</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Borba, Joyce Villa Verde Borba</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ramos, Pablo Ivan Pereira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Paveley, Ross A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Muratov, Eugene N.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Andrade, Carolina Horta</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Furnham, Nicholas</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/33514</identifier><datestamp>2026-10-20T21:43:28Z</datestamp><setSpec>com_icict_3790</setSpec><setSpec>col_icict_9624</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report</dcterms:title>
   <dcterms:alternative language="pt-BR">Amaurose e oftalmoplegia total após injeção facial de polimetilmetacrilato: relato de caso</dcterms:alternative>
   <dcterms:abstract language="pt-BR">A injeção de polimetilmetacrilato (PMMA) é prática difundida na medicina estética como medida rejuvenecedora. No entanto, a injeção facial do PMMA carreia sérios riscos, especialmente se realizada na região glabelar. Descrevemos o caso de uma mulher que imediatamente após injeção glabelar de PMMA apresentou amaurose e oftalmoplegia total, revendo ainda a literatura pertinente.</dcterms:abstract>
   <dcterms:abstract language="en">Microspheres of polymethyl-methacrylate (PMMA) are exciting new soft-tissue fillers that are becoming increasing popular for facial rejuvenation. Some reports of side effects of this procedure are basically in respect to dermal reaction, with late-onset granulomatous lesion with giant cells and vacuoles. We report blindness and total ophthalmoplegia after PMMA injection into glabellar area in a healthy woman and review the literature.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Polimetilmetacrilato</dcterms:subject>
   <dcterms:subject language="pt-BR">Injeção facial</dcterms:subject>
   <dcterms:subject language="pt-BR">Amaurose</dcterms:subject>
   <dcterms:subject language="pt-BR">Oftalmoplegia</dcterms:subject>
   <dcterms:subject language="pt-BR">Polimetil Metacrilato</dcterms:subject>
   <dcterms:subject language="pt-BR">Cegueira</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/33514</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Marcus Tulius T.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Curi, André Land</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/50952</identifier><datestamp>2026-07-24T18:50:21Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events</dcterms:title>
   <dcterms:abstract language="en">In the present study, we characterized the phagocytic capacity, cytokine profile along with the Fe gamma-R and TLR expression in leukocytes from Chagas disease patients (indeterminate-IND and cardiac-CARD) before and one-year after Bz-treatment (INDT and CARD(T)). A down-regulation of IL-17, IFN-gamma and IL-10 synthesis by neutrophils was observed in CARD(T). The Bz-treatment did not impact on the expression of phagocytosis-related surface molecules or monocyte-derived cytokine profile in INDT. Although CARDT showed unaltered monocyte-phagocytic capacity, up-regulated expression of Fc gamma-RI/III and TLR-4 may be related to their ability to produce IL-10 and TGF-beta. Down-regulation of lymphocyte-derived cytokine was observed in INDT whereas up-regulated cytokine profile was observed for lymphocytes in CARD(T). Analysis of cytokine network revealed that IND displayed a multifaceted cytokine response characterized by strong connecting axes involving pro-inflammatory/regulatory phagocytes and lymphocytes. On the other hand, CARD presented a modest cytokine network. The Bz-treatment leads to distinct cytokine network: decreasing the links in INDT, with a pivotal role of IL-10(+) monocytes and expanding the connections in CARD(T). Our findings highlighted that the Bz-treatment contributes to an overall immunomodulation in INDT and induces a broad change of immunological response in CARD(T), eliciting an intricate phenotypic/functional network compatible with beneficial and protective immunological events. (C) 2014</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/50952</capes:outputUri>
   <dcterms:rights>Acesso embargado</dcterms:rights>
   <dcterms:available>2059-01-01</dcterms:available>
   <creator>
      <dcterms:creator>Azevedo, Ana Carolina Campi</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gomes, Juliana de Assis Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Carvalho, Andréa Teixeira de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lemos, Denise Silveira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Avelar, Danielle Marquete Vitelli</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Avelar, Renato Sathler</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Magalhães, Vanessa Peruhype</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Béla, Samantha Rodrigues</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ferreira, Karine Silvestre</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Batista, Mauricio Azevedo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Schachnik, Natália Castro de Carvalho</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Rodrigo Corrêa de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santos, Silvana Maria Elói</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martins Filho, Olindo Assis</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/46159</identifier><datestamp>2026-07-24T18:50:22Z</datestamp><setSpec>com_123456789_2</setSpec><setSpec>col_icict_156</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">SARS-CoV-2 pandemic in the Brazilian community of rare diseases: a patient reported survey</dcterms:title>
   <dcterms:abstract language="en">The COVID-19 pandemic has led to a reorganization of health systems to prioritize the fight against the virus. The adoption of social distancing interfered with the flow of existing policies, and may thus negatively affect the most vulnerable groups, such as the rare disease community. Aimming at characterizing the perception of the impact of COVID-19 on the health care of the Brazilian rare disease community, an online questionnaire addressed to patients with rare diseases and their caregivers was disseminated in the Brazilian territory between June 1st to July 5th, 2020. The questions dealt with the sanitary measures adopted; access to medical services; and mental suffering during the pandemic. The survey was answered by 1,466 participants (&amp;lt;18 yo = 53.3%) representing 192 rare diseases. Regarding physical distancing, 1,372 (93.6%) participants did not leave their residence, or did so only when essential; 1,321 (90.1%) always wore masks when leaving home. 1,042 (71.1%) and 995 (67.9%) participants, respectively, referred medical genetics appointments and rehabilitation therapies were postponed/canceled. Telemedicine was experienced by 1,026 (70%), and 68.3% agreed this is a good strategy for health care. Patients with Inborn Errors of Metabolism (IEM, n = 624, 42.5%) appear to have more access to information and ability to overcome difficulties, and feel less threatened, lonely and depressed than the non-IEM group (p &amp;lt; .05). There was an increment of the rare disease patients&amp;apos; vulnerability in the pandemic scenario. The cooperation of patients/caregivers along with adaptation of the health system is crucial and may be so even post-pandemic.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/46159</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Schwartz, Ida Vanessa Doederlein</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Randon, Dévora Natalia</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Monsores, Natan</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Souza, Carolina Fischinger Moura de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Horovitz, Dafne Dain Gandelman</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Wilke, Matheus Vernet Machado Bressan</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Brunoni, Decio</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/63647</identifier><datestamp>2026-10-17T19:29:09Z</datestamp><setSpec>com_icict_63616</setSpec><setSpec>com_icict_16930</setSpec><setSpec>com_123456789_1</setSpec><setSpec>col_icict_63617</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Entre a cruz e a espada: dimensões do aparecimento em partilhas do sensível de travestis na prostituição durante a pandemia de covid-19</dcterms:title>
   <dcterms:alternative language="es">Entre la cruz y la espada: dimensiones de la aparición en distribución de lo sensible de travestis en la prostitución durante la pandemia de covid-19</dcterms:alternative>
   <dcterms:alternative language="en">Between a rock and a hard place: dimensions of appearance in the partition of the sensible of transvestite prostitutes during the covid-19 pandemic</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Este artigo tem como objetivo compreender as diferentes dimensões do aparecimento das travestis da Av. Pedro II, importante avenida da cidade de Belo Horizonte, durante a pandemia de covid-19. A partir de conceitos como partilhas do sensível e aparecimento foram analisados relatos das travestis, extraídos: a) do livro Translado - com o objetivo de contextualizar as rotinas pré-pandemia; b) de entrevistas realizadas por telefone em 2020; e c) de um grupo focal realizado em 2021 presencialmente. O método utilizado para sistematizar e analisar o material foi a montagem de cena, inspirada em Jacques Rancière. Os resultados indicam, por um lado, situações de humilhação, desigualdade e violência. Por outro, desvelam formas de subversão de hierarquias, estratégias de aparecimento e subjetivação política.</dcterms:abstract>
   <dcterms:abstract language="en">The article aims to understand the different dimensions of the appearance of transvestites during the Covid-19 pandemic. The study focused on transvestites located on Av. Pedro II, an important avenue in the city of Belo Horizonte. Based on concepts such as distribution of the sensible and appearance, reports by transvestites were analysed. They were extracted from: a) the book Translado – to contextualize pre-pandemic routines; b) interviews by telephone in 2020; and c) a face-to-face focus group carried out in 2021. The method used to systematise and analyse the material was scene montage, inspired by Jacques Rancière. The results indicate, on the one hand, situations of humiliation, inequality, and violence. On the other hand, they reveal forms of subversion of hierarchies, strategies of appearance and political subjectivati.</dcterms:abstract>
   <dcterms:abstract language="en">The article aims to understand the different dimensions of the appearance of transvestites during the Covid-19 pandemic. The study focused on transvestites located on Av. Pedro II, an important avenue in the city of Belo Horizonte. Based on concepts such as distribution of the sensible and appearance, reports by transvestites were analysed. They were extracted from: a) the book Translado – to contextualize pre-pandemic routines; b) interviews by telephone in 2020; and c) a face-to-face focus group carried out in 2021. The method used to systematise and analyse the material was scene montage, inspired by Jacques Rancière. The results indicate, on the one hand, situations of humiliation, inequality, and violence. On the other hand, they reveal forms of subversion of hierarchies, strategies of appearance and political subjectivation.</dcterms:abstract>
   <dcterms:abstract language="es">El artículo tiene como objetivo comprender las diferentes dimensiones del aparecimiento de los travestis de la Av. Pedro II, una importante avenida de la ciudad de Belo Horizonte, durante la pandemia de covid-19. A partir de conceptos como distribución de lo sensible y aparecimiento, se analizaron relatos de travestis, extraídos: a) del libro Translado – con el objetivo de contextualizar rutinas prepandemia; b) de entrevistas realizadas medio de telefóno en 2020; y c) de un grupo focal realizado en 2021 de forma presencial. El método utilizado para sistematizar y analizar el material fue el montaje de escena, inspirado en Jacques Rancière. Los resultados indican, por un lado, situaciones de humillación, desigualdad y violencia. Por otro lado, revelan formas de subversión de jerarquías, estrategias de aparición y subjetivación política.</dcterms:abstract>
   <dcterms:abstract language="es">El artículo tiene como objetivo comprender las diferentes dimensiones del aparecimiento de los travestis dela Av. Pedro II, una importante avenida de la ciudad de Belo Horizonte, durante la pandemia de covid-19.A partir de conceptos como distribución de lo sensible y aparecimiento, se analizaron relatos de travestis,extraídos: a) del libro Translado – con el objetivo de contextualizar rutinas prepandemia; b) de entrevistasrealizadas medio de telefóno en 2020; y c) de un grupo focal realizado en 2021 de forma presencial. Elmétodo utilizado para sistematizar y analizar el material fue el montaje de escena, inspirado en JacquesRancière. Los resultados indican, por un lado, situaciones de humillación, desigualdad y violencia. Por otrolado, revelan formas de subversión de jerarquías, estrategias de aparición y subjetivación política.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Travestis</dcterms:subject>
   <dcterms:subject language="pt-BR">COVID-19</dcterms:subject>
   <dcterms:subject language="pt-BR">Relatos de si</dcterms:subject>
   <dcterms:subject language="pt-BR">Partilhas do sensível</dcterms:subject>
   <dcterms:subject language="pt-BR">Aparecimento</dcterms:subject>
   <dcterms:subject language="en">Transvestites</dcterms:subject>
   <dcterms:subject language="en">Self-reports</dcterms:subject>
   <dcterms:subject language="en">Partition of the sensible</dcterms:subject>
   <dcterms:subject language="en">Appearance</dcterms:subject>
   <dcterms:subject language="es">Transgenero</dcterms:subject>
   <dcterms:subject language="es">Autoinformes</dcterms:subject>
   <dcterms:subject language="es">Distribución de lo sensible</dcterms:subject>
   <dcterms:subject language="es">Aparecimiento</dcterms:subject>
   <dcterms:subject language="pt-BR">Aparência Física</dcterms:subject>
   <dcterms:subject language="pt-BR">Relatos de Casos como Assunto</dcterms:subject>
   <dcterms:subject language="pt-BR">Relatos de Casos</dcterms:subject>
   <dcterms:subject language="pt-BR">Autorrelato</dcterms:subject>
   <dcterms:subject language="pt-BR">Pessoas Transgênero</dcterms:subject>
   <dcterms:subject language="pt-BR">Modalidades de Aparecimento e Desaparecimento</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/63647</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>German, Tomás Soares Pereira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Garcêz, Regiane Lucas de Oliveira</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/72237</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_3802</setSpec><setSpec>col_icict_9180</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Efficient cell model for assessing inflammatory responsive genes in Mycobacterium tuberculosis and SARS-CoV-2 co-infection</dcterms:title>
   <dcterms:abstract language="en">Mycobacterium tuberculosis (Mtb) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may induce immunopathology with extensive lung damage in hosts. To elucidate the dynamics of co-infection Mtb and SARS-CoV-2 and its impact on inflammatory mediators&amp;apos; expression, we conducted a study to evaluate A549, lung epithelial cells, as a potential model for hosting both pathogens simultaneously. Cell infection initiated with Mtb H37Rv and following a 24-h incubation period, the cells were then infected with SARS-CoV-2. After a 72 h incubation period, a precision test was conducted for both pathogens, and total RNA was extracted for subsequent analysis of gene expression by RT-qPCR of the target genes: IFN-γ, TNF-α, IL-6, and IL-1β. Additionally, the levels of IL-1β, IL-2, IL-4, IL-6, IL-10, IFN-γ, and TNF-α in the culture supernatants were measured. A549 cells are a stable and reliable cellular model for co-infection between Mycobacterium tuberculosis and SARS-CoV-2. Co-infection with both pathogens led to downregulation of IFN-γ, TNF-α, and IL-10, and upregulation of IL-6 and IL-1β compared to uninfected cells. A549 cells function as a cellular model for co-infection and seems a good model for elucidating host inflammatory responses in the initial site of infection.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Tuberculose</dcterms:subject>
   <dcterms:subject language="pt-BR">COVID-19</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/72237</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Lucena, Thays Maria Costa de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Miranda, Débora Elienai de Oliveira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Arcoverde, Juliana Vieira de Barros</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cavalcanti, Mariana Souza Bezerra</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dantas, Willyenne Marília</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pena, Lindomar José</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lorena, Virginia Maria Barros de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rabello, Michelle Christiane da Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Jaqueline de Azevêdo</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/3725</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Natural infection of wild rodents by Schistosoma mansoni parasitological aspects</dcterms:title>
   <dcterms:abstract language="en">he evaluation of the role of rodents as natural hosts of Schistosoma mansoni was studied at the Pamparrão Valley, Sumidouro, RJ, with monthly captures and examination of the animals. Twenty-three Nectomys squamipes and 9 Akodom arviculoides with a shistosomal infection rate of 56.5% and 22.2% respectively eliminated a great majority of viable eggs. With a strain isolated from one of the naturally infected N. squamipes, we infected 75% of simpatric Biomphalaria glabrata and 100% of albino Mus musculus mice. The adult worms, isolated from N. squamipes after perfusion were located mainly in the liver (91.5%) and the mesenteric veins (8.5%). The male/female proportion was 2:1. The eggs were distributed on small intestine segments (proximal, medial and distal portions) and the large intestine without any significant differences in egg concentration of these segments. In A. arviculoides, the few eggs eliminated by the stools were viable and there was litlle egg retention on intestinal segments. Considering the ease to complete S. mansoni biological cycle in the Nectomys/Biomphalaria/Nectomys system under laboratory conditions, probably the same is likely to occur in natural conditions. In support to this hypotesis there are also the facts that human mansonic shistosomiasis has a very low prevalence in Sumidouro and endemicity among the rodents has not changed even after repetead treatments of the local patients. Based on our experiments, we conclude that N. squamipes has become a natural host of S. mansoni and possibly may participate in keeping the cycle of schistosomiasis transmission at Pamparrão Valley.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Schistosoma mansoni</dcterms:subject>
   <dcterms:subject language="pt-BR">Roedores</dcterms:subject>
   <dcterms:subject language="pt-BR">Infecções</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/3725</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Rosângela Rodrigues e</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, José Roberto Machado e</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Faerstein, Nilcéa Freire</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lenzi, Henrique Leonel</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rey, Luis</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/70606</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_13663</setSpec><setSpec>com_icict_67237</setSpec><setSpec>com_icict_58640</setSpec><setSpec>col_icict_13664</setSpec><setSpec>col_icict_67242</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">A história de construção das portarias de consolidação do Sistema Único de Saúde: um marco normativo</dcterms:title>
   <dcterms:alternative language="es">La historia de la construcción de las ordenanzas de consolidación del Sistema Único de Salud: un hito normativo</dcterms:alternative>
   <dcterms:alternative language="en">The history of the construction of the consolidation ordinances of the Unified Health System: a normative milestone</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Apresentar, por meio de resenha analítica, a obra &amp;apos;Consolidação, Simplificação e Revisão do Arco Normativo Infralegal da Saúde: um projeto, muitas vozes&amp;apos;, publicado pelo CONASS e que narra a história biográfica de um projeto pioneiro e inovador da consolidação do arco normativo infralegal do Sistema Único de Saúde.</dcterms:abstract>
   <dcterms:abstract language="en">To present, through an analytical review, the work &amp;apos;Consolidation, Simplification, and Review of the Infralegal Normative Arch of Health: one project, many voices&amp;apos;, published by CONASS, which narrates the biographical history of a pioneering and innovative project in consolidating the infralegal normative arch of the Unified Health System.</dcterms:abstract>
   <dcterms:abstract language="es">Presentar, a través de una reseña analítica, la obra &amp;apos;Consolidación, Simplificación y Revisión del Arco Normativo Infralegal de la Salud: un proyecto, muchas voces&amp;apos;, publicada por CONASS y que narra la historia biográfica de un proyecto pionero e innovador en la consolidación del arco normativo infralegal del Sistema Único de Salud.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Sistema Único de Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Direito sanitário</dcterms:subject>
   <dcterms:subject language="pt-BR">Portarias de consolidação</dcterms:subject>
   <dcterms:subject language="es">Sistema Único de Salud</dcterms:subject>
   <dcterms:subject language="es">Derecho sanitario</dcterms:subject>
   <dcterms:subject language="es">Ordenanzas de consolidación</dcterms:subject>
   <dcterms:subject language="pt-BR">Resenhas de Livros</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/70606</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Mendes, Daphne Sarah Gomes Jacob</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rodrigues, Maria Ester Simões Nogueira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Montagner, Miguel Ângelo</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/65516</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_44678</setSpec><setSpec>com_icict_1707</setSpec><setSpec>col_icict_44680</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>doctoral thesis</dcterms:type>
   <dcterms:title language="pt-BR">Estimativas de feminicídio íntimo no Brasil: uma análise espaço-temporal de 1996 a 2019</dcterms:title>
   <dcterms:abstract language="pt-BR">O interesse pelos feminicídios aumentou no Brasil após o ano de 2015, em função da Lei do Feminicídio. Os feminicídios íntimos – homicídios de mulheres perpetrados por parceiros ou ex-parceiros das vítimas – são bastante recorrentes em residências, embora não aconteçam somente nesse espaço. O objetivo desta tese foi estimar as tendências espaciais e espaço-temporais de feminicídio íntimo no Brasil, por meio de um indicador, entre os anos de 1996 e 2019. Foi realizado um estudo ecológico, que utilizou como unidade de análise as 133 regiões intermediárias brasileiras e registros de óbitos por agressão, oriundos do Sistema de Informações sobre Mortalidade, entre mulheres de 15 a 59 anos. Para a elaboração do indicador foram capturados 80% dos óbitos domiciliares somados a 20% de registros em outros locais de ocorrência. Foram apresentadas séries temporais anuais, segundo regiões brasileiras e aplicada a técnica de varredura espacial e espaço-temporal de Kulldorff para a identificação de aglomerados do evento. No país, 31.726 óbitos de mulheres de 15 a 59 anos foram considerados como feminicídios íntimos entre 1996 e 2019, sendo estimado risco de 2,4 óbitos a cada 100 mil mulheres na faixa etária citada. Para as regiões Norte e Nordeste verificou-se tendência de crescimento do risco e para a região Sudeste, queda. Foram delimitados 15 clusters espaço-temporais para feminicídios íntimos ao longo de 24 anos de análise, com o cluster mais provável sendo formado pelas regiões intermediárias de São Mateus, Colatina e Vitória (risco relativo igual a 2,29 e duração de 10 anos). Clusters espaço-temporais secundários, mais recentes, incluíram as regiões intermediárias de Vitória da Conquista; Santo Antônio de Jesus; Ilhéus – Itabuna (risco relativo igual a 1,57) e Fortaleza; Quixadá; Sobral; Iguatu; Crateús; Mossoró (risco relativo igual a 1,76). A utilização das regiões intermediárias instiga o aprofundamento de investigações sobre possíveis estruturas de determinação diferenciadas ao longo dos anos nestes espaços. O indicador proposto permitiu reconstruir o histórico de feminicídios íntimos no país, ao utilizar o local de ocorrência desses óbitos, registrados no SIM. A validação desse indicador é uma perspectiva viável para as Secretarias de Saúde, a partir de outras fontes de dados do Sistema Único de Saúde, assim como com registros de outros órgãos envolvidos no enfrentamento à violência contra a mulher.</dcterms:abstract>
   <dcterms:abstract language="en">Interest in feminicides increased in Brazil after 2015, due to the Femicide Law. Intimate feminicides – homicides of women perpetrated by partners or ex-partners of the victims – are quite recurrent in homes, although they do not only happen in this space. The main objective was to estimate the spatial and spatiotemporal trends of intimate femicide in Brazil, using an indicator, between the years 1996 and 2019. An ecological study was carried out, which used the 133 intermediate Brazilian regions as a unit of analysis and records of deaths from aggression from the Mortality Information System, among women aged 15 to 59 years. For the elaboration of the indicator, 80% of deaths at home were captured, together with 20% of records in other places of occurrence. Time series were presented, according to Brazilian regions. The space-time clusters were identified using the Kulldorff scan statistic. In Brazil, 31,726 deaths of women aged 15 to 59 years were considered intimate femicide between 1996 and 2019, with an estimated risk of 2.4 deaths per 100,000 women. For the North and Northeast regions, there was a trend towards an increase in risk and for the Southeast region, a decline. Fifteen spacetime clusters were delimited for intimate feminicides over the 24 years of analysis, with the most likely cluster being formed by the intermediate regions of São Mateus, Colatina and Vitória (relative risk equal to 2.29 and duration of 10 years). More recent secondary space-time clusters include the intermediate regions of Vitória da Conquista; Santo Antônio de Jesus; Ilhéus – Itabuna (relative risk equal to 1.57) and Fortaleza; Quixadá; Sobral; Iguatu; Crateus; Mossoró (relative risk equal to 1.76). The use of intermediate regions instigates further investigations into possible different determination structures over the years in these spaces. The proposed indicator made it possible to reconstruct the history of intimate feminicides in the country, using the record of the place where these deaths occurred, with SIM data. The validation of this indicator is a viable prospect for the Health Departments, based on other sources of data from the Unified Health System, as well as records from other bodies involved in combating violence against women.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Homicídio</dcterms:subject>
   <dcterms:subject language="pt-BR">Violência por parceiro íntimo</dcterms:subject>
   <dcterms:subject language="pt-BR">Conglomerados espaço-temporais</dcterms:subject>
   <dcterms:subject language="pt-BR">Violência contra a mulher</dcterms:subject>
   <dcterms:subject language="pt-BR">Registros de mortalidade</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/65516</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-graduação em Epidemiologia em Saúde Pública</capes:hasProgram>
   <capes:programCode>31010016019P6</capes:programCode>
   <bibo:numPages>115</bibo:numPages>
   <capes:defenseDate>2022-11-18</capes:defenseDate>
   <creator>
      <dcterms:creator>Cruz, Débora Medeiros de Oliveira e</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Cruz, Oswaldo Gonçalves</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Costa, Antônio José Leal</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Saraceni, Valéria</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Pinto, Liana Wernersbach</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Carvalho, Marília Sá</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/32819</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_5491</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_7327</setSpec><setSpec>col_icict_11350</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="en">Prevalence of occult Hepatitis B in patients infected with the hepatitis C will be treated with oral direct acting antivirals</dcterms:title>
   <dcterms:subject language="pt-BR">Hepatite B oculta</dcterms:subject>
   <dcterms:subject language="pt-BR">Antivirais orais de ação direta</dcterms:subject>
   <dcterms:subject language="pt-BR">Hepatite C</dcterms:subject>
   <dcterms:subject language="pt-BR">Hepatite B</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/32819</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Almeida, Nathália Alves Araujo de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Barros, José Junior França de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Campos, Letícia Bomfim</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Spitz, Natália</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Brandão, Carlos Eduardo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santana, Catarina Góis de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Paula, Vanessa Salete de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/66096</identifier><datestamp>2026-07-24T18:50:23Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Benign-by-design SAHA analogues for human and animal vector-borne parasitic diseases</dcterms:title>
   <dcterms:abstract language="en">The search for new drugs fulfilling One Health and Green Chemistry requirements is an urgent call. Here, for the first time, we envisaged developing SAHA analogues by starting from the cashew nutshell liquid (CNSL) agro-industrial waste and employing a metathesis approach. This sustainable combination (comprising principles #7 and #9) allowed a straightforward synthesis of compounds 13–20. All of them were found to not be toxic on HepG2, IMR-32, and L929 cell lines. Then, their potential against major human and animal vector-borne parasitic diseases (VBPDs) was assessed. Compound 13 emerged as a green hit against the trypomastigote forms of T. b. brucei. In silico studies showed that the T. b. brucei HDAC (TbDAC) catalytic pocket could be occupied with a similar binding mode by both SAHA and 13, providing a putative explanation for its antiparasitic mechanism of action (13, EC₅₀ = 0.7 ± 0.2 μM).</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/66096</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Rossi, Michele</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martinengo, Bianca</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Diamanti, Eleonora</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Salerno, Alessandra</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rizzardi, Nicola</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Fato, Romana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bergamini, Christian</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Andressa Souza de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ferreira, Thais de Araújo Marques</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Holanda, Cleonice Andrade</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Romeiro, Luiz Antonio Soares</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Soeiro, Maria de Nazaré Correia</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Costa, Krislayne Nunes da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Fiuza, Ludmila Ferreira de Almeida</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Batista, Marcos Meuser</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Fraga, Carlos Alberto Manssour</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alkhalaf, Hamed E. A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Elmahallawy, Ehab Kotb</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ebiloma, Godwin U.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>de Koning, Harry P.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Vittorio, Serena</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Vistoli, Giulio</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Blanquart, Christophe</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bertrand, Philippe</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bolognesi, Maria Laura</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/37385</identifier><datestamp>2026-10-20T15:26:13Z</datestamp><setSpec>com_icict_44668</setSpec><setSpec>com_icict_1707</setSpec><setSpec>col_icict_44669</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Aspectos da Qualidade de Vida de Agentes Socioeducadores de Instituições Privativas de Liberdade</dcterms:title>
   <dcterms:alternative language="en">Quality of Life Aspects of Socioeducational Agents of Private Institutions of Freedom</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Esta dissertação teve como objetivo estudar os &amp;quot;Aspectos da Qualidade de Vida de Agentes Socioeducadores de Instituições Privativas de Liberdade&amp;quot;. Aborda um tema considerado relevante e atual face à complexidade do trabalho dos (as) agentes socioeducadores (as) do Departamento Geral de Ações Socioeducativas (Degase), localizado no Estado do Rio de Janeiro, diante da responsabilidade social e política junto aos (às) adolescentes em conflito com a lei. Objetivo geral da pesquisa: investigar os aspectos da qualidade de vida dos agentes socioeducativos a partir do WHOQOL-bref e de seus domínios. Objetivos Específicos: investigar a qualidade de vida dos agentes socioeducativos segundo os valores das médias individuais revelados pelos itens do WHOQOL-bref; descrever a qualidade de vida no trabalho dos agentes socioeducadores do Degase segundo os resultados revelados pelos domínios do WHOQOL-bref; correlacionar as dimensões qualidade de vida com base nos escores do WHOQOL, segundo a visão dos agentes socioeducadores. A Metodologia utilizada foi exploratória e descritiva. Os instrumentos utilizados na pesquisa de campo foram: os questionários World Health Organization Quality of Life – Bref (WHOQOL-Bref). Os Resultados obtidos pela análise dos dados mostraram uma variabilidade de concepção sobre a qualidade de vida. As questões relacionadas ao Meio Ambiente revelaram a preocupação mais recorrente no grupo de agentes entrevistados, obteve o menor escore. Os valores ficaram em torno de v=2,2. O domínio &amp;quot;Relações Sociais&amp;quot; foi o que apresentou maior homogeneidade nos valores e revelou-se como o fator mais relevante na constituição de um bom nível de qualidade de vida no trabalho. Em relação à Média Geral, que avaliou a respeito da autopercepção da qualidade de vida e da satisfação com a saúde, os resultados obtidos pela análise dos dados e pelo estudo de casos dos agentes socioeducadores pesquisados nos proporcionaram valores variáveis entre = 3,5 e 4,0. Conclusão: Consideramos que o trabalho socioeducativo está em processo de mudança e que muitos projetos estão sendo implantados. O próprio significado da Socioeducação precisa de ressignificação na medida em que a socioeducação é permeada por tensões, violências, desinformações, que na tendem a bloquear ações emancipadoras e transformadoras. Compreendemos que há momentos de impasses entre uma ação mais libertadora e uma ação de imposição, entre vontades que se chocam e se confrontam o tempo todo e são tensionadas por uma mediação ideológica repressora que ecoa da sociedade como um todo. Desta forma consideramos que o investimento em formação continuada, direcionada aos agentes socioeducadores e aos demais, aponta mudanças efetivas, não só no ambiente físico, mas na promoção de uma cultura da socioeducação que perceba o jovem inserido no sistema socioeducativo como um ser humano em formação, ao qual foram negados acesso às principais políticas públicas.</dcterms:abstract>
   <dcterms:abstract language="en">This work aimed to study the &amp;quot;Aspects of the Quality of Life of Socio-educative Agents of Private Institutions of Freedom&amp;quot;. The topic is considered relevant and current due to the complexity of the work of the socio-educational agents of the General Department of Socio-educational Actions (Degase,), located in Rio de Janeiro, Brazil, as socially and politically responsibles for adolescents in conflict with the law. General objective of the research: to investigate aspects of the quality of life of socio-educational agents from the WHOQOL-bref and its domains. Specific Objectives: to investigate the quality of life of socio-educational agents according to the values of the individual averages revealed by the WHOQOL-bref items; to describe the quality of life in the work of the socio-educative agents of Degase according to the results revealed by the WHOQOL-bref domains; correlate quality of life dimensions based on the WHOQOL scores, according to the view of socioeducator agents. The Methodology used was exploratory and descriptive. The instruments used in field research were: the World Health Organization Quality of Life - Bref questionnaires (WHOQOL-Bref). The results obtained by the analysis of the data showed a variability of conception on the quality of life. The issues related to the Environment revealed the most recurrent concern in the group of agents interviewed, obtained the lowest score. The values were around v = 2.2. The domain &amp;quot;Social Relations&amp;quot; was the one that presented greater homogeneity in the values and was revealed as the most relevant factor in the constitution of a good level of quality of life at work. In relation to General Average, which evaluated the self-perception of quality of life and health satisfaction, the results obtained by the data analysis and by the case study of the socioeducator agents surveyed gave us values ranging from 3.5 to 4, 0. Conclusion: We consider that socio-educational work is in the process of change and that many projects are being implemented. The very meaning of Socioeducation needs redemption insofar as &amp;quot;socio-education is surrounded by tensions, violence, disinformation, which, in most cases, tends to block emancipatory and transformative actions.&amp;quot; We understand that there are moments of impasses between a more liberating action and an action of imposition, between wills that clash and confront each other all the time and are strained by a repressive ideological mediation that echoes from society as a whole. Continuing education, aimed at socio-educational agents and others, points to effective changes, not only in the physical environment, but also in the promotion of a socio-educational culture that perceives the young person inserted in the socio-educational system as a human being in training, who were denied access the main public policies.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Trabalho Socioeducativo</dcterms:subject>
   <dcterms:subject language="pt-BR">Estresse Ocupacional</dcterms:subject>
   <dcterms:subject language="pt-BR">Qualidade de Vida</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde do trabalhador</dcterms:subject>
   <dcterms:subject language="en">Socio-educational Work</dcterms:subject>
   <dcterms:subject language="en">Occupational Stress</dcterms:subject>
   <dcterms:subject language="en">Quality of Life</dcterms:subject>
   <dcterms:subject language="en">Worker Safety</dcterms:subject>
   <dcterms:subject language="pt-BR">Pessoal de Educação</dcterms:subject>
   <dcterms:subject language="pt-BR">Delinquência Juvenil</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde Ocupacional</dcterms:subject>
   <dcterms:subject language="pt-BR">Assistência Social</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/37385</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde Pública</capes:hasProgram>
   <capes:programCode>31010016002P6</capes:programCode>
   <bibo:numPages>86</bibo:numPages>
   <capes:defenseDate>2019-04-04</capes:defenseDate>
   <creator>
      <dcterms:creator>Tavares, Olga Vieira Lima</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/34777</identifier><datestamp>2026-10-20T21:43:05Z</datestamp><setSpec>com_icict_1744</setSpec><setSpec>col_icict_57384</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Ru(II)-thymine complex causes DNA damage and apoptotic cell death in human colon carcinoma HCT116 cells mediated by JNK/p38/ERK1/2 via a p53-independent signaling</dcterms:title>
   <dcterms:abstract language="en">Ru(II)-thymine complex [Ru(PPh3)2(Thy)(bipy)]PF6 (where PPh3 = triphenylphosphine, Thy = thyminate and bipy = 2,2&amp;apos;-bipyridine) is a potent cytotoxic agent with ability to bind to DNA, inducing caspase-mediated apoptosis in leukemia cells. In this study, we investigated the mechanism underlying the cell death induction by Ru(II)-thymine complex in human colon carcinoma HCT116 cells, as well as its effect in xenograft tumor model. The Ru(II)-thymine complex increased significantly the percentage of apoptotic HCT116 cells. Co-treatment with a JNK/SAPK inhibitor, p38 MAPK inhibitor and MEK inhibitor, which inhibit the activation of ERK1/2, caused a marked reduction of the percentage of complex-induced apoptotic cells. Moreover, the Ru(II)-thymine complex induced an increase in phospho-JNK2 (T183/Y185), phospho-p38α (T180/Y182) and phospho-ERK1 (T202/Y204) levels in HCT116 cells. Treatment with the Ru(II)-thymine complex increased significantly the phospho-histone H2AX (S139) expression, a DNA damage marker. The expression of phospho-p53 (S15) and MDM2 were not changed, and the co-treatment with a p53 inhibitor (cyclic pifithrin-α) did not reduce the complex-induced apoptosis in HCT116 cells, indicating that the Ru(II)-thymine complex induces DNA damage-mediated apoptosis by JNK/p38/ERK1/2 via a p53-independent signaling. The Ru(II)-thymine complex (1 and 2 mg/kg/day) also inhibited HCT116 cell growth in a xenograft model, reducing the tumor mass at 32.6-40.1%. Altogether, indicate that the Ru(II)-thymine complex is a promising anti-colon cancer drug candidate.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Carcinoma</dcterms:subject>
   <dcterms:subject language="pt-BR">Câncer Colorretal</dcterms:subject>
   <dcterms:subject language="pt-BR">Apoptose</dcterms:subject>
   <dcterms:subject language="pt-BR">Celulas</dcterms:subject>
   <dcterms:subject language="pt-BR">Morte celular</dcterms:subject>
   <dcterms:subject language="pt-BR">Rutênio</dcterms:subject>
   <dcterms:subject language="pt-BR">Neoplasias Colorretais</dcterms:subject>
   <dcterms:subject language="pt-BR">Células</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/34777</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Suellen Leila Rocha</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Baliza, Ingrid Rayssa Souza</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dias, Rosane Borges</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sales, Caroline Brandi Schlaepfer</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rocha, Clarissa Araújo Gurgel</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Soares, Milena Botelho Pereira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Correa, Rodrigo de Souza</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Batista, Alzir Azevedo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bezerra, Daniel Pereira</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/63321</identifier><datestamp>2026-10-20T21:43:06Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Informações sobre a fauna helminthologica de Matto Grosso (II Nota)</dcterms:title>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">Mato Grosso</dcterms:subject>
   <dcterms:subject language="pt-BR">Classificação</dcterms:subject>
   <dcterms:subject language="pt-BR">Hexaglandula Inermis</dcterms:subject>
   <dcterms:subject language="pt-BR">Echinorhynchus Jucundus</dcterms:subject>
   <dcterms:subject language="pt-BR">Nycticorax Nycticorax</dcterms:subject>
   <dcterms:subject language="pt-BR">Colossoma Brachypomum</dcterms:subject>
   <dcterms:subject language="pt-BR">Coleção PROMAN</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/63321</capes:outputUri>
   <dcterms:rights>Acesso embargado</dcterms:rights>
   <dcterms:available>2040-11-20</dcterms:available>
   <creator>
      <dcterms:creator>Travassos, Lauro</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/60935</identifier><datestamp>2026-10-20T14:13:25Z</datestamp><setSpec>com_icict_22901</setSpec><setSpec>com_icict_3802</setSpec><setSpec>col_icict_22902</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Avaliação da infecção natural de flebotomíneos (Diptera Psychodidae) por Leishmania spp. no município de São Vicente Férrer, Pernambuco</dcterms:title>
   <dcterms:alternative language="en">Evaluation of natural infection of sandflies (Diptera: Psychodidae) with Leishmania spp. in the municipality of San Vicente Ferrer, Pernambuco</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Nas últimas décadas, tem se observado uma considerável expansão geográfica das leishmanioses em todas as regiões do Brasil. Em Pernambuco, São Vicente Férrer localizado na Zona da Mata Norte do Estado, se destaca pela ocorrência de ambas as formas da doença. De 1999 a 2010 foram registrados 157 casos autóctones de leishmaniose tegumentar americana (LTA) e 15 de leishmaniose visceral americana (LVA). Este estudo objetivou avaliar a infecção natural de flebotomíneos por Leishmania spp. As capturas foram realizadas no período entre setembro de 2009 e setembro de 2010, com armadilhas luminosas tipo CDC, entre 18:00h e 6:00h, durante quatro noites consecutivas de cada mês, dispostas em diferentes ecótopos: no intradomicílio, peridomícilio e resquícios de mata primária. Adicionalmente, foram realizadas capturas com capturador manual de Castro com o auxílio da armadilha de Shannon. Os espécimes capturados foram identificados de acordo com a classificação proposta por Young &amp;amp; Duncan (1994). Foram formados grupos contendo 10 fêmeas separadas por espécie, para extração e detecção de DNA do parasito através de dois sistemas de PCR, sendo um específico para o complexo Leishmania braziliensis (subgênero Viannia) e o outro para complexo donovani (Leishmania infantum). Foram capturados 13.872 flebotomíneos pertencentes a 20 espécies. L. migonei foi a espécie mais abundante, com 9.964 exemplares (71%) da fauna, a qual estava presente em todos os ecótopos investigados, com predominância no intradomicílio e peridomicílio. Nos resquícios de mata, as espécies mais frequentes foram L. complexa (65%) e L. sordellii (20,8%). As taxas de infecção natural encontradas foram: L. migonei (2,1%), L. complexa (0,5%), L. sordellii (5,1%) e L. walkeri (50%), sendo todas para a Leishmania (Viannia) spp. Os dados demonstram uma importante circulação deste parasito em São Vicente Férrer, inclusive em espécies que nunca foram encontrados naturalmente infectados por Leishmania, como L. sordellii e L. walkeri, revelando a necessidade de estudos que esclareçam o real papel destas espécies na epidemiologia da LTA. A infecção natural de L. migonei, aliada à significativa taxa de infecção obtida e à sua predominância na área de estudo, sugere a participação desta espécie no ciclo zoonótico da LTA. A infecção natural de L. complexa reforça a hipótese da participação da espécie no ciclo enzoótico da LTA na Zona da Mata Norte de Pernambuco .</dcterms:abstract>
   <dcterms:abstract language="en">In the latest decades, has been observed a considerable geographic distribution of leishmaniasis in all regions of Brazil. São Vicente Ferrer, located in the northern Zona da Mata of Pernambuco State, is distinguished for occurrence of both manifestations of the disease. From 1999 to 2010, 157 autochthonous cases of American Cutaneous Leishmaniais (ACL) and 15 of American Visceral Leishmaniasis (VL) have been registered. The objective of this study was to evaluate the phlebotominae natural infection by Leishmania spp. The collected were carried from September 2009 to September 2010 with Centers for Disease Control and Prevention (CDC) light traps, from 6:00 pm to 6:00 am, during four successive nights distributed inside houses, peridomicile areas and forest patches. Additionally, were carried collections with Castro catcher and through Shannon trap. The specimens were identified according the classification proposed by Young &amp;amp; Duncan (1994). Pools containing 10 females separated by species were submitted to DNA extraction and detection of parasite by two differents systems of PCR, one specific for the Leishmania braziliensis complex (subgenus Viannia) and other for donovani complex (Leishmania infantum). A total of 13.872 sand flies belonging the twenty species were captured, with predominance of L. migonei, which presented 9,964 specimens (71%), being founded in all investigated ecotopes, with predominance inside houses and peridomicile areas. In the forest patches, the species more frequent were L. complexa (65%) and L. sordellii (20,8%). The rates of natural infection by Leishmania (Viannia) spp. were: L. migonei (2,1%), L. complexa (0,5%), L. sordellii (5,1%) and L. walkeri (50%). This study evidence the important circulation of the parasite in São Vicente Férrer Municipality, including in species that were never founded naturally infected by Leishmania, such as L. sordellii and L. walkeri, revealing the need of more studies that can elucidate the real role of these species in the LTA epidemiology. The natural infection of L. migonei, associated to the significant infection rate that was obtained and its predominance in the study area, suggest its participation in the LTA zoonotic cycle. The natural infection of L. complexa strengthens the hypothesis of the participation of this specie in the LTA enzootic cycle at Zona da Mata Norte of Pernambuco State .</dcterms:abstract>
   <dcterms:subject language="pt-BR">Leishmaniose</dcterms:subject>
   <dcterms:subject language="pt-BR">Phlebotomus</dcterms:subject>
   <dcterms:subject language="pt-BR">Vetores de doenças</dcterms:subject>
   <dcterms:subject language="pt-BR">Reação em cadeia da polimerase</dcterms:subject>
   <dcterms:subject language="en">Leishmaniasis</dcterms:subject>
   <dcterms:subject language="en">Disease vectors</dcterms:subject>
   <dcterms:subject language="en">Polymerase chain reaction</dcterms:subject>
   <dcterms:subject language="es">flebótomo</dcterms:subject>
   <dcterms:subject language="es">Vectores de enfermedades</dcterms:subject>
   <dcterms:subject language="es">Reacción en cadena de la polimerasa</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmania</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/60935</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde Pública</capes:hasProgram>
   <capes:programCode>25007017001P5</capes:programCode>
   <capes:defenseDate>2011-06-20</capes:defenseDate>
   <creator>
      <dcterms:creator>Guimarães, Vanessa Cristina Fitipaldi Veloso</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Brandão Filho, Sinval Pinto</capes:advisor>
   </advisor>
   <coAdvisor>
      <capes:coAdvisor>Rodrigues, Eduardo Henrique Gomes</capes:coAdvisor>
   </coAdvisor>
   <committeeMember>
      <capes:committeeMember>Brandão Filho, Sinval Pinto</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Melo, Fábio Lopes de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Ximenes, Maria de Fátima Freire de Melo</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/10956</identifier><datestamp>2026-07-24T18:50:23Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Vibrio madracius sp. nov. Isolated from Madracis decactis (Scleractinia) in St Peter &amp;amp; St Paul Archipelago, Mid-Atlantic Ridge, Brazil</dcterms:title>
   <dcterms:abstract language="en">Three novel isolates (A-354T, A-328, and A-384) were retrieved from apparently healthy scleractinian Madracis decactisin the remote St Peter &amp;amp; St Paul Archipelago, MidAtlantic Ridge, Brazil. The novel isolates formed a distinct lineage based on the phylogenetic reconstruction using the 16S rRNA and pyrH gene sequences. They fell into the Mediterranei clade and their closest phylogenetic neighbour was V. mediterranei species, sharing upto 98.1 % 16S rRNA gene sequence similarity. Genomic analysis including in silico DDH, MLSA, AAI and genomic signature distinguished A-354T from V. mediterranei LMG 19703 (=AK1) with values of 33.3, 94.2, 92 %, and 11.3, respectively. Phenotypically, the novel isolates can be differentiated from V. mediterranei based on the four following features. They do not grow at 8 % NaCl; use D-gluconic acid but not L-galactonic acid lactone as carbon source; and do not have the fatty acid C18:0. Differentiation from both the other Mediterranei clade species (V. maritimus and V. variabilis) is supported by fifteen features. The novel species show lysine decarboxylase and tryptophan deaminase, but not gelatinase and arginine dihydrolase activity; produce acetoin; use a-D-lactose, N-acetyl-D-galactosamine, myo-Inositol, D-gluconic acid, and b-hydroxy-D,L-butyric acid; and present the fatty acids C14:0 iso, C15:0 anteiso, C16:0 iso, C17:0 anteiso, and C17:1x8c. Wholecell protein profiles, based on MALDI-TOF, showed that the isolates are not clonal and also distinguished them from the closes phylogenetic neighbors. The name Vibrio madracius sp. nov. is proposed to encompass these novel isolates. The G?C content of the type strain A-354T (=LMG 28124T =CBAS 482T ) is 44.5 mol%</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/10956</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Moreira, Ana Paula B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Duytschaever, Gwen</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Tonon, Luciane A. Chimetto</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dias, Graciela M.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mesquita, Milene</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cnockaert, Margo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Francini Filho, Ronaldo B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>de Vos, Paul</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Thompson, Cristiane</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Thompson, Fabiano L.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/33637</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Foreword</dcterms:title>
   <dcterms:subject language="pt-BR">Trypanosoma cruzi</dcterms:subject>
   <dcterms:subject language="pt-BR">Doença de Chagas</dcterms:subject>
   <dcterms:subject language="pt-BR">Carlos Chagas</dcterms:subject>
   <dcterms:subject language="pt-BR">Centenário</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/33637</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Oliveira, Ricardo Lourenço de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lannes-Vieira, Joseli</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/39095</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_13663</setSpec><setSpec>col_icict_28777</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="pt-BR">Eficácia e segurança no uso do medicamento concentrado de Fibrinogênio para tratamento de pacientes com hemorragias pós traumáticas</dcterms:title>
   <dcterms:abstract language="pt-BR">INTRODUÇÃO. A diminuição da capacidade de manutenção da hemostasia em pacientes vítimas de lesões traumáticas graves com hemorragia importante é provocada por diversos fatores, como consumo ou diluição de fatores de coagulação, plaquetas e outras células sanguíneas envolvidas na regulação da hemostasia, resultando em distúrbios na coagulação. As concentrações plasmáticas de fibrinogênio podem atingir níveis criticamente baixos mais cedo do que qualquer outro fator de coagulação durante o sangramento intenso, exigindo a terapia de reposição de fibrinogênio. A reposição de fibrinogênio pode ser realizada por meio da transfusão de plasma fresco congelado, crioprecipitado e concentrado de fibrinogênio. OBJETIVO. Avaliar a eficácia e segurança no uso do medicamento concentrado de fibrinogênio para tratamento de pacientes com hemorragias pós traumáticas, tendo como desfechos principais a diminuição da mortalidade global, mortalidade associada e episódios hemorrágicos. MÉTODOS. Foi realizada uma revisão de literatura segundo as Diretrizes Metodológicas do Ministério da Saúde para elaboração de pareceres técnico-científicos, foram utilizadas as bases de dados The Cochrane Library e Medline (via Pubmed). Os critérios de inclusão e exclusão dos estudos envolveram a seleção de revisões sistemáticas e ensaios clínicos para avaliação de eficácia e segurança do concentrado de fibrinogênio no tratamento de hemorragia pós-traumática. RESULTADOS. A partir de um total de 303 estudos encontrados nas buscas de literatura científica, foram selecionadas 2 revisões sistemáticas e 1 ensaio clínico. Na primeira revisão sistemática foram incluídos 8 estudos, sendo 4 relatos de casos e 4 séries de casos. Apenas um estudo apresentou dado de mortalidade comparado ao grupo controle não-tratado, não apresentando diferença em 24 horas ou 30 dias na mortalidade intra-hospitalar. No segundo estudo, foi realizada uma revisão sistemática com metanálise de 7 estudos, sendo que 6 deles apresentaram dados de mortalidade como desfecho primário, porém, não foi encontrado benefício pelo uso de concentrado de fibrinogênio. No ensaio clínico randomizado com 39 pacientes, foi avaliada a eficácia da administração de concentrado de fibrinogênio vs placebo em pacientes com hemorragia. No entanto, o estudo não envolveu a análise de desfechos clínicos, somente laboratoriais, como o aumento da concentração plasmática de fibrinogênio. CONCLUSÃO. As evidências que dão suporte à avaliação da tecnologia em saúde do concentrado de fibrinogênio são frágeis, não sendo possível indicar superioridade do medicamento concentrado de fibrinogênio pois a escassez de estudos experimentais compromete a qualidade das revisões apresentadas. Portanto, esta síntese não recomenda a incorporação deste medicamento para tratamento de pacientes hemorragia pós traumática.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Fibrinogênio</dcterms:subject>
   <dcterms:subject language="pt-BR">Hemorragia</dcterms:subject>
   <dcterms:subject language="pt-BR">Avaliação de Medicamentos</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/39095</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Larissa Ferreira da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Everton Macêdo</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/33287</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Silent neuritis in multibacillary leprosy evaluated through the development of disabilities before, during and after multidrug therapy</dcterms:title>
   <dcterms:abstract language="pt-BR">FUNDAMENTOS - A neurite silenciosa é definida como deterioração da função nervosa na ausência de dor neural, diferenciando-se da neurite franca, em que ocorre dor no nervo periférico, com ou sem prejuízo da função nervosa. Sua detecção precoce é importante para tentar impedir o estabelecimento de seqüelas decorrentes da hanseníase. OBJETIVOS - Conhecer a freqüência das neurites silenciosas em portadores de formas multibacilares de hanseníase. MÉTODOS - Cento e três pacientes (18,4% BB, 47,6% BL e 34% LL) foram acompanhados durante o período médio de 64,6 meses a partir do momento do diagnóstico, durante e após a poliquimioterapia, por meio da avaliação do grau de incapacidade. RESULTADOS - Foram analisados doentes que tiveram piora do grau de incapacidade no término de tratamento, ou ao fim do seguimento, em relação ao grau manifestado antes do tratamento ou no término do tratamento medicamentoso. Ao todo, pelo menos cinco pacientes (4,9% do total) evoluíram com neurite silenciosa, durante ou após a poliquimioterapia. CONCLUSÃO - Preconiza-se exame neurológico seqüencial cuidadoso dos pacientes multibacilares, de modo a detectar e tratar precocemente a neurite silenciosa.</dcterms:abstract>
   <dcterms:abstract language="en">BACKGROUND - Silent neuritis is defined as deterioration of the neural function without neural pain, in contrast to overt neuritis, characterized by pain in the peripheral nerve that may accompany damage to neural function. Its early detection is important to prevent the development of leprosy disabilities. OBJECTIVES - To evaluate the frequency of silent neuritis in multibacillary leprosy patients. METHODS - One hundred and three patients (18.4% BB, 47.6% BL and 34% LL) were followed-up for an average of 64.6 months from diagnosis, during and after multidrug therapy, in relation to physical impairments and according to a disability grade. RESULTS - Patients that presented a worsening of the disability grade by the end of treatment or at the end of follow-up compared to the baseline grade or to the end of treatment, were studied. Altogether we detected five patients (4.9% of the total) that developed silent neuritis, during or after multidrug therapy.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Avaliação da deficiência</dcterms:subject>
   <dcterms:subject language="pt-BR">Hanseníase</dcterms:subject>
   <dcterms:subject language="pt-BR">Neurite</dcterms:subject>
   <dcterms:subject language="pt-BR">Neuritos</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/33287</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Pimentel, Maria Inês Fernandes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Nery, José Augusto da Costa</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Borges, Esther</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rolo, Rosângela</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sarno, Euzenir Nunes</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/7026</identifier><datestamp>2026-10-20T21:43:04Z</datestamp><setSpec>com_icict_6876</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_6877</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Avaliação do teste de detecção simultânea do antígeno core do vírus da Hepatite c (HCV) e anticorpos anti-HCV no diagnóstico laboratorial da Hepatite C</dcterms:title>
   <dcterms:abstract language="pt-BR">A infecção pelo vírus da hepatite C (HCV) é um problema de saúde pública, não somente no Brasil, mas em todo o mundo. A disponibilidade de testes diagnósticos data de 1989, quando foi caracterizado o genoma do HCV. A partir desses estudos foi possível o desenvolvimento de testes que permitem a detecção de anticorpos contra o HCV, como os testes imunoenzimáticos (ELISA ou enzyme-linked immunosorbent assay) e RIBA (recombinant immunoblot assay), bem como técnicas para detecção qualitativa e quantitativa do RNA do HCV por meio da reação em cadeia de polimerase (PCR) e técnicas para determinação dos genótipos do HCV. Recentemente, foi lançado um teste comercial de detecção simultânea de anticorpos anti-HCV e antígeno core do HCV, cujos estudos têm demonstrado uma redução significativa no período de janela imunológica quando comparado à detecção de anticorpos anti-HCV, tornando-o de grande eficácia para o diagnóstico precoce. Dessa forma, o presente estudo teve como objetivo avaliar o desempenho do teste imunoenzimático baseado na detecção simultânea de anticorpos anti-HCV e antígenos core do HCV (Murex HCV Combinação Ag/Ac) no diagnóstico de pacientes com infecção aguda e crônica pelo HCV. A partir da análise do banco de dados do Programa de Diagnóstico Molecular da Hepatite C, foram selecionadas amostras de soro de pacientes com infecção crônica e com resultados inconclusivos de anti-HCV, além de amostras negativas para controle negativo e de um painel de casos agudos de hepatite C. Estas amostras foram submetidas ao teste Murex HCV Combinação Ag/Ac, ao teste de detecção de anticorpos anti-HCV (HCV Ab; RADIM) e testes de detecção qualitativa e quantitativa do HCV-RNA (COBAS AMPLICOR HCV Detection v2.0 e COBASTM AMPLICOR HCV MONITOR v2.0). Os resultados foram registrados em banco de dados criado no programa Access e analisados com auxílio do programa estatístico EpiInfo versão 3.3.2. O teste Murex HCV Combinação Ag/Ac, além de ser de fácil e rápida execução, demonstrou ótimo desempenho em comparação com os outros testes sorológicos e moleculares analisados, sendo 100% eficiente na detecção de amostras reativas independente do genótipo e do subtipo infectante. O teste Murex HCV Combinação Ag/Ac forneceu resultados 100% concordantes com os resultados obtidos pelos outros testes realizados nos diferentes grupos, excetuando-se apenas o grupo de amostras de pacientes com resultados inconclusivos de anti-HCV, onde o teste Murex HCV Combinação Ag/Ac teve uma concordância de 96,4% em relação à detecção de anticorpos anti-HCV. Contudo, o teste Murex HCV Combinação Ag/Ac pode ser uma alternativa para o diagnóstico molecular da infecção pelo HCV em países em desenvolvimento, onde a utilização dos testes baseados em NAT ainda é pouco exequível.</dcterms:abstract>
   <dcterms:subject language="pt-BR">HCV</dcterms:subject>
   <dcterms:subject language="pt-BR">Anti-HCV</dcterms:subject>
   <dcterms:subject language="pt-BR">Antígenos core</dcterms:subject>
   <dcterms:subject language="pt-BR">Diagnóstico sorológico</dcterms:subject>
   <dcterms:subject language="en">Antigens core</dcterms:subject>
   <dcterms:subject language="en">Serological diagnosis</dcterms:subject>
   <dcterms:subject language="pt-BR">Hepacivirus</dcterms:subject>
   <dcterms:subject language="pt-BR">Testes Sorológicos</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/7026</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação Medicina Tropical</capes:hasProgram>
   <capes:programCode>31010016003P2</capes:programCode>
   <bibo:numPages>81</bibo:numPages>
   <capes:defenseDate>2010-03-15</capes:defenseDate>
   <creator>
      <dcterms:creator>Meneses, Viviane Fernandes de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Lampe, Elisabeth</capes:advisor>
   </advisor>
   <coAdvisor>
      <capes:coAdvisor>Rodrigues, Lia Laura Lewis Ximenes de Souza</capes:coAdvisor>
   </coAdvisor>
   <committeeMember>
      <capes:committeeMember>Bóia, Márcio Neves</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Yoshida, Clara Fumiko Tashibana</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Almeida, Adilson José de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Villar, Lívia Melo</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Oliveira, Jaqueline Mendes de</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/56637</identifier><datestamp>2026-07-24T18:50:23Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Characterization of agglutinating antibodies detected by the direct agglutination test for visceral leishmaniasis diagnosis</dcterms:title>
   <dcterms:abstract language="en">This study aimed to characterize agglutinating antibodies detected by the direct agglutination test (DAT-LPC) for the diagnosis of visceral leishmaniasis (VL). The DAT-LPC antigen/antibodies complex was recovered, washed, and used as antigenic substrate in a modified enzyme-linked immunosorbent assay (modified ELISA), revealed with anti-human IgM, IgG, and IgG subtype conjugates, and in the immunofluorescent antibodies test (IFAT), revealed with anti-human IgG and IgG1 conjugates. IgM antibodies were detected in 50%, IgG and IgG1 in 100%, and IgG3 in 52.8% of the 36 samples from VL patients. IFAT showed that agglutinating IgG and IgG1 antibodies recognized more intensely antigens located in the membrane and kinetoplast of the parasite. No antibodies were detected in the 15 samples from healthy individuals. This study shows for the first time that the antibodies responsible for agglutination in DAT-LPC are mostly of the IgG1 subtype.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/56637</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Lopes, Karine Ferreira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lanna, Thana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Edward José de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/2281</identifier><datestamp>2026-07-24T18:50:23Z</datestamp><setSpec>com_123456789_1</setSpec><setSpec>col_icict_840</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis</dcterms:title>
   <dcterms:abstract language="en">Abstract We conducted a meta-analysis of studies assessing adherence to highly active antiretroviral therapy (HAART) and a qualitative systematic review of factors associated with better HAART outcomes among HIV? drug users (DU). Thirty-eight studies were considered, which analyzed 14,960 patients (11,394 HIV? DU, 76.2%). Overall adherence (pooled percent of DU classified as adherent in each study) was 0.60 (95% CI: 0.52– 0.68), similar to levels identified by studies conducted with HIV? patients who are not drug users. Time frame used to measure adherence was an independent predictor of interstudy heterogeneity. The systematic review identified better HAART outcomes among former DU, those with less severe psychiatric conditions, those receiving opioid substitution therapy and/or psychosocial support. Patients initiating HAART with lower viral load and higher CD4 counts, and those without co-infections also had better treatment outcomes. Our findings suggest that HIV? DU tend to be inappropriately assumed to be less adherent and unlikely to achieve desirable treatment outcomes, when compared to their non-DU cohort.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/2281</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Malta, Monica Siqueira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Magnanini, Monica Maria Ferreira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Steffanie A. Strathdee</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bastos, Francisco Inácio Pinkusfeld Monteiro</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/43251</identifier><datestamp>2026-10-20T15:23:15Z</datestamp><setSpec>com_icict_6870</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_6872</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>doctoral thesis</dcterms:type>
   <dcterms:title language="pt-BR">Febre Amarela e Malária: investigação de dois surtos zoonóticos no Sudeste brasileiro</dcterms:title>
   <dcterms:abstract language="pt-BR">Tem-se observado expansão territorial da febre amarela silvestre da área endêmica (Amazônia e parte do Centro-oeste) para o sul e leste no Brasil. Paralelamente, a região serrana do Rio de Janeiro (RJ), onde a malária foi erradicada há décadas, registrava casos humanos autóctones de terçã benigna onde o caso índice não era identificado, sendo a hipótese de origem simiana do parasito aventada por pesquisadores. Entre 2015-2017, o RJ registrou surto de malária e a reemergência do vírus amarílico (YFV), este último se alastrando na Mata Atlântica, considerada indene por quase 80 anos. Registrou-se o maior surto silvestre do YFV no país. Estas situações sanitárias estimularam a realização deste estudo, onde buscamos esclarecer aspectos da transmissão desses agravos a partir de amostragens em primatas não-humanos (PNHs) e mosquitos. Após padronização das técnicas de captura, foi possível coletar e examinar, entre 2015 e 2019, 146 PNHs de seis espécies e 17.940 mosquitos de 89 espécies, em 44 municípios de cinco estados brasileiros sob influência da Mata Atlântica. A única espécie de PNH infectada com Plasmodium sp. foi Alouatta guariba clamitans (N=11), sendo cinco com P. simium/vivax, quatro com P. brasilianum/malariae e dois co-infectados. Polimorfismos de nucleotídeos únicos (SNPs) específicos de P. simium foram encontrados em todos os bugios infectados, e em todos os casos humanos autóctones fluminense, o que, aliado à sobreposição geográfica dos humanos e PNHs infectados, reforça a hipótese da transmissão zoonótica Antes do surto de YFV, a região se mostrava receptiva, com detecção de vetores silvestres tradicionais (Haemagogus e Sabethes) em 82% dos municípios amostrados e PNHs susceptíveis em 100% deles. Após a reemergência do YFV, detectou-se o vírus em duas espécies de PNHs, Callithrix jacchus e A. g. clamitans, e em cinco espécies de mosquitos, Hg. leucocelaenus, Hg. janthinomys, Sa. chloropterus, Aedes scapularis e Ae. taeniorhynchus, os dois primeiros considerados os vetores primários devido às altas taxas de infecção e larga distribuição geográfica nos focos. Mosquitos urbanos ou periurbanos não estavam infectados, reforçando o caráter silvestre do surto. O vírus circulante pertence ao genótipo Sul Americano I, subclado 1E, e apresenta assinatura molecular representada por nove alterações de aminoácidos. O sequenciamento do genoma de 30 YFV obtidos de mosquitos, PNHs e humanos, revelou a circulação recente de duas sub-linhagens em Goiás, uma delas tendo chegado ao RJ e se dividindo em duas cadeias de transmissão \2013 uma costeira e uma continental \2013 separadas pela Serra do Mar. Demonstrou-se que o YFV é capaz de permanecer numa mesma área por três estações de transmissão consecutivas independentemente de nova introdução. Não houve evidência de reemergência da febre amarela urbana a partir do surto de caráter silvestre e nem de circulação silvestre do vírus ZIKV e de outros arbovírus no RJ. Em conjunto, nossos resultados alargam o conhecimento acerca da epidemiologia destas duas zoonoses na Mata Atlântica, confirmam o papel central dos bugios na epidemiologia destes dois agravos e contribuem com informações originais úteis na otimização de processos para vigilância e controle.</dcterms:abstract>
   <dcterms:abstract language="en">A territorial expansion of wild yellow fever from the endemic area (Amazonia) toward the south and southeast in Brazil has been recently recorded. The mountainous areas of Rio de Janeiro state (RJ), where malaria was eradicated decades ago, have reported autochthonous human cases of benign tertian malaria. Their simian origin has been hypothesized as no index case was identified. Between 2015-2017, RJ registered a malaria outbreak as well as the re-emergence of yellow fever virus (YFV) transmission and spread in the Atlantic forest (AF), considered YFV-free for almost 80 years. Thus, Brazil recorded its most severe sylvatic YFV outbreak. These sanitary circumstances prompted the present study, where we aim to clarify transmission pieces concerning both diseases through sampling nonhuman primates (PNHs) and mosquitoes as well as conducting multidisciplinary analyzes of detected agents. After standardization of capture techniques, 146 PNHs of six species and 17,940 mosquitoes of 89 species were collected and examined between 2015 and 2019 in 44 municipalities of five Brazilian states under the influence of the AF. The only NHP species infected with Plasmodium sp. was Alouatta guariba clamitans (N = 11), five with P. simium/vivax, four with P. brasilianum/malariae and two co-infected. P. simium specific Single Nucleotide Polymorphisms were found in all infected howler monkeys, and in all RJ autochthonous human cases, which, together with the geographical overlap of humans and infected PNH, confirms the zoonotic transmission Before the YFV outbreak, the region was receptive, with traditional sylvatic vectors (Haemagogus and Sabethes) detections in 82% of the sampled municipalities, and susceptible NHPs in 100% of them. After re-emergence of YFV, the virus was detected in two species of NHPs, Callithrix jacchus and A. g. clamitans and in five species of mosquitoes, Hg. leucocelaenus, Hg. janthinomys, Sa. chloropterus, Ae. scapularis and Ae. taeniorhinchus, the first two considered the primary vectors due to their high infection rate and wide geographic distribution in foci. Urban or peri-urban mosquitoes were not found infected, reinforcing the wild character of the YFV outbreak. The circulating virus belongs to the South American genotype I, subclade 1E, and presents a molecular signature represented by nine amino acid changes. Sequencing of 30 YFV genomes obtained from mosquitoes, PNHs and humans revealed the recent essentially simultaneous circulation of two sub-lineages in Goiás, one of them having arrived in RJ and dividing into two transmission chains, one coastal and one continental, separated by Serra do Mar. It was demonstrated that the YFV is able to remain in the same AF area at least for three consecutive transmission seasons without new introduction. There was no evidence of spillovers from the sylvatic outbreak to the urban ecosystem or from the urban to a wild cycle of ZIKA virus or any other arboviruses in RJ. Altogether, our results broaden the knowledge about the transmission features of these two zoonoses in the AF, confirm the central role of howler monkeys in the epidemiology of these two diseases and contribute with original and useful information for optimizing their surveillance and control.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Febre Amarela</dcterms:subject>
   <dcterms:subject language="pt-BR">Malária</dcterms:subject>
   <dcterms:subject language="pt-BR">Culicidae</dcterms:subject>
   <dcterms:subject language="pt-BR">Primatas</dcterms:subject>
   <dcterms:subject language="pt-BR">Zoonoses</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/43251</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Biologia Parasitária</capes:hasProgram>
   <capes:programCode>31010016001P0</capes:programCode>
   <bibo:numPages>247</bibo:numPages>
   <capes:defenseDate>2019-06-28</capes:defenseDate>
   <creator>
      <dcterms:creator>Abreu, Filipe Vieira Santos de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Oliveira, Ricardo Lourenço de</capes:advisor>
   </advisor>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/60085</identifier><datestamp>2026-10-19T21:52:27Z</datestamp><setSpec>com_icict_13663</setSpec><setSpec>col_icict_13664</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Dádiva como conceito de socialização do Olubaje do Candomblé na RIDE – Distrito Federal</dcterms:title>
   <dcterms:alternative language="es">El regalo como concepto de socialización del Olubaje do Candomblé en el RIDE – Distrito Federal</dcterms:alternative>
   <dcterms:alternative language="en">The gift as a concept of socialization of Olubaje do Candomblé in RIDE – Distrito Federal</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Neste artigo o objetivo é tratar da celebração de Olubajé a partir de uma experiência vivida em um terreiro de Candomblé da Região Integrada de Desenvolvimento do Distrito federal e Entorno – Ride-DF. A metodologia segue o caminho da abordagem etnográfica e se propõe a articular o conceito de dádiva do antropólogo Marcel Mauss à festa do Olubaje no Candomblé do Distrito Federal, como resultado de nossa pesquisa de campo de terreiros. No terreiro vivido na festa do Olubaje, verifica-se uma fartura de comida que é oferecida gratuitamente à todos os presentes, subvertendo à noção consumista e utilitarista do capitalismo atual. Percebe-se também que dentro do terreiro em tempos de Olubaje, o Orixá que rege a casa não necessariamente vai interferir nas escolhas alimentares. O que de fato irá determinar essas escolhas são: o período, as festas e os orixás de cada pessoa. Isso concorre ainda mais para a explicação conceitual da dádiva comunal sem intenções egoístas.</dcterms:abstract>
   <dcterms:abstract language="en">The objective of this article is to address the celebration of Olubajé from an experience lived in a Candomblé terreiro in the Integrated Development Region of the Federal District and Surroundings – Ride-DF. The methodology follows the steps of the ethnographic approach and proposes to articulate the concept of gift by the anthropologist Marcel Mauss to the Olubaje party in the Candomblé of the Federal District, as part of our field research in terreiros. In the terreiro lived in the Olubaje festival, there is an abundance of food that is offered free of charge to all those present, subverting the consumerist and utilitarian notion of current capitalism. Of note, inside the terreiro in times of Olubaje, the Orisha that governs the house will not necessarily interfere with food choices. Food choices will therefore be determined by the period, the parties and the orixás of each person. This contributes even more to the conceptual explanation of communal giving without selfish intentions.</dcterms:abstract>
   <dcterms:abstract language="es">En este artículo, el objetivo es tratar la celebración del Olubajé a partir de una experiencia vivida en un terreiro de Candomblé de la Región de Desarrollo Integrado del Distrito Federal y Alrededores – Ride-DF. La metodología sigue el camino del abordaje etnográfico y propone articular el concepto de donación del antropólogo Marcel Mauss a la fiesta de Olubaje en el Candomblé del Distrito Federal, como resultado de nuestra investigación de campo de terreiros. En el terreiro vivido en la fiesta del Olubaje, abunda la comida que se ofrece gratuitamente a todos los presentes, subvirtiendo la noción consumista y utilitaria del capitalismo actual. También se advierte que dentro del terreiro en tiempos de Olubaje, el Orisha que gobierna la casa no necesariamente interfiere en la elección de alimentos. Lo que realmente determinará estas elecciones son: el período, las fiestas y los orixás de En este artículo, el objetivo es tratar la celebración del Olubajé a partir de una experiencia vivida en un terreiro de Candomblé de la Región de Desarrollo Integrado del Distrito Federal y Alrededores – Ride-DF. La metodología sigue el camino del abordaje etnográfico y propone articular el concepto de donación del antropólogo Marcel Mauss a la fiesta de Olubaje en el Candomblé del Distrito Federal, como resultado de nuestra investigación de campo de terreiros. En el terreiro vivido en la fiesta del Olubaje, abunda la comida que se ofrece gratuitamente a todos los presentes, subvirtiendo la noción consumista y utilitaria del capitalismo actual. También se advierte que dentro del terreiro en tiempos de Olubaje, el Orisha que gobierna la casa no necesariamente interfiere en la elección de alimentos. Lo que realmente determinará estas elecciones son: el período, las fiestas y los orixás de cada persona. Esto se presta aún más a la explicación conceptual de la entrega comunitaria sin intenciones egoístas.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Candomblé</dcterms:subject>
   <dcterms:subject language="pt-BR">Olubajé</dcterms:subject>
   <dcterms:subject language="pt-BR">Comida de santo</dcterms:subject>
   <dcterms:subject language="pt-BR">Práticas comunais</dcterms:subject>
   <dcterms:subject language="es">Holy food</dcterms:subject>
   <dcterms:subject language="es">Communal practices</dcterms:subject>
   <dcterms:subject language="pt-BR">Religião</dcterms:subject>
   <dcterms:subject language="pt-BR">Alimentos e Bebidas</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/60085</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Rocha, Fábio Libório</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/8235</identifier><datestamp>2026-10-20T13:49:18Z</datestamp><setSpec>com_icict_78995</setSpec><setSpec>com_icict_3808</setSpec><setSpec>col_icict_78997</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>doctoral thesis</dcterms:type>
   <dcterms:title language="pt-BR">Identificação, resistência a antimicrobianos e caracterização molecular de Enterococcus isolados de alimentos</dcterms:title>
   <dcterms:alternative language="en">Identification, antimicrobial resistence and molecular characterization of Enterococcus isolated from food</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Os enterococos são patógenos com considerável capacidade de expressar resistência a vários antimicrobianos. Sua natureza ubiqüitária e resistência às condições ambientais adversas explicam sua habilidade para colonizar diferentes habitats e seu potencial para se disseminar com facilidade através da cadeia alimentar. No presente estudo avaliamos a distribuição das espécies e a susceptibilidade aos antimicrobianos entre enterococos isolados a partir de alimentos de origem animal (carne de frango e leite pasteurizado) obtidos de supermercados e feiras livres no Rio de Janeiro / RJ, Brasil. As seguintes espécies foram identificadas, entre 167 amostras isoladas obtidos de carne de frango e 127 obtidas de leite pasteurizado: E. faecalis (184 – 62,6%), E. casseliflavus (51 – 17,3%), E. durans (19 – 6,5%), E. gallinarum (9 – 3%), E. gilvus (7 – 2,4%), E. faecium 6 – 2%), E. hirae (4 – 1,4%) e E. sulfureus (3 – 1%). Os percentuais de resistência aos antimicrobianos entre os isolados foram: 32,1% à tetraciclina; 23,3% à eritromicina; 11,3% à estreptomicina; 0,7% ao cloranfenicol; 3,9% à gentamicina, 2,1% ao imipenem; 1,1% à norfloxacina; 0,7% à ciprofloxacina, nitrofurantoína e penicilina e 0,4% /à ampicilina. Resistência intermediária foi detectada em percentuais que variaram de 0,5% para a linezolida até 62% para a eritromicina. Nenhuma das amostras bacterianas apresentou resistência aos glicopeptídeos testados, vancomicina e teicoplanina. Resistência a níveis elevados de aminoglicosídeos foi observada em 13,1% dos isolados. Multirresistencia aos antimicrobianos foi observada nas espécies E. faecalis, E. casseliflavus, E. faecium, E. gallinarum, E. durans e E. gilvus. Entre os enterococos isolados de carne de frango e leite pasteurizado foi possível detectar a presença do gene ermB, responsável pela resistência à eritromicina entre E. faecalis, E. casseliflavus, E. gallinarum e E. durans. Os genes tetL, tetM e tetO, foram detectados nas espécies E. faecalis, E. casseliflavus e E. gallinarum isoladas a partir carne de frango. A diversidade genética de E. faecalis (54 isolados) apresentando características de multirresistencia aos antimicrobianos, procedentes de carne de frango e de leite pasteurizado foi avaliada através da análise dos perfis de fragmentação do DNA cromossômico utilizando a endonuclease de restrição SmaI e eletroforese em campo pulsado (PFGE). Foi detectado um número elevado (39) de diferentes perfis de fragmentação do DNA cromossômico. Deste total, a maioria (30) foi constituída por apenas um isolado, revelando um elevada diversidade genética.</dcterms:abstract>
   <dcterms:abstract language="en">The enterococci are important nosocomial pathogens with a remarkable capacity of expressing resistance to several antimicrobial agents. Their ubiquitous nature and resistance to adverse environmental conditions take account for their ability to colonize different habitats and for their potential for easy spreading through the food chain. In the present study we evaluated the distribution of species and antimicrobial susceptibility among enterococcal isolates recovered from food obtained in retail stores in Rio de Janeiro, Brazil. The following species were identified among 167 isolates obtained from poultry meat and 127 from pasteurized milk: Enterococcus faecalis (62.6%), Enterococcus casseliflavus (17.3%), Enterococcus durans (6.5%), Enterococcus gallinarum (3.0%), Enterococcus gilvus (2.4%), Enterococcus faecium (2.0%), Enterococcus hirae (1.4%), and Enterococcus sulfureus (1.0%). The overall percentages of antimicrobial resistant isolates were: 31.2 % to tetracycline, 23.8% to erythromycin, 11.3% to streptomycin, 4.3% to chloramphenicol, 3.9% to gentamicin, 1.4% to norfloxacin, 1.1% to imipenem, 0.7% to ciprofloxacin, nitrofurantoin, and penicillin and 0.4% to ampicillin. Intermediate resistance was detected in frequencies varying from 0.5% for linezolid to 58.2% for erythromycin. None of the isolates showed resistance to glycopeptides. High-level resistance to aminoglycosides was observed in 13.1% of the isolates. Multiresistance was observed in E. faecalis, E. casseliflavus, E. faecium, E. gallinarum, E. durans and E. gilvus. The presence of the gene ermB, coding for the resistance to erythromycin, was detected by PCR in E. faecalis, E. casseliflavus, E. gallinarum and E. durans. The presence of the genes tetL, tetM and tetO, associated with resistance to tetracycline, were detected by PCR, among E. faecalis, E. casseliflavus, and E. gallinarum isolatede from poultry meat. The genetic diversity among multiresistant E. faecalis (54 isolates) from poultry meat and pasteurized milk, was evaluated by the analysis of the cromossomic DNA fragmentation profile by PFGE after cleavage with SmaI by PFGE. A variety (39) of different cromossomic DNA fragmentation profile or clonal complexes was found among multiresistant E. faecalis from poultry meat and milk, indicating a high level of genetic diversity.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Resistência aos antimicrobianos</dcterms:subject>
   <dcterms:subject language="pt-BR">Enterococcus</dcterms:subject>
   <dcterms:subject language="pt-BR">Modelos Moleculares</dcterms:subject>
   <dcterms:subject language="pt-BR">Testes de Sensibilidade a Antimicrobianos por Disco-Difusão</dcterms:subject>
   <dcterms:subject language="pt-BR">Genes MDR</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/8235</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Vigilância Sanitária</capes:hasProgram>
   <capes:programCode>31010016007P8</capes:programCode>
   <bibo:numPages>176</bibo:numPages>
   <capes:defenseDate>2007-11-28</capes:defenseDate>
   <creator>
      <dcterms:creator>Fracalanzza, Suely Aparecida Pimenta</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Teixeira, Lúcia Martins</capes:advisor>
   </advisor>
   <advisor>
      <capes:advisor>Leite, Paola Cardarelli</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Mondino, Silvia Susana Bona de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Andrade, João Ramos Costa</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Leite, Paola Cardarelli</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/69040</identifier><datestamp>2026-07-24T18:50:23Z</datestamp><setSpec>com_icict_68607</setSpec><setSpec>com_icict_17640</setSpec><setSpec>com_icict_7119</setSpec><setSpec>col_icict_68608</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Establishment of anthocyanin-producing habituated callus cultures of Tarenaya rosea (Vahl ex DC.) Soares Neto &amp;amp; Roalson</dcterms:title>
   <dcterms:abstract language="en">A growth regulators-free anthocyanin-producing habituated callus line of Tarenaya rosea was establishment through the selective subculture of cell aggregates from a 2,4-D-dependent anthocyanin callus line to a growth regulators-free MS medium (MS0). After the establishment of the habituated line, new culture conditions were evaluated in order to increase de pigment production. Calluses were transferred to MS0 containing different sucrose concentration (30; 50; 70; 90 g.L-1), total nitrogen concentration (50; 60; 70 mM), NH4+ to NO3 - ratio (1:1; 1:2; 1:4; 1:6), and total mineral salt concentration (MS; MS1/2; MS1/4). The most suitable culture conditions to pigment induction have combined to create two new culture formulations, named M1 (70 mM total nitrogen + 70 g.L-1 sucrose) and M2 (1:4 NH4 +:NO3 - ratio + 70 g.L-1 sucrose). Calluses cultivated on M1 and M2 reached an increase on anthocyanin productivity of 3- and 4-fold, respectively, when compared to cultures maintained in standard MS0 medium. The present work demonstrated the feasibility of eliminating the supplementation with 2,4-D in callus cultures of T. rosea without the loss of anthocyanin production. Moreover, the manipulation of basal medium and sucrose concentration contributed with the increment in anthocyanin content.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/69040</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Simões-Gurgel, Claudia</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cordeiro, Lívia da Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Castro, Tatiana Carvalho de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Albarello, Norma</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/13543</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Impact of reduced levels of APE1 transcripts on the survival of patients with urothelial carcinoma of the bladder</dcterms:title>
   <dcterms:abstract language="en">Abstract Molecular evidence indicates that alterations in genes involved in the maintenance of genome stability may be related to susceptibility to bladder carcinoma. Our goal was to evaluate the prognostic role of base excision repair (BER) genes in a cohort of patients diagnosed with primary urothelial carcinoma of the bladder (UCB). The levels of all APE1, XRCC1 and POLB transcripts were detected by quantitative real-time PCR (qPCR) technique in tumor samples from 52 patients undergoing transurethral resection (TUR) for primary UCB at the Department of Urology, Brazilian National Cancer Institute, Rio de Janeiro. Increased levels of APE1, XRCC1 and POLB transcripts were significantly associated with high-grade tumors when compared to these levels in low-grade tumors (p&amp;lt;0.01) and could be attributed to different mechanisms of transcriptional regulation as a response to tumorigenesis and oxidative stress. By analyzing the collected data in the present study, regardless of pathological grade or stage, univariate analysis revealed that the reduced levels of APE1 transcripts were significantly associated with cancer-specific mortality (p=0.032). Furthermore, the variant genotype (TG/GG) of the APE1 T1349G polymorphism was observed in 75% of a subset of patients who concomitantly experienced reduced levels of the APE1 transcript and death and/or recurrence events. Taken together, our data reinforce the idea that human DNA repair mechanisms must be finely regulated in order to avoid instability leading to tumorigenesis and poor clinical outcomes in UCB patients.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Bexiga Urinária</dcterms:subject>
   <dcterms:subject language="pt-BR">Neoplasias</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/13543</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Justino, Mariana Chantre</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alves, Gilda</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Britto, Constança</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cardoso, Angélica</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Scherrer, Luciano</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Moreira, Aline dos Santos</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Quirino, Raul</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ornellas, Antonio</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Leitão, Alvaro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lage, Claudia</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/72493</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_3808</setSpec><setSpec>col_icict_11332</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="pt-BR">Verificação da penetrabilidade de nanopartículas poliméricas contendo Anfotericina B em larvas de zebrafish (Danio rerio)</dcterms:title>
   <dcterms:abstract language="pt-BR">A Anfotericina B (AmB) é um fármaco utilizado para o tratamento de diversas infecções fúngicas, assim como outras condições, como a leishmaniose. Esse é utilizada por via intravenosa pois apresenta baixíssima biodisponibilidade oral. Ademais, é um fármaco que apresenta diversos efeitos adversos, sendo o mais grave deles a nefrotoxicidade. Assim, diversos são os trabalhos que buscam uma melhora desse efeito adverso, além de uma administração por via oral desse fármaco. Grande parte dele utiliza nanopartículas para esse fim. Desta forma, buscou-se utilizar o modelo animal zebrafish (Danio rerio) para determinar a penetrabilidade de nanopartículas poliméricas (NPPs) de poli (D,L-ácido lático) (PLA) e policaprolactona (PCL) contendo AmB, desenvolvidas na tentativa de obter uma formulação capaz de aumentar a biodisponibilidade oral e diminuir os efeitos colaterais desse fármaco. Objetivo: Avaliar a penetrabilidade da AmB encapsulada em larvas de zebrafish, após a exposição ao fármaco. Metodologia: A fim de verificar a internalização da Anfotericina B encapsulada e também a Anfotericina B livre em larvas de zebrafish após 120 horas de tratamento com PCL+AmB, PLA+AmB ou AmB FL e sabendo que AmB é capaz de emitir fluorescência na região de 560 nm, utilizou-se um microscópio de fluorescência (Nikon, TS100-F, Japão), com o filtro FITC (Excitação 475 nm; emissão 530nm) aplicado para identificar se as larvas após a exposição ao fármaco encapsulado emitiriam fluorescência acima do nível basal. Resultados e Discussão: Pode-se perceber que a intensidade de fluorescência aumentou para as larvas testadas com ambas as nanopartículas contendo Amb, principalmente na região caudal dos animais e especialmente nas larvas submetidas a PLA+Amb, dito que nas mesmas concentrações pode-se perceber que os modelos animais apresentaram maior intensidade de luminosidade. Conclusão: Foi possível concluir que a Anfotericina B encapsulada apresentou maior capacidade de penetrar no corpo das larvas de zebrafish, nas concentrações estudadas, o que sugere a possibilidade do uso das NPPs utilizadas em formulações tópicas. Entretanto, pode-se perceber que o encapsulamento também causou aumento da toxicidade, fazendo-se necessário estudos sobre a dose a ser utilizada.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Zebrafish</dcterms:subject>
   <dcterms:subject language="pt-BR">Anfotericina B</dcterms:subject>
   <dcterms:subject language="pt-BR">Nanopartículas Poliméricas</dcterms:subject>
   <dcterms:subject language="pt-BR">Peixe-Zebra</dcterms:subject>
   <dcterms:subject language="pt-BR">Nanopartículas</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/72493</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <dcterms:relation>https://arca.fiocruz.br/handle/icict/72378</dcterms:relation>
   <creator>
      <dcterms:creator>Carvalho, Luiza Figueiredo de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Paula, Damarys Victórya Santos de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Medeiros, Renata Jurema</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Maciel-Magalhães, Magno</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/52293</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_5491</setSpec><setSpec>col_icict_7327</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="en">Physicochemical and stability evaluation of functionalized polymeric nanoparticles for potential drug delivery</dcterms:title>
   <dcterms:subject language="pt-BR">Nanopartículas</dcterms:subject>
   <dcterms:subject language="pt-BR">Funcionalidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Entrega de drogas</dcterms:subject>
   <dcterms:subject language="pt-BR">Efeito Corona de Proteína</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/52293</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Pereira, Kaique Alves Brayner</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gonçalves, Vinícius de Lima</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Premazzi, Melissa Chamon Alves</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Jurgilas, Patrícia Barbosa</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bastos, Renata Chagas</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/28421</identifier><datestamp>2026-10-19T21:52:27Z</datestamp><setSpec>com_icict_3802</setSpec><setSpec>col_icict_9180</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Cutaneous and visceral leishmaniasis in dogs from a rural community in northeastern Brazil</dcterms:title>
   <dcterms:abstract language="en">A community-based epidemiological study was carried out in a rural area in northeastern Brazil, where visceral leishmaniasis is endemic, but the primary vector Lutzomyia longipalpis has never been found. Forty-one dogs were screened by an indirect immunofluorescence antibody test (IFAT) for the presence of anti-Leishmania antibodies and 12 (29.3%) of them were positive. One of the IFAT-positive dogs was also positive for Leishmania amastigotes in bone marrow cytology and for Leishmania infantum by real-time polymerase chain reaction (PCR) on blood. One IFAT-negative dog was positive for L. infantum by PCR on bone marrow and other for Leishmania amastigotes in skin stained-smears. When tested for L. braziliensis by PCR, 20 dogs were positive. Considering all diagnostic tests, the estimated prevalence of Leishmania spp. infection in the studied rural dog population was 58.5%. There was no significant difference in IFAT-positivity in relation to age, gender, and clinical status of the dogs. When tested for L. infantum by real-time PCR, 20 ticks collected from IFAT-positive dogs were all negative. This study shows a high level of exposure to Leishmania spp. infection in dogs from a rural community in northeastern Brazil. In general, the results do not support the participation of ticks as vectors of L. infantum in this area, which is likely to be transmitted by Lutzomyia spp. other than L. longipalpis. Finally, this study highlights that the use of IFAT in areas where both L. infantum and L. braziliensis are present should be withdraw in order to avoid the unnecessary culling of dogs that are actually infected only by L. braziliensis.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Cães</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmania braziliensis</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmania infantum</dcterms:subject>
   <dcterms:subject language="pt-BR">Carrapatos</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">Animais</dcterms:subject>
   <dcterms:subject language="pt-BR">Doenças do Cão</dcterms:subject>
   <dcterms:subject language="pt-BR">Técnica Indireta de Fluorescência para Anticorpo</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmaniose Cutânea</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmaniose Visceral</dcterms:subject>
   <dcterms:subject language="pt-BR">Reação em Cadeia da Polimerase</dcterms:subject>
   <dcterms:subject language="pt-BR">Prevalência</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/28421</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Dantas-Torres, Filipe</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Paiva-Cavalcanti, Milena de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Figueredo, Luciana A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Melo, Marcela F.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Fernando J. da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Amílton L. da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Almeida, Ericka L.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Brandão-Filho, Sinval P.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/76108</identifier><datestamp>2026-10-20T13:05:44Z</datestamp><setSpec>com_icict_1744</setSpec><setSpec>col_icict_9324</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Letramento em saúde e autoeficácia na qualidade de vida de pessoas em tratamento oncológico em um centro especializado em salvador - Bahia</dcterms:title>
   <dcterms:alternative language="en">Health literacy and self-efficacy in the quality of life of people undergoing cancer treatment at a specialized center in Salvador, Bahia</dcterms:alternative>
   <dcterms:abstract language="pt-BR">INTRODUÇÃO: O letramento em saúde e a autoeficácia são variáveis centrais na compreensão de como pacientes oncológicos interpretam e utilizam as informações em saúde, e sua capacidade de tomar decisões a partir delas, podendo influenciar na sua qualidade de vida. OBJETIVO: Avaliar a associação entre letramento em saúde e autoeficácia com a qualidade de vida de pacientes oncológicos. METODOLOGIA: Estudo transversal realizado entre setembro e dezembro de 2024 com pacientes em tratamento antineoplásico endovenoso em um centro oncológico de Salvador (BA). A coleta de dados utilizou quatro instrumentos: questionário sociodemográfico e clínico, S-TOFHLA (letramento em saúde), Escala Geral de Autoeficácia e EORTC QLQ-C30 (qualidade de vida). Foram analisadas as correlações de Spearman, e associações entre as variáveis independentes (letramento, autoeficácia, dados sociodemográficos e clínicos) e a qualidade de vida, por meio de razão de prevalência, qui-quadrado e regressão linear múltipla, com nível de significância de p &amp;lt; 0,05. RESULTADOS: Foram incluídos 143 pacientes, com média de idade de 57,7 anos, sendo 79% do sexo feminino. A maioria autodeclarou-se parda ou preta (62%) e possuía ensino superior (53%) ou pós-graduação (43%). Os tipos de câncer mais prevalentes foram o de mama (60%) e do trato gastrointestinal (19%), predominando os estágios localmente avançado e metastático. Os participantes apresentaram níveis satisfatórios de qualidade de vida, autoeficácia e letramento funcional em saúde. Contudo, a análise de correlação bivariada não identificou associações estatisticamente significativas entre essas três variáveis. Na análise de regressão, observou-se que maiores níveis de dor (p &amp;lt; 0,001) e fadiga (p = 0,032) impactaram negativamente na qualidade de vida, indicando que maiores escores desses sintomas se associam a uma pior percepção de bem-estar. Em contrapartida, a autoeficácia (p = 0,018) apresentou associação positiva e significativa com a qualidade de vida, evidenciando seu efeito protetor frente aos impactos físicos e emocionais do tratamento oncológico. CONCLUSÃO: A qualidade de vida de pacientes oncológicos resulta da interação entre aspectos físicos, psicológicos e contextuais. Embora não tenha havido correlação direta entre letramento, autoeficácia e qualidade de vida, observou-se que a autoeficácia tem papel protetor, contribuindo para o enfrentamento dos sintomas, especialmente dor e fadiga e para a manutenção do bem-estar emocional.</dcterms:abstract>
   <dcterms:abstract language="en">INTRODUCTION: Health literacy and self-efficacy are central variables in understanding how cancer patients interpret and use health information, and their ability to make decisions based on it, which can influence their quality of life. OBJECTIVE: To evaluate the relationship between health literacy and self-efficacy and the quality of life of cancer patients. METHODOLOGY: A cross-sectional study was conducted between September and December 2024 with patients undergoing intravenous antineoplastic treatment at a cancer center in Salvador, Bahia. Data collection used four instruments: a sociodemographic and clinical questionnaire, S-TOFHLA (health literacy), the General Self-Efficacy Scale, and the EORTC QLQ-C30 (quality of life). The associations between independent variables (literacy, self-efficacy, sociodemographic and clinical data) and quality of life were analyzed using odds ratios and multiple linear regression, with a significance level of p &amp;lt; 0.05. RESULTS: A total of 143 patients were included, with a mean age of 57.7 years, 79% of whom were female. The majority self-identified as brown or black (62%) and had higher education (53%) or postgraduate degrees (43%). The most prevalent types of cancer were breast (60%) and gastrointestinal tract (19%), with locally advanced and metastatic stages predominating. Participants had satisfactory levels of quality of life, self-efficacy, and functional health literacy. However, bivariate correlation analysis did not identify statistically significant associations between these three variables. In the regression analysis, it was observed that higher levels of pain (B = -0.22; p &amp;lt; 0.001) and fatigue (B = -0.09; p = 0.032) negatively impacted quality of life, indicating that the increase in these symptoms is related to a worse perception of well-being. In contrast, self-efficacy (B = 5.36; p = 0.018) showed a positive and significant association with quality of life, demonstrating its protective effect against the physical and emotional impacts of cancer treatment. CONCLUSION: The quality of life of cancer patients results from the interaction between physical, psychological, and contextual factors. Although there was no direct correlation between literacy, self-efficacy, and quality of life, it was observed that self-efficacy plays a protective role, contributing to coping with symptoms.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Letramento em saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Câncer</dcterms:subject>
   <dcterms:subject language="pt-BR">Autoeficácia</dcterms:subject>
   <dcterms:subject language="pt-BR">Qualidade de vida</dcterms:subject>
   <dcterms:subject language="en">Health literacy</dcterms:subject>
   <dcterms:subject language="en">Cancer</dcterms:subject>
   <dcterms:subject language="en">Self-efficacy</dcterms:subject>
   <dcterms:subject language="en">Quality of life.</dcterms:subject>
   <dcterms:subject language="pt-BR">Literacia para a Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Neoplasias</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/76108</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Pesquisa Clínica e Translacional</capes:hasProgram>
   <bibo:numPages>110</bibo:numPages>
   <capes:defenseDate>2025</capes:defenseDate>
   <creator>
      <dcterms:creator>Santos, Janaina Arcanjo Santos e</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Fraga, Deborah Bittencourt Mothé</capes:advisor>
   </advisor>
   <coAdvisor>
      <capes:coAdvisor>Amaral, Juliana Bezerra do</capes:coAdvisor>
   </coAdvisor>
   <committeeMember>
      <capes:committeeMember>Silva, Valéria Costa da</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Veras, Patricia Sampaio Tavares</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/60754</identifier><datestamp>2026-10-19T21:52:27Z</datestamp><setSpec>com_icict_1744</setSpec><setSpec>col_icict_57384</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Imunologia no diagnóstico, patogênese, tratamento e prevenção pelas vacinas para a covid-19</dcterms:title>
   <dcterms:alternative language="es">Inmunología en el diagnóstico, patogénesis, tratamiento y prevención por las vacunas contra el COVID-19</dcterms:alternative>
   <dcterms:alternative language="en">Immunology in diagnosis, pathogenesis, treatment and prevention by vaccines for COVID-19</dcterms:alternative>
   <dcterms:abstract language="pt-BR">A pandemia de covid-19 causada pelo SARS-CoV-2 destacou os riscos cada vez mais frequentes das mudanças significativas na Terra. Tanto o aquecimento global, por alterar os ecossistemas, quanto o aumento da mobilidade, promovendo o contato rápido e regular entre as populações em diferentes regiões, estão implicados no surgimento de surtos epidêmicos e pandemias. Ao longo deste evento, a ciência desempenhou um papel proeminente, evidente em vários campos. A biologia promoveu o rápido conhecimento sobre o SARS-CoV-2 e a epidemiologia, ao estudar os padrões de transmissão do vírus e na disseminação da infecção. A matemática e a física contribuíram para a elaboração de modelos para prever a evolução da doença e o impacto das medidas não farmacológicas de contenção, e.g. Em múltiplas especialidades, as ciências da saúde como medicina, fisioterapia e enfermagem também estiveram em evidência. Neste texto, destacamos a contribuição da imunologia por meio de seu papel no campo do diagnóstico, na compreensão dos mecanismos da doença, que levam a métodos de tratamento mais eficazes, e no desenvolvimento de vacinas capazes de proteger contra o mencionado vírus.</dcterms:abstract>
   <dcterms:abstract language="en">The COVID-19 pandemic, caused by SARS-CoV-2, highlighted the risks, more and more frequently, from the significant changes on Earth. Global warming, which alters ecosystems, and increased mobility by promoting rapid and regular contact between populations in different regions, are implicated in the emergence of epidemic outbreaks and pandemics. Throughout the COVID-19 pandemic, science played a prominent role. The role of science has been very much in evidence in several fields. In biology, it promoted the rapid knowledge of SARS-CoV-2, in epidemiology, by studying patterns of virus transmission and spread of infection. Mathematics and physics contributed to the elaboration of models to predict the evolution of the disease and the impact of non-pharmacological measures of containment, e.g. In multiple specialties, the health sciences such as medicine, physiotherapy, and nursing, among others, were in evidence. In this text, we highlight the contribution of immunology through its role in the fields of diagnosis, understanding the mechanisms of disease, which lead to more efficient treatment methods, and the development of vaccines capable of protecting against COVID-19.</dcterms:abstract>
   <dcterms:abstract language="es">La pandemia de COVID-19, causada por el SARS-CoV-2, puso de relieve los riesgos, cada vez más frecuentes, de los cambios significativos en la Tierra. Tanto el calentamiento global, al alterar los ecosistemas, como el aumento de la movilidad, promoviendo un contacto rápido y regular entre poblaciones de diferentes regiones, están implicados en la aparición de brotes epidémicos y pandemias. Durante la pandemia de COVID-19, la ciencia jugó un papel destacado en varios campos. La biología permitió el rápido conocimiento del SARS-CoV-2 y la epidemiología el estudio de los patrones de transmisión de virus y propagación de la infección. Las matemáticas y la física aportaron la elaboración de modelos para predecir la evolución de la enfermedad y el impacto de las medidas de contención no farmacológicas, e. g. Las múltiples especialidades de las ciencias de la salud, como la medicina, la fisioterapia, o la enfermería, entre otras, también desempeñaron un papel evidente. En este texto, destacamos la contribución de la inmunología a través de su papel en los campos del diagnóstico, la comprensión de los mecanismos de la enfermedad, que conducen a métodos de tratamiento más eficientes, y el desarrollo de vacunas capaces de proteger contra el COVID-19.</dcterms:abstract>
   <dcterms:subject language="pt-BR">COVID-19</dcterms:subject>
   <dcterms:subject language="pt-BR">SARS-CoV-2</dcterms:subject>
   <dcterms:subject language="pt-BR">Imunologia</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="es">Inmunología</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/60754</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Barral, Aldina</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Barral Netto, Manoel</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/16664</identifier><datestamp>2026-10-20T21:43:31Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Kanagawa-negative, tdh- and trh-positive Vibrio parahaemolyticus isolated from fresh oysters marketed in Fortaleza, Brazil</dcterms:title>
   <dcterms:abstract language="en">Between October 2008 and June 2009, 15 samples of 10 live oysters each (Crassostrea rhizophorae) measuring 8.31-10.71 cm were purchased from a restaurant on the seashore of Fortaleza, Brazil. The Vibrio count ranged from 75 (estimated) to 43,500 CFU/g. Fourteen species were identified among the 56 isolated Vibrio strains, with V. parahaemolyticus as the most prevalent. Two of the 17 V. parahaemolyticus strains were urease-positive and tdh- and trh-positive on multiplex PCR, but neither produced β-hemolysis halos in Wagatsuma agar. Thus, fresh oysters served in natura in Fortaleza, Brazil, were found to contain Vibrio strains known to cause gastroenteritis in humans.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Vibrio parahaemolyticus</dcterms:subject>
   <dcterms:subject language="pt-BR">Fresh Oysters</dcterms:subject>
   <dcterms:subject language="pt-BR">Fortaleza</dcterms:subject>
   <dcterms:subject language="pt-BR">Comércio</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/16664</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Vieira, Regine H. S. F.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Costa, Renata A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Menezes, Francisca G. R.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Giselle C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Theophilo, Grace N. D.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rodrigues, Dália P.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Maggioni, Rodrigo</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/72361</identifier><datestamp>2026-10-19T21:52:27Z</datestamp><setSpec>com_icict_1745</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1747</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Genomic characterization, origin, and local transmission of Oropouche virus in Bolivia in 2024</dcterms:title>
   <dcterms:abstract language="en">Background: The Oropouche virus (OROV) is an arthropod-borne virus that causes an acute febrile illness, like other arboviral diseases. In 2024, Oropouche cases sharply increased in several countries of the Americas, including Bolivia. Here, we investigate the origin and spread of OROV in the Bolivian Amazon region. Methods: Full-length OROV genomes from 34 positive samples collected in the three affected Bolivian departments during the 2024 outbreak were sequenced using an amplicon-based approach. Maximum Likelihood (ML) phylogenetic analyses of separate viral segments were conducted to identify the responsible viral lineage. Bayesian phylogeographic analysis of concatenated viral segments was used to reconstruct the viral spatiotemporal dispersion pattern within the country. Findings: The first Oropouche cases in Bolivia 2024 were reported using samples collected from the Pando department during mid-January, and the peak of Oropouche cases occurred in mid-April. The phylogenetic analysis of OROV genomes revealed that all cases detected in Bolivia belong to the novel reassortant OROV clade that drove the recent epidemic in Brazil. Our phylogeographic analysis detected at least two exportation events from the Brazilian state of Acre to the Bolivian municipalities of Guayaramerín and Riberalta, both located in the Beni department, with subsequent dissemination to municipalities of Pando and La Paz departments. Viral introductions likely occurred between early October and early November 2023, indicating a lag of approximately three months between the introduction of OROV and its detection. Interpretation: Our findings confirm that OROV spread at least twice from the western Brazilian Amazon to the neighboring Bolivian department of Beni in late 2023, successfully establishing regional transmission chains. These findings underscore the critical need for active OROV surveillance across the border Amazonian region between Brazil and Bolivia. They also confirm the potential for sustained OROV transmission within the Bolivian Amazon, highlighting the importance of preparedness for future outbreaks.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Infecções por Bunyaviridae</dcterms:subject>
   <dcterms:subject language="pt-BR">Bolívia</dcterms:subject>
   <dcterms:subject language="pt-BR">Patologia Molecular</dcterms:subject>
   <dcterms:subject language="pt-BR">Filogenia</dcterms:subject>
   <dcterms:subject language="pt-BR">Filogeografia</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/72361</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Chuquimia Valdez, Joel Alejandro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gomes, Ighor Leonardo Arantes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sasías Martínez, Sebastián</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Orellana Mendoza, Cleidy</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mendoza Loayza, Nelly</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Marquina, Jhonatan D.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Castillo Laura, Helen</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Salamanca Kacic, Roxana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Espinoza Morales, Maya Xochitl</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gresh, Lionel</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martínez Gómez, Mariela</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Leite, Juliana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Franco, Leticia</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Méndez-Rico, Jairo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bello Bentancor, Gonzalo José</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Naveca, Felipe Gomes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Loayza Mafayle, Leidy Roxana</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/38808</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_13663</setSpec><setSpec>col_icict_28777</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="pt-BR">Ouvidoria ativa em saúde na Rede Cegonha do Distrito Federal</dcterms:title>
   <dcterms:abstract language="pt-BR">Introdução: A Rede Cegonha (RC) é composta por um conjunto de medidas que visa garantir às mulheres usuárias do SUS atendimento adequado, seguro e humanizado, desde a confirmação da gravidez, atenção ao pré-natal, parto, puerpério, incluindo a saúde da criança até dois anos de idade. Foi criada pela portaria 1.459/2011, do Ministério da Saúde. Em 2011, na Secretaria de Estado de Saúde do Distrito Federal (SES/DF), formou-se o Grupo Condutor que elaborou um Plano de Ação para implementação da RC no DF. A Ouvidoria Ativa em Saúde (OAS) é um conceito inovador que objetiva defender os direitos do usuário do Sistema Único de Saúde (SUS) e atuar como um instrumento de avaliação da gestão pública, mediante a promoção do exercício da democracia direta e de pesquisas sobre a satisfação do usuário. Objetivos: Avaliar a qualidade dos serviços prestados pela RC, sob a perspectiva da mulher usuária cujo parto ocorreu em maternidades públicas do DF. Metodologia: Estudo transversal, tipo inquérito, realizado por via telefônica, pela equipe da Ouvidoria da SES/DF. No período estudado (15/10/2013 a 19/11/2013), foram realizados 3.750 partos nas 12 maternidades da SES/DF. Foram entrevistadas 1007 puérperas (26,8%). O questionário, constituído de 26 questões fechadas, do tipo múltipla escolha ou Likert, incluiu os seguintes itens: 1. Dados sociodemográficos; 2. Assistência materno-infantil; 3. Acesso aos serviços; 4. Relação com os profissionais de saúde; e, 5. Infraestrutura. Resultados: A faixa etária mais frequente foi 25-29 anos (26,3%, N=265/1007). O local de residência era o DF em 69,7% (N=702/1007). 74,2% fizeram acompanhamento pré-natal exclusivo no DF (N=748/1007) e 22,4% totalmente fora do DF (N= 226/1007). Apenas 0,2% não realizaram acompanhamento pré-natal (N=2/1007) e 67,8% realizaram 6 ou mais consultas de pré-natal (N=683/1007). Entre as que realizaram acompanhamento pré-natal exclusivo no DF, o acesso a consultas foi avaliado como bom/ótimo em 86,1% (N=644/748) e a exames laboratoriais como bom/ótimo em 85,2% (N=637/748). Acesso aos exames de imagem teve pior desempenho com 45,7% (N= 342/748) de avaliações boas/ótimas. 79,5% das entrevistadas realizaram o parto na maternidade onde buscaram atendimento inicial (N=801/1007). Somente 18,3% haviam recebido visita domiciliar por agente comunitário de saúde após a alta (N=184/1007). A maioria relatou que os recém-nascidos foram colocados em seus colos ou peitos imediatamente após o nascimento (69,0%, N=695/1007). Porém, somente 48,9% tiveram presença de acompanhante no momento do parto (N=492/1007). 76,3% foram informadas pela equipe de saúde em relação a data e Centro de Saúde no qual deveriam levar o recém-nascido para a 1a consulta (N=768/1007) e 94,8% receberam orientação para prática do aleitamento materno ainda na maternidade (N=955/1007). Quanto a avaliação do relacionamento com os profissionais de saúde, 85,9% (N= 865/1007) consideraram acolhimento e cordialidade recebidos durante o pré-natal como bom/ótimo e 94,8% (N=955/1007) classificaram a qualidade do atendimento recebido na maternidade como bom/ótimo. Conclusão: Este trabalho de OAS funcionou como um dispositivo inovador para avaliação da qualidade da gestão pública, pois viabilizou a incorporação da perspectiva da mulher usuária nos processos decisórios para a melhoria dos serviços de saúde da Rede Cegonha no DF.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Atendimento à gestante</dcterms:subject>
   <dcterms:subject language="pt-BR">Direito à saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Gestantes</dcterms:subject>
   <dcterms:subject language="pt-BR">Humanização da Assistência</dcterms:subject>
   <dcterms:subject language="pt-BR">Serviços de Saúde Materno-Infantil</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/38808</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Almeida, Karlo Jozefo Quadros de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Roure, Francis Nakle de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gottems, Leila Bernarda Donato</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bittencourt, Roberto José</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santos, Regina Maria Dias Buani dos</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bittencourt, Fernanda Viana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Amorim, Fábio Ferreira</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/22740</identifier><datestamp>2026-10-17T19:19:45Z</datestamp><setSpec>com_icict_18439</setSpec><setSpec>com_icict_16930</setSpec><setSpec>com_123456789_1</setSpec><setSpec>col_icict_22725</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Mulheres na atenção primária à saúde: exercício físico, estilo de vida e fatores de risco cardiovascular</dcterms:title>
   <dcterms:alternative language="es">Mujeres en la atención primaria de salud: ejercicio corporal, estilo de vida y factores de riesgo cardiovascular</dcterms:alternative>
   <dcterms:alternative language="en">Women in primary health care: physical exercise, lifestyle and cardiovascular risk factors</dcterms:alternative>
   <dcterms:abstract language="pt-BR">As doenças do estilo de vida estão relacionadas a hábitos inadequados. Programas de exercícios físicos podem reduzir o risco de tê-las. Com o objetivo de avaliar os efeitos de dois programas produziriam em diversos parâmetros de saúde de mulheres atendidas em uma Unidade Básica de Saúde, 54 delas, de 40 a 80 anos de idade, foram dispostas em dois grupos: G1 (n=26) para realizar o programa padrão (caminhada) e G2 (n=28) para exercitar o programa alternativo (calistenia + caminhada). As sessões de 50 minutos ocorreram quatro vezes/semana, durante 16 semanas. As participantes de G1 e G2 exibiram redução (p&amp;lt;0,05) do peso, do índice de massa corporal, do percentual de gordura e da pressão arterial, além de aumento da velocidade e do consumo de oxigênio. G1 apresentou redução da pressão arterial diastólica, aumento da capacidade vital forçada e redução do colesterol. G2 exibiu redução do colesterol total, triglicerídeos e VLDL. Concluiuse que, apesar dos resultados do programa do G2 terem sido superiores, os dois programas ocasionaram resultados positivos semelhantes. Entretanto, não reduziram risco cardiovascular.</dcterms:abstract>
   <dcterms:abstract language="pt-BR">As doenças do estilo de vida estão relacionadas a hábitos inadequados. Programas de exercícios físicos podem reduzir o risco de tê-las. Com o objetivo de avaliar os efeitos de dois programas produziriam em diversos parâmetros de saúde de mulheres atendidas em uma Unidade Básica de Saúde, 54 delas, de 40 a 80 anos de idade, foram dispostas em dois grupos: G1 (n=26) para realizar o programa padrão (caminhada) e G2 (n=28) para exercitar o programa alternativo (calistenia + caminhada). As sessões de 50 minutos ocorreram quatro vezes/semana, durante 16 semanas. As participantes de G1 e G2 exibiram redução (p&amp;lt;0,05) do peso, do índice de massa corporal, do percentual de gordura e da pressão arterial, além de aumento da velocidade e do consumo de oxigênio. G1 apresentou redução da pressão arterial diastólica, aumento da capacidade vital forçada e redução do colesterol. G2 exibiu redução do colesterol total, triglicerídeos e VLDL. Concluiu-se que, apesar dos resultados do programa do G2 terem sido superiores, os dois programas ocasionaram resultados positivos semelhantes. Entretanto, não reduziram risco cardiovascular.</dcterms:abstract>
   <dcterms:abstract language="en">Lifestyle disorders are related to inappropriate habits. Exercise programs can reduce the risk of to be affected by them. To evaluate and compare the effects of two programs on some of the parameters that determine the health of women attended at a Unidade Básica de Saúde (community health center), 54 women aged from 40 to 80 were grouped together into two groups: G1 (n = 26) to exercise the standard program (walking) and G2 (n = 28) to do the exercises of an alternative program (calisthenics + walking). The sessions for sixty minutes occurred four times a week for 16 weeks. The G1 and G2 participants exhibited loses (p &amp;lt;0.05) weight, reduced their body mass index, body fat percentage and blood pressure, as well as higher speed and higher oxygen consumption. G1 exhibited reduced diastolic blood pressure, increased forced vital capacity, and reduced cholesterol. G2 showed reduction of the total cholesterol level, the triglycerides levels and the VLDL. Our conclusion is that the programs showed similar positive results, in spite of superiority of the results presented by G2. However, they did not reduce cardiovascular risk.</dcterms:abstract>
   <dcterms:abstract language="en">Lifestyle disorders are related to inappropriate habits. Exercise programs can reduce the risk of to be affected by them. To evaluate and compare the effects of two programs on some of the parameters that determine the health of women attended at a Unidade Básica de Saúde (community health center), 54 women aged from 40 to 80 were grouped together into two groups: G1 (n = 26) to exercise the standard program (walking) and G2 (n = 28) to do the exercises of an alternative program (calisthenics + walking). The sessions for sixty minutes occurred four times a week for 16 weeks. The G1 and G2 participants exhibited loses (p &amp;amp;lt;0.05) weight, reduced their body mass index, body fat percentage and blood pressure, as well as higher speed and higher oxygen consumption. G1 exhibited reduced diastolic blood pressure, increased forced vital capacity, and reduced cholesterol. G2 showed reduction of the total cholesterol level, the triglycerides levels and the VLDL. Our conclusion is that the programs showed similar positive results, in spite of superiority of the results presented by G2. However, they did not reduce cardiovascular risk.</dcterms:abstract>
   <dcterms:abstract language="es">Las enfermedades del estilo de vida están relacionadas con costumbres inadecuados. Programas de ejercicios pueden reducir el riesgo de estas enfermedades. Con el objetivo de evaluar los efectos de dos programas sobre parámetros relacionados a la salud de mujeres atendidas en una Unidade Básica de Saúde (Unidad Básica de Salud), 54 de esas mujeres, de 40 a 80 años, fueron agrupadas en dos grupos: G1 (n=26) para ejercitar el programa estándar (caminata) y G2 (n=28) el programa alternativo (calistenia + caminata). Las sesiones de 60 minutos ocurrieron cuatro veces/semana, durante 16 semanas. Las mujeres participantes de G1 y G2 mostraron reducción (p&amp;lt;0,05) del peso, del índice de masa corporal, el porcentaje de grasa y de la presión arterial, además de aumento de la velocidad y consumo de oxígeno. G1 mostró reducción de la presión de la diástole, aumento de la capacidad vital forzada y reducción del colesterol. G2 mostró reducción del colesterol total, de los triglicéridos y del VLDL. Las conclusiones extraídas son que los programas mostraron resultados positivos similares, aunque los resultados superiores del G2, pero no redujeron el riesgo cardiovascular.</dcterms:abstract>
   <dcterms:abstract language="es">Las enfermedades del estilo de vida están relacionadas con costumbres inadecuados. Programas de ejercicios pueden reducir el riesgo de estas enfermedades. Con el objetivo de evaluar los efectos de dos programas sobre parámetros relacionados a la salud de mujeres atendidas en una Unidade Básica de Saúde (Unidad Básica de Salud), 54 de esas mujeres, de 40 a 80 años, fueron agrupadas en dos grupos: G1 (n=26) para ejercitar el programa estándar (caminata) y G2 (n=28) el programa alternativo (calistenia + caminata). Las sesiones de 60 minutos ocurrieron cuatro veces/semana, durante 16 semanas. Las mujeres participantes de G1 y G2 mostraron reducción (p&amp;amp;lt;0,05) del peso, del índice de masa corporal, el porcentaje de grasa y de la presión arterial, además de aumento de la velocidad y consumo de oxígeno. G1 mostró reducción de la presión de la diástole, aumento de la capacidad vital forzada y reducción del colesterol. G2 mostró reducción del colesterol total, de los triglicéridos y del VLDL. Las conclusiones extraídas son que los programas mostraron resultados positivos similares, aunque los resultados superiores del G2, pero no redujeron el riesgo cardiovascular.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Estilo de Vida</dcterms:subject>
   <dcterms:subject language="pt-BR">Mulheres</dcterms:subject>
   <dcterms:subject language="pt-BR">Exercício físico</dcterms:subject>
   <dcterms:subject language="pt-BR">Fatores de risco</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção primária à saúde</dcterms:subject>
   <dcterms:subject language="en">life style</dcterms:subject>
   <dcterms:subject language="en">women</dcterms:subject>
   <dcterms:subject language="en">physical exercise</dcterms:subject>
   <dcterms:subject language="en">risk factors</dcterms:subject>
   <dcterms:subject language="en">primary health care.</dcterms:subject>
   <dcterms:subject language="es">Mujeres</dcterms:subject>
   <dcterms:subject language="es">Ejercicio corporal</dcterms:subject>
   <dcterms:subject language="es">Factores de riesgo</dcterms:subject>
   <dcterms:subject language="es">Atención primaria de salud</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/22740</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Araújo, Sara Pereira de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Natália Cristina de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Corrêa, Cristiane Dias</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pontes, Hellen Tatiane de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cerqueira, Paulo Alves</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Portes, Leslie Andrews</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/59592</identifier><datestamp>2026-07-24T18:50:57Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">SARS-CoV CH.1.1 Variant: Genomic and Structural Insight</dcterms:title>
   <dcterms:abstract language="en">In early February 2023, the Omicron subvariant XBB.1.5, also known as &amp;quot;Kraken&amp;quot;, accounted for more than 44% of new COVID-19 cases worldwide, whereas a relatively new Omicron subvariant named CH.1.1, deemed &amp;quot;Orthrus&amp;quot;, accounted for less than 6% of new COVID-19 cases during the subsequent weeks. This emerging variant carries a mutation, L452R, previously observed in the highly pathogenic Delta and the highly transmissible BA.4 and BA.5 variants, necessitating a shift to active surveillance to assure adequate preparedness for likely future epidemic peaks. We provide a preliminary understanding of the global distribution of this emerging SARS-CoV-2 variant by combining genomic data with structural molecular modeling. In addition, we shield light on the number of specific point mutations in this lineage that may have functional significance, thereby increasing the risk of disease severity, vaccine resistance, and increased transmission. This variant shared about 73% of the mutations with Omicron-like strains. Our homology modeling analysis revealed that CH.1.1 may have a weakened interaction with ACE2 and that its electrostatic potential surface appears to be more positive than that of the reference ancestral virus. Finally, our phylogenetic analysis revealed that this likely-emerging variant was already cryptically circulating in European countries prior to its first detection, highlighting the importance of having access to whole genome sequences for detecting and controlling emerging viral strains</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/59592</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Bazzani, Liliana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Imperia, Elena</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Scarpa, Fabio</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sanna, Daria</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Casu, Marco</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Borsetti, Alessandra</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pascarella, Stefano</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Petrosillo, Nicola</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cella, Eleonora</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Giovanetti, Marta</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ciccozzi, Massimo</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/18192</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Global genetic diversity of Aedes aegypti</dcterms:title>
   <dcterms:abstract language="en">Mosquitoes, especially Aedes aegypti, are becoming important models for studying invasion biology. We characterized genetic variation at 12 microsatellite loci in 79 populations of Ae. aegypti from 30 countries in six continents, and used them to infer historical and modern patterns of invasion. Our results support the two subspecies Ae. aegypti formosus and Ae. aegypti aegypti as genetically distinct units. Ae. aegypti aegypti populations outside Africa are derived from ancestral African populations and are monophyletic. The two subspecies co-occur in both East Africa (Kenya) and West Africa (Senegal). In rural/forest settings (Rabai District of Kenya), the two subspecies remain genetically distinct, whereas in urban settings, they introgress freely. Populations outside Africa are highly genetically structured likely due to a combination of recent founder effects, discrete discontinuous habitats and low migration rates. Ancestral populations in sub-Saharan Africa are less genetically structured, as are the populations in Asia. Introduction of Ae. aegypti to the New World coinciding with trans-Atlantic shipping in the 16th to 18th centuries was followed by its introduction to Asia in the late 19th century from the New World or from now extinct populations in the Mediterranean Basin. Aedes mascarensis is a genetically distinct sister species to Ae. aegypti s.l. This study provides a reference database of genetic diversity that can be used to determine the likely origin of new introductions that occur regularly for this invasive species. The genetic uniqueness of many populations and regions has important implications for attempts to control Ae. aegypti, especially for the methods using genetic modification of populations.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Diversidade genética</dcterms:subject>
   <dcterms:subject language="pt-BR">Aedes aegypti</dcterms:subject>
   <dcterms:subject language="pt-BR">Invasão</dcterms:subject>
   <dcterms:subject language="pt-BR">História</dcterms:subject>
   <dcterms:subject language="pt-BR">Aedes mascarensis</dcterms:subject>
   <dcterms:subject language="pt-BR">Microstélites</dcterms:subject>
   <dcterms:subject language="pt-BR">Variação Genética</dcterms:subject>
   <dcterms:subject language="pt-BR">Aedes</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/18192</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Gloria-Soria, Andrea</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ayala, Diego</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Bheecarry, Ambicadutt</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Calderon-Arguedas, Olger</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Chadee, Dave D.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Chiappero, Marina</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Coetzee, Maureen</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Elahee, Khouaildi Bin</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Fernandez-Salas, Ildefonso</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Kamal, Hany A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Kamgang, Basile</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Khater, Emad I. M.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Kramer, Laura D.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Kramer, Vicki</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lopez-Solis, Alma</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lutomiah, Joel</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Martins, Ademir</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Micieli, Maria Victoria</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Paupy, Christophe</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ponlawat, Alongkot</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rahola, Nil</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rasheed, Syed Basit</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Richardson, Joshua B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Saleh, Amag A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sanchez-Casas, Rosa Maria</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Seixas, Gonçalo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Sousa, Carla A.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Tabachnick, Walter J.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Troyo, Adriana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Powell, Jeffrey R.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/7860</identifier><datestamp>2026-10-21T00:06:05Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Farmacêutico: um profissional em busca de sua identidade</dcterms:title>
   <dcterms:abstract language="pt-BR">A segunda metade do século XX se caracterizou por uma profunda transformação no papel do farmacêutico como profissional da área da saúde. O tradicional papel do boticário do início do século foi sendo substituído paulatinamente com o advento da industrialização do setor farmacêutico. Para não extinguir a profissão, e atender aos interesses que configuravam um novo panorama no setor industrial farmacêutico do país foram criadas áreas alternativas para o profissional que não tinham seu principal foco no medicamento. Neste contexto surgiram as áreas de formação Farmácia-bioquímica e a Farmácia industrial. Com isso, a formação destes profissionais passou por intensa transformação deixando de focar o usuário como beneficiário direto do trabalho farmacêutico. A partir do final dos anos 1980, com a implantação do Sistema Único de Saúde (SUS) e sua nova concepção de saúde, priorizando a prevenção e a promoção, faz-se necessário uma mudança do perfil do profissional farmacêutico com consequente retomada de sua responsabilidade e habilidade como profissional da saúde coletiva. Este trabalho faz uma reflexão sobre essa realidade histórica e traz alguns elementos que podem explicar as razões do farmacêutico não estar inserido nas unidades básicas de saúde e nos programas de atenção aos usuários do sistema público de saúde do Brasil.</dcterms:abstract>
   <dcterms:abstract language="en">Over the second half of the 20th century the traditional role played by the pharmacists changed considerably as health professionals. The main work performed by the apothecaries was gradually changed as the pharmaceutical industry mechanization process was taking place. In order to prevent such profession from disappearing, it was necessary to create new areas for the professional who did not have its principal focus in medicine. In this context came the training areas Pharmacy-Biochemistry and Pharmacy industry. Thus, the training of health professionals has undergone intense transformation leaving to focus on the user as a direct beneficiary of the pharmacist work. By the end of the 1980&amp;apos;s, with the implementation of the Unified Healthcare System in Brazil, it was necessary to change the pharmacists&amp;apos; profile to make them able to recover their positions as health professionals. This paper presents some aspects of the pharmacist&amp;apos;s development over the time, and discusses the possible reasons for such professionals not being engaged in the healthcare workforce in Brazil.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Farmacêutico</dcterms:subject>
   <dcterms:subject language="pt-BR">Assistência farmacêutica</dcterms:subject>
   <dcterms:subject language="pt-BR">História da farmácia</dcterms:subject>
   <dcterms:subject language="pt-BR">Educação Farmacêutica</dcterms:subject>
   <dcterms:subject language="pt-BR">Farmacêuticos</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/7860</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Saturnino, Luciana Tarbes Mattana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Perini, Edson</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Luz, Zélia Maria Profeta da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Modena, Celina Maria</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/52015</identifier><datestamp>2026-07-24T18:50:58Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Triggering the proboscis extension reflex (PER) in Rhodnius prolixus</dcterms:title>
   <dcterms:abstract language="en">The heat emitted by the host body constitutes a short distance orientation cue for most blood-sucking insects, as is the case of the kissing-bug Rhodnius prolixus. We evaluated here how kissing bugs assess the distance to a warm target, in order to reach it by displaying the Proboscis Extension Reflex (PER). We confronted blind-folded insects to a thermal source either at 35° or at 40 °C under both, open- and closed-loop conditions. The results showed that nymphs were able to estimate the distance to a thermal source just using thermal information. Free walking insects displayed PER with a maximum frequency at 5 mm from the object, even without touching it. Yet, our experiments showed that the insects need to walk freely to estimate the distance to the source accurately, i.e. performing the PER at a distance allowing them to reach the target with the tip of the proboscis. The distance at which PER was triggered was independent of the temperature of the thermal source (35° or 40 °C). Moreover, our results also unravelled that mechanical stimuli can be integrated with thermal cues, being capable of affecting the triggering of PER in kissing bugs. This is the first study providing evidence that blood-sucking vector insects use mechanoreception for eliciting their bites. We discuss our findings in the light of present models explaining the ability of kissing bugs to estimate the distance and the temperature of a potential food sources.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/52015</capes:outputUri>
   <dcterms:rights>Acesso embargado</dcterms:rights>
   <dcterms:available>2092-01-01</dcterms:available>
   <creator>
      <dcterms:creator>Ferreira, Raquel Aparecida</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lorenzo, Marcelo Gustavo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lazzari, Claudio R.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/22897</identifier><datestamp>2026-10-20T14:12:19Z</datestamp><setSpec>com_icict_22858</setSpec><setSpec>com_icict_3802</setSpec><setSpec>col_icict_22860</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>doctoral thesis</dcterms:type>
   <dcterms:title language="pt-BR">Células-tronco mesenquimais do tecido adiposo e cordão umbilical de seres humanos: caracterização, análises comparativas e avaliação da capacidade imunomodulatória sobre as células estreladas hepáticas</dcterms:title>
   <dcterms:alternative language="en">Mesenchymal stem cells from adipose tissue and umbilical cord of humans: characterization and evaluation of the immunomodulatory capacity in hepatic stellate cells</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O potencial de imunomodulação das células-tronco mesenquimais (CTM) vem sendo avaliado no reparo e/ou regeneração de tecidos com lesão. As CTM podem ser isoladas de diversos tecidos, entre os quais o tecido adiposo e cordão umbilical, são considerados fontes bastante importantes para obtenção dessas células. Contudo, características biológicas básicas das CTM do tecido adiposo e cordão umbilical ainda precisam ser elucidadas. Uma das promissoras aplicações das CTM é na terapia de doenças hepáticas, mas os mecanismos pelos quais essas células promoveriam a melhora da função do fígado não estão bem elucidados. Nesse contexto, caracterizamos aspectos fenotípicos de CTM do tecido adiposo e cordão umbilical, analisando o potencial imunomodulador sobre as células estreladas hepáticas (CEH), célula-chave da fibrogênese no fígado. Para isso, a capacidade de diferenciação em linhagens, imunofenotipagem, perfil de ligação de lectinas e características ultraestruturais das CTM foram analisadas. Após o co-cultivo indireto entre as CTM e CEH, a marcação para das células CEH para apoptose foi realizada e o sobrenadante foi coletado para avaliação de citocinas. Na comparação entre as CTM de ambas a fontes, foram observados diferentes aspectos ultraestruturais e intensidade de ligação de lectinas. As CTM do tecido adiposo apresentaram melhor capacidade de diferenciação adipogênica e osteogênica, contudo ambas as CTM apresentaram perfil imunofenotípico e diferenciação condrogênica similares. No cocultivo indireto, foi observado que as CTM levaram a redução significativa da produção de MCP-1 (citocina considerada relevante para o aumento da resposta inflamatória e fibrogênese no fígado) pelas CEH. Aumento da produção de IL-10 pelas CTM do cordão umbilical e IL-6 pelas CEH foi identificado, o que poderia estar associado à manutenção de um microambiente regulatório. Os resultados demonstraram que as CTM do tecido adiposo e cordão umbilical apresentam consideráveis diferenças fenotípicas. Apesar de ambas as CTM apresentarem ação imunomodulatória sobre as CEH, as CTM do cordão umbilical podem representar uma população de células mais promissoras para a aplicação terapêutica nas doenças hepáticas fibrosantes quando comparadas às CTM do tecido adiposo. Esses resultados podem contribuir para o aprimoramento dos estudos na área de terapia celular que avaliem os possíveis efeitos proporcionados pela aplicação das CTM do tecido adiposo e cordão umbilical (AU)</dcterms:abstract>
   <dcterms:abstract language="en">The immunomodulation potential of the mesenchymal stem cells (MSCs) has been evaluated in the repair and/ or regeneration of injured tissues. Among the various tissues that MSCs are able to be isolated, adipose tissue and umbilical cord are considered very important, however, there is no consensus as to the similarity of these cells. One of promising applications of MSCs is in therapy of liver diseases, but the mechanisms by which they would promote improved liver function are not well understood. It is possible that one of the actions of MSC occurs on hepatic stellate cells (HSC), a key cell of fibrogenesis in the liver. In this context, we characterize and compare phenotypic aspects of MSCs from adipose tissue and umbilical cord, analyzing their potential immunomodulatory on HSC. The ability to differentiate into lineages, immunophenotyping, ultrastructural analysis and lectin binding profile were analyzed. In the indirect co-culture of MSCs with HSC, marking was carried out with annexin V and propidium iodide, and the supernatant was collected for assessment of cytokines. We identify different ultrastructural aspects, as well as intensity and intracellular profile lectin binding. The adipose tissue MSCs showed better osteogenic and adipogenic differentiation capacity, however both MSCs presented immunophenotypic profile and similar chondrogenic differentiation. In relation to indirect co-cultivation, it was observed that the adipose tissue and umbilical cord MSCs led to significant reduction in production of MCP-1 for the HSC, this cytokine is regarded as relevant to the increased inflammatory response and liver fibrogenesis. The results indicate that there were considerable phenotypic differences between the MSC and adipose tissue cord. Furthermore, adipose tissue and umbilical cord MSCs have immunomodulatory action through paracrine effect on HSC. These results may improve knowledge about the phenotypic characteristics of the adipose tissue and umbilical cord MSCs and understanding of the possible mechanisms involved in the therapeutic effect of MSCs in liver diseases.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Células-tronco</dcterms:subject>
   <dcterms:subject language="pt-BR">Células Mesenquimais Estromais</dcterms:subject>
   <dcterms:subject language="pt-BR">Tecido adiposo</dcterms:subject>
   <dcterms:subject language="pt-BR">Cordão umbilical</dcterms:subject>
   <dcterms:subject language="pt-BR">Fibrose hepática</dcterms:subject>
   <dcterms:subject language="pt-BR">Células-Tronco Mesenquimais</dcterms:subject>
   <dcterms:subject language="pt-BR">Citologia</dcterms:subject>
   <dcterms:subject language="pt-BR">Cirrose Hepática</dcterms:subject>
   <dcterms:subject language="pt-BR">Lectinas</dcterms:subject>
   <dcterms:subject language="pt-BR">Imunomodulação</dcterms:subject>
   <dcterms:subject language="pt-BR">Humanos</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/22897</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Biociências e Biotecnologia em Saúde</capes:hasProgram>
   <capes:programCode>31010016030P0</capes:programCode>
   <bibo:numPages>96</bibo:numPages>
   <capes:defenseDate>2016-07-05</capes:defenseDate>
   <creator>
      <dcterms:creator>Carvalho, Camila Lima</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Montenegro, Sílvia</capes:advisor>
   </advisor>
   <advisor>
      <capes:advisor>Oliveira, Sheilla Andrade de</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Montenegro, Sílvia Maria Lucena</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Medeiros, Zulma Maria de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Pena, Lindomar José</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Feitosa, Ana Paula Sampaio</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Souza, Valdênia Maria Oliveira de</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/70657</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_3790</setSpec><setSpec>col_icict_9624</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Relato de experiência sobre um curso de especialização em medicina tropical na modalidade a distância oferecido pela Unyleya</dcterms:title>
   <dcterms:alternative language="es">Relato de experiencia sobre un curso de especialización en medicina tropical en modalidad a distancia ofrecido por Unyleya</dcterms:alternative>
   <dcterms:alternative language="en">Experience report on a distance learning specialization course in tropical medicine offered by Unyleya</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O presente artigo apresenta um relato de experiência sobre a concepção, implementação e desenvolvimento de um curso de pós-graduação lato sensu em Medicina Tropical, ofertado na modalidade de Ensino a Distância (EAD) pela Unyleya. Parte-se de uma contextualização histórica do EAD, destacando suas principais metodologias, plataformas tecnológicas e impactos na democratização do ensino superior, especialmente em áreas remotas. O curso em foco foi concebido para atender às demandas de capacitação médica em regiões endêmicas, com ênfase na abordagem clínica, epidemiológica e terapêutica das doenças tropicais negligenciadas. A metodologia utilizada inclui aulas teóricas, estudos de caso, fóruns interativos e uso da ferramenta Paciente360®, que simula situações clínicas reais. A flexibilidade da modalidade EAD aliada à qualidade pedagógica assegura uma formação sólida e atualizada. O estudo também discute a atuação de um médico especializado em Medicina Tropical, sua relevância e abrangência, não somente em regiões tropicais, mas também no contexto internacional, propondo reflexões sobre o papel da educação digital na formação de especialistas em saúde pública.</dcterms:abstract>
   <dcterms:abstract language="en">This article presents an experience report on the design, implementation, and development of a lato sensu postgraduate specialization course in Tropical Medicine, offered in the Distance Education (DE) modality by Unyleya. The report begins with a historical overview of DE, highlighting its main methodologies, technological platforms, and its impact on the democratization of higher education, especially in remote areas. The course was developed to meet the demand for medical training in endemic regions, with a strong emphasis on the clinical, epidemiological, and therapeutic management of neglected tropical diseases. The teaching methodology includes theoretical classes, case studies, interactive forums, and the use of the Paciente360® tool, which simulates real clinical scenarios. The flexibility of the DE format, combined with high pedagogical quality, ensures a comprehensive and up-to-date education. The article also discusses the role of physicians specialized in Tropical Medicine, emphasizing their relevance and broad scope—not only in tropical regions but also in international health contexts—and reflects on the role of digital education in training public health specialists.</dcterms:abstract>
   <dcterms:abstract language="es">Este artículo presenta un informe de experiencia sobre el diseño, implementación y desarrollo de un curso de posgrado lato sensu en Medicina Tropical, ofrecido por Unyleya en la modalidad de Educación a Distancia (EaD). Se inicia con una contextualización histórica de la EaD, destacando sus principales metodologías, plataformas tecnológicas e impacto en la democratización de la educación superior, especialmente en regiones remotas. El curso fue concebido para responder a las demandas de formación médica en regiones endémicas, con énfasis en el abordaje clínico, epidemiológico y terapéutico de las enfermedades tropicales desatendidas. La metodología didáctica empleada incluye clases teóricas, estudios de caso, foros interactivos y el uso de la herramienta Paciente360®, que simula situaciones clínicas reales. La flexibilidad del modelo EaD, aliada a una pedagogía de calidad, garantiza una formación sólida y actualizada. Además, se discute el papel del médico especializado en Medicina Tropical, su relevancia y alcance no solo en regiones tropicales, sino también en el contexto internacional, proponiendo reflexiones sobre el papel de la educación digital en la formación de especialistas en salud pública.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Ensino a distância</dcterms:subject>
   <dcterms:subject language="pt-BR">Medicina tropical</dcterms:subject>
   <dcterms:subject language="pt-BR">Educação Médica</dcterms:subject>
   <dcterms:subject language="pt-BR">Capacitação profissional</dcterms:subject>
   <dcterms:subject language="pt-BR">Doenças tropicais negligenciadas</dcterms:subject>
   <dcterms:subject language="es">Educación a distancia</dcterms:subject>
   <dcterms:subject language="es">Educación médica</dcterms:subject>
   <dcterms:subject language="es">Capacitación profesional</dcterms:subject>
   <dcterms:subject language="es">Enfermedades tropicales desatendidas</dcterms:subject>
   <dcterms:subject language="pt-BR">Educação a Distância</dcterms:subject>
   <dcterms:subject language="pt-BR">Doenças Negligenciadas</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/70657</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Hasslocher-Moreno, Alejandro Marcel</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Hargreaves, Luiz Henrique</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Hasslocher, Ciro Carneiro</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/29186</identifier><datestamp>2026-10-20T21:42:59Z</datestamp><setSpec>com_icict_26722</setSpec><setSpec>com_icict_17640</setSpec><setSpec>com_icict_7119</setSpec><setSpec>col_icict_29158</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>editorial</dcterms:type>
   <dcterms:title language="pt-BR">Editorial Edição Especial 2018</dcterms:title>
   <dcterms:abstract language="pt-BR">Apresenta a edição especial da revista Fitos, que está publicando manuscritos em formato de carta, perspectiva e comunicação breve, das palestras proferidas por conferencistas renomados que participaram do 1º Seminário Internacional das RedesFito: inovação e biodiversidade na perspectiva da sustentabilidade, realizado em 2016, no Rio de Janeiro, organizado pelo Núcleo de Gestão em Biodiversidade e Saúde de Farmanguinhos/Fiocruz, em parceria com o Instituto SENAI de Inovação – Química Verde. O evento teve como objetivo promover a discussão da inovação a partir da biodiversidade à luz das premissas da complexidade, da transição paradigmática do mundo contemporâneo e da perspectiva da sustentabilidade, destacando o papel das políticas de ciência, tecnologia e inovação, da ciência aberta neste contexto, assim como a importância do trabalho em rede voltado para a práxis.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Editorial</dcterms:subject>
   <dcterms:subject language="pt-BR">Revista Fitos</dcterms:subject>
   <dcterms:subject language="pt-BR">Biodiversidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Inovação</dcterms:subject>
   <dcterms:subject language="pt-BR">Gestão da Informação</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/29186</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Villas Bôas, Glauco de Kruse</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Abreu, Rosane de Albuquerque dos Santos</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Arruda, Yolanda</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/18420</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_14035</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_14036</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>video</dcterms:type>
   <dcterms:title language="pt-BR">Quais os fatores de risco da febre amarela?</dcterms:title>
   <dcterms:abstract language="pt-BR">Vídeoaula do pesquisador Rivaldo Venâncio da Cunha, infectologista da Fiocruz que esclarece para a população, por meio de perguntas e respostas os riscos de surto de febre Amarela no Rio de Janeiro. Fora de áreas urbanas desde 1942, o vírus da febre amarela voltou a assustar moradores do Estado do Rio. Uma morte atribuída à doença causou apreensão em Casimiro de Abreu. Vacinação em massa e maior controle sobre o trânsito de pessoas em turismo ecológico são duas medidas tomadas imediatamente, por precaução. Os postos de saúde registram filas diariamente por conta do aumento da busca pela vacina. A notícia de que os cinco macacos mortos na Gávea e Jardim Botânico não tinham febre amarela, causou alívio. Em 27 de março começou campanha de vacinação preventiva.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Doenças infecciosas</dcterms:subject>
   <dcterms:subject language="pt-BR">REA</dcterms:subject>
   <dcterms:subject language="pt-BR">Videoaula</dcterms:subject>
   <dcterms:subject language="pt-BR">Febre Amarela</dcterms:subject>
   <dcterms:subject language="pt-BR">Aedes aegypti</dcterms:subject>
   <dcterms:subject language="pt-BR">Vacinação</dcterms:subject>
   <dcterms:subject language="pt-BR">Riscos</dcterms:subject>
   <dcterms:subject language="pt-BR">Aedes</dcterms:subject>
   <dcterms:subject language="pt-BR">Grupos de Risco</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/18420</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Cunha, Rivaldo Venâncio da</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/32438</identifier><datestamp>2026-10-21T00:16:52Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Trypanosoma cruzi Transmission Cycle Among Wild and Domestic Mammals in Three Areas of Orally Transmitted Chagas Disease Outbreaks</dcterms:title>
   <dcterms:abstract language="en">We report Trypanosoma cruzi infection in wild and domestic mammals from three orally acquired Chagas disease outbreak areas in Brazil. Cachoeiro do Arari (Pará) displayed a panzootic scenery (positive mammals in all ecologic strata), and human cases were probably the consequence of their exposure within the sylvatic T. cruzi transmission cycle. In Navegantes (Santa Catarina), Didelphis spp. was the main reservoir host, given that 93% were infected. In Redenção (Ceará), Monodelphis domestica and Thrichomys laurentius were also important for parasite maintenance. TCI was present in the three studied areas. Additionally, Z3 was detected in an armadillo from Pará and TCII in a triatomine from Navegantes. Domestic animals showed a high seroprevalence and should be considered sentinels in surveillance programs. The importance of a reduction in wild mammalian fauna diversity and selection of suitable T. cruzi reservoir hosts are discussed as risk factors for the re-emergence of Chagas disease.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Trypanosoma cruzi</dcterms:subject>
   <dcterms:subject language="pt-BR">Doença de Chagas</dcterms:subject>
   <dcterms:subject language="pt-BR">Surtos</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">Mamíferos selvagens e domésticos</dcterms:subject>
   <dcterms:subject language="pt-BR">Surtos de Doenças</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/32438</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Roque, André Luiz R.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Xavier, Samanta C. C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rocha, Marconny G, da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Duarte, Ana Cláudia M.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>D&amp;apos;Andrea, Paulo S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Jansen, Ana Maria</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/705</identifier><datestamp>2026-10-21T00:06:04Z</datestamp><setSpec>com_123456789_1</setSpec><setSpec>col_icict_840</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">A dinâmica do HIV/AIDS entre os usuários de drogas injetáveis: desafios e sucessos na terceira década da epidemia</dcterms:title>
   <dcterms:abstract language="pt-BR">Nas décadas de 1980/90, epidemias de HIV/AIDS de grande magnitude e difusão acelerada ocorreram em todo mundo entre usuários de drogas inetáveis (UDI). Recentemente, em diversos contextos, vem sendo observado o declínio da epidemia e a estabilização das taxas de prevalência em níveis substancialmente mis baixos do que os observados anteriormente. Os UDI têm particular importância na epidemia do HIV, funcionando como uma &amp;apos;ponte&amp;apos; para a disseminação do HIV em outras populações. São considerados um grupo difícil em relação à perspectiva de mudança de comportamento. No entanto, há evidências de que as políticas preventivas podem promover e/ou reforçar a mudança espontânea na direção de comportamentos mais saudáveis nessa população, revertendo, parcialmente, epidemias extensas.</dcterms:abstract>
   <dcterms:abstract language="en">In the 1980s/90s, HIV/AIDS epidemics in injectable drug users (IDUs)occurred all over the world, many time affecting a large number of people in a very short time period. Recently, in different setings, declining epidemics have been observed, with stabilization of prevalence rates at levels substantially lower than before.IDUs have a key role in the dynamics of HIV/AIDS, functioning as a &amp;apos;bridge&amp;apos; for the dissemination of HIV in the other populations. This is considered a difficult group in terms of behavior change. Nevertheless there are evidences that preventive policies may promote and/or reinforce spontaneous behavior changes toward healthier behaviors amongst this population, partially reverting extensive epidemics.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Aids</dcterms:subject>
   <dcterms:subject language="pt-BR">Usuários de drogas injetáveis</dcterms:subject>
   <dcterms:subject language="pt-BR">Prevenção e Controle</dcterms:subject>
   <dcterms:subject language="pt-BR">Síndrome da Imunodeficiência Adquirida</dcterms:subject>
   <dcterms:subject language="pt-BR">Usuários de Drogas</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/705</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Bastos, Francisco Inácio Pinkusfeld Monteiro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Vilas-Boas Hacker, Mariana de Andrea</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/71591</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_13663</setSpec><setSpec>col_icict_52028</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>bachelor thesis</dcterms:type>
   <dcterms:title language="pt-BR">Elaboração e proposta de implantação de protocolo de renovação de receita da UBS 03 Recanto das Emas, Brasília</dcterms:title>
   <dcterms:abstract language="pt-BR">O atendimento médico ao paciente que sofre de uma doença crônica e faz uso contínuo de medicamento deve incorporar a avaliação da eficácia terapêutica, uso correto da medicação e dependência. A renovação de prescrição dos medicamentos de uso contínuo sem uma consulta médica adequada pode interferir diretamente no tratamento do paciente. Embora haja vários impasses éticos, essa é uma prática comum na Atenção Básica, no Brasil e em outros países, e deve ser regulamentada e normatizada para benefício dos pacientes. Este trabalho visa estabelecer um protocolo de renovação de receitas que oriente os profissionais das Equipes de Saúde da Família a fim de ser implantado na Unidade Básica de Saúde (UBS) n° 3 Recanto das Emas. O desenvolvimento deste plano de intervenção, descritivo e exploratório, foi baseado no Planejamento Estratégico Situacional. Através de revisões de protocolos presentes em literatura e reuniões com as Equipes de Saúde da Família foi possível elaborar um protocolo que se adeque à realidade da comunidade em questão. O paciente em uso contínuo deum medicamento e que deseja renovar sua receita deve ser acolhido pela Equipe de Saúde da Família. Dessa forma, será possível avaliar seu prontuário, interações medicamentosas, adesão do paciente aos medicamentos, identificar as queixas do paciente e os sinais de alarme, desde a última visita à UBS. É fundamental estabelecer um plano terapêutico que seja acessível à realidade do paciente, sendo elucidado de forma clara a ele sempre que possível. Portanto, o protocolo estabelecido tem como função melhorar a gestão dos pacientes portadores de doenças crônicas que buscam a renovação de receita, através da padronização e identificação de fatores de risco e vulnerabilidade pelos outros membros da Equipe de Saúde da Família. Reforçando sempre a importância do atendimento médico periódico antes ou depois da prescrição renovada.</dcterms:abstract>
   <dcterms:abstract language="en">Medical care for patients who suffer from a chronic disease and who make continuous use of medication must incorporate the assessment of therapeutic efficacy, correct use of medication and dependence. Renewing prescriptions for continuous use medications without proper medical consultation can directly interfere with patient treatment. Although there are several ethical impasses, this is a common practice in primary care, in Brazil and in other countries, which must be regulated and standardized for the benefit of patients. This work aimsto establish a protocol for renewing prescriptions that guides the professionals of the family health teams in order to be implemented in the Basic Health Unit (UBS) n°3 Recanto das Emas. The development of this descriptive and exploratory intervention plan was based on the Situational Strategic Planning. Through revisions of protocols present in the literature and meetings with the family health teams, it was possible to develop a protocol that fits the reality of the community in question. The patient using a medication of continuous use and who wants to renew his prescription must be welcomed by the family health team. In this way, it will be possible to assess their medical records, drug interactions, patient adherence to medications, identify patient complaints and alarm signs, since the last visit to the UBS. It is essential to establish a therapeutic plan that is accessible to the patient&amp;apos;s reality, being clearly explained to him whenever possible. Therefore, the established protocol has the function of improving the management of patients with chronic diseases who seek to renew their prescription, through the standardization and identification of risk and vulnerability factors by other members of the family health team. Always reinforcing the importance of periodic medical care before or after the renewed prescription.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Prescrição de repetição</dcterms:subject>
   <dcterms:subject language="pt-BR">Renovação de receitas</dcterms:subject>
   <dcterms:subject language="pt-BR">Doenças crônicas</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção primária à saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Doença Crônica</dcterms:subject>
   <dcterms:subject language="pt-BR">Preparações Farmacêuticas</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/71591</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-graduação em Residência em Medicina de Família e Comunidade</capes:hasProgram>
   <bibo:numPages>24</bibo:numPages>
   <capes:defenseDate>2022-02-24</capes:defenseDate>
   <creator>
      <dcterms:creator>Vasconcelos, Maria Rita da Costa</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Rocha, Vinícius Ximenes Muricy da</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Merhi, Tâmara Elias Tamer Cunha</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Nitão, Samara Rachel Vieira</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Rocha, Vinícius Ximenes Muricy da</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/75336</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_65070</setSpec><setSpec>com_icict_65069</setSpec><setSpec>com_icict_33380</setSpec><setSpec>com_icict_13554</setSpec><setSpec>col_icict_65071</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>other periodical</dcterms:type>
   <dcterms:title language="pt-BR">INFO Gripe Boletim Semanal: semana 05 de 2025</dcterms:title>
   <dcterms:abstract language="pt-BR">O presente relatório é referente aos dados digitados até a SE 05 2025, que encerra-se no dia 2025-02-01. Apresentamos análises nacional, por região geopolítica, por regional baseada em perfil de atividade, e por UF, relatando o nível relativo ao plano de contingência, zona no canal endêmico e nível de atividade semanal para os dados de SRAG, SRAG por Influenza, e óbitos de SRAG por Influenza.</dcterms:abstract>
   <dcterms:subject language="pt-BR">COVID-19</dcterms:subject>
   <dcterms:subject language="pt-BR">Febre</dcterms:subject>
   <dcterms:subject language="pt-BR">Tosse</dcterms:subject>
   <dcterms:subject language="pt-BR">Dor de garganta</dcterms:subject>
   <dcterms:subject language="pt-BR">Dispnéia</dcterms:subject>
   <dcterms:subject language="pt-BR">Saturação de oxigênio</dcterms:subject>
   <dcterms:subject language="pt-BR">Dificuldade respiratória</dcterms:subject>
   <dcterms:subject language="pt-BR">Hospitalização</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">SRAG</dcterms:subject>
   <dcterms:subject language="pt-BR">Influenza</dcterms:subject>
   <dcterms:subject language="pt-BR">Óbitos</dcterms:subject>
   <dcterms:subject language="pt-BR">Documentos institucionais</dcterms:subject>
   <dcterms:subject language="pt-BR">Infecções por Coronavirus</dcterms:subject>
   <dcterms:subject language="pt-BR">Síndrome Respiratória Aguda Grave</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/75336</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Fundação Oswaldo Cruz</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Fundação Getúlio Vargas</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/33824</identifier><datestamp>2026-07-24T18:50:59Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Ecoepidemiological aspects of visceral leishmaniasis in an endemic area in the Steel Valley in Brazil: An ecological approach with spatial analysis</dcterms:title>
   <dcterms:abstract language="en">Leishmaniases are a group of infectious diseases transmitted by phlebotomine sand flies, and their distribution depends on the presence of vectors, parasites, reservoirs and susceptible hosts in the same environment. In the last decades, visceral leishmaniasis (VL) has become urbanized and reached economically important cities in countries within the transmission zone. Our study was conducted in one of those cities–Ipatinga–in the state of Minas Gerais, Brazil, where the first autochthonous case of VL dates back to 2011. Since no data regarding the epidemiological triad of VL (etiological agent/vector/domestic reservoir) were available for this city, we characterized the local entomological fauna, identified the presence of specific Leishmania DNA in the captured phlebotomine sand flies, and assessed the incidence of canine and human VL. For the entomological survey, we set twenty light traps in ten districts of the city with reports of human and canine VL. The insect captures were performed monthly, during one year, starting in March 2015. A total of 1501 specimens of phlebotomine sand flies belonging to 16 distinct species were captured, with predominance (61.9%) of Lutzomyia longipalpis. Leishmania infantum DNA was detected in L. longipalpis and in Evandromyia cortelezzii test samples. A total of 9,136 dogs were examined, 1,355 of which (14.8%) were serologically positive for VL. The cases were georeferenced and the data were plotted in thematic maps, along with human cases of VL registered by the local Department of Health, during the study period. Our results confirm that the VL transmission cycle is active in Ipatinga, with the presence of vectors carrying Leishmania DNA, canine and human cases of the disease. Spatial analysis allowed for the observation of a positive relationship between canine and human cases of VL and the identification of areas with high priority for control actions in the city. The mapping of high-risk areas, together with an epidemiological study in urban areas, is fundamental to improve the efficacy of the Program for Surveillance and Control of VL (PSCVL) in Brazil.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Leishmanioses</dcterms:subject>
   <dcterms:subject language="pt-BR">Phlebotomineos</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/33824</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Lana, Rosana Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Michalsky, Érika Monteiro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lopes, Lívia Oliveira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Fabiana Oliveira Lara</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Nascimento, Jeiza Lopes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pinheiro, Letícia Cavalari</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, João Carlos França</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mendes, Telma S. C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dias, Consuelo Latorre Fortes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Dias, Edelberto Santos</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/73057</identifier><datestamp>2026-10-19T21:52:26Z</datestamp><setSpec>com_icict_3802</setSpec><setSpec>col_icict_9180</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Development and field validation of a reverse transcription loop-mediated isothermal amplification assay (RT-LAMP) for the rapid detection of Chikungunya virus in patient and mosquito samples</dcterms:title>
   <dcterms:abstract language="en">Objectives: We aimed to develop a reverse transcription loop-mediated isothermal amplification (RT-LAMP) platform for the rapid detection of chikungunya virus (CHIKV) in both patient and mosquito samples from Brazil. Methods: We optimized an RT-LAMP assay and then evaluated the specificity and sensitivity using visual detection. In comparison with the RT-qPCR reference method, we validated the utility of this assay as a molecular diagnostic test in a reference laboratory for arbovirus diagnostics using 100 serum samples collected from suspected CHIKV cases. Results: Our RT-LAMP assay specifically detected CHIKV without cross-reactivity against other arboviruses. The limit of detection of our RT-LAMP was estimated in −1.18 PFU (confidence interval [CI] ranging from –2.08 to 0.45), resulting in a similar analytical sensitivity when directly compared with the reference standard RT-qPCR assay. Then, we demonstrate the ability of our RT-LAMP assay to detect the virus in different human specimens (serum, urine, and saliva), and crude lysate of Aedes aegypti mosquitoes in as little as 20–30 minutes and without a separate RNA isolation step. Lastly, we showed that our RT-LAMP assay could be lyophilized and reactivated by adding water, indicating potential for room-temperature storage. Our RT-LAMP had a clinical sensitivity of 100% (95% CI, 90.97–100.00%), clinical specificity of 96.72% (95% CI, 88.65–99.60%), and overall accuracy of 98.00% (95% CI, 92.96–99.76%). Discussion: Taken together, these findings indicate that the RT-LAMP assay reported here solves important practical drawbacks to the deployment of molecular diagnostics in the field and can be used to improve testing capacity, particularly in low- and middle-income countries.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Vírus Chikungunya</dcterms:subject>
   <dcterms:subject language="pt-BR">Diagnóstico</dcterms:subject>
   <dcterms:subject language="pt-BR">Culicidae</dcterms:subject>
   <dcterms:subject language="pt-BR">Pacientes</dcterms:subject>
   <dcterms:subject language="pt-BR">Sistemas Automatizados de Assistência Junto ao Leito</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/73057</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Severino Jefferson Ribeiro da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Magalhães, Jurandy Júnior Ferraz de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Matthews, Quinn</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Divarzak, Ana Luísa Lot</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mendes, Renata Pessôa Germano</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santos, Bárbara Nazly Rodrigues</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cabral, Diego Guerra de Albuquerque</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Jacilane Bezerra da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Kohl, Alain</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pardee, Keith</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pena, Lindomar José</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/3213</identifier><datestamp>2026-07-24T18:50:58Z</datestamp><setSpec>com_123456789_1</setSpec><setSpec>col_icict_2825</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>bachelor thesis</dcterms:type>
   <dcterms:title language="pt-BR">Biblioterapia para pacientes adultos internados em ima unidade hospitalar: uma proposta de humanização</dcterms:title>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/3213</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Informação Científica e Tecnológica em Saúde</capes:hasProgram>
   <bibo:numPages>33</bibo:numPages>
   <creator>
      <dcterms:creator>Benedetti, Luciane Berto</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Meira, Ana Cláudia</capes:advisor>
   </advisor>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/47439</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Sobre a importância no diagnostico post-mortem da febre amarella, das lesões microscopicas descriptas por H. da Rocha Lima e por Hoffmann</dcterms:title>
   <dcterms:subject language="pt-BR">Febre Amarela</dcterms:subject>
   <dcterms:subject language="pt-BR">Diagnóstico post-mortem</dcterms:subject>
   <dcterms:subject language="pt-BR">Lesões microscópicas</dcterms:subject>
   <dcterms:subject language="pt-BR">Anatomia patológica</dcterms:subject>
   <dcterms:subject language="pt-BR">Diagnóstico</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/47439</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Torres, Magarinos</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/56313</identifier><datestamp>2026-10-20T21:43:05Z</datestamp><setSpec>com_icict_9176</setSpec><setSpec>col_icict_11241</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>book part</dcterms:type>
   <dcterms:title language="pt-BR">Como a tecnologia pode colaborar com as ações de Saúde Única</dcterms:title>
   <dcterms:subject language="pt-BR">Plataformas Digitais</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde Única</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/56313</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Silva, Klena Sarges Marruaz</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Campos, Carla Freitas de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pontes, Alessandra Nascimento</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Jaqueline Maria da</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/61791</identifier><datestamp>2026-10-19T21:52:28Z</datestamp><setSpec>com_icict_3805</setSpec><setSpec>col_icict_7519</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Bicentenário de emancipação e a história da saúde em Sergipe: um campo em desenvolvimento e suas potencialidades</dcterms:title>
   <dcterms:abstract language="pt-BR">A proposta deste artigo se insere nos movimentos de comemorações do bicentenário de independência política de Sergipe que se deu em 1820. Sobre a trajetória de 200 anos de um território independente, lançaremos luz sobre a história da saúde sergipana, a partir do que foi produzido na historiografia sobre a temática da saúde, não no sentido de realizar um balanço historiográfico, mas de enveredamos por apontar as potencialidades deste domínio da história em Sergipe, sublinhado temas, objetos e abordagens ainda não experimentadas do ponto de vista da história. Isto é possível, uma vez que referente à saúde em Sergipe, contamos com uma gama de fontes históricas ainda não exploradas, que configura nesse nicho historiográfico lote fértil para desvendarmos nuances e particularidades do pretérito sergipano. Sendo assim, este estudo foi configurado em três frentes que irão balizar nossa discussão por entendermos que são os pilares da história da saúde brasileira: O patrimônio cultural da saúde em Sergipe; A história da doença em 200 anos de Sergipe independente; Produções científicas e sujeitos sergipanos da arte de curar. O que se pretende evidenciar é a importância de aprofundarmos os estudos sobre a história da saúde em Sergipe em diferentes vertentes, imersa no contexto histórico nacional, dando relevo às nossas particularidades e agentes históricos.</dcterms:abstract>
   <dcterms:abstract language="en">The purpose of this article is part of the movement to commemorate Sergipe&amp;apos;s bicentenary of political independence, which took place in 1820. On the trajectory of 200 years of an independent territory, we will shed light on the history of health in Sergipe, based on what was produced in historiography on the topic of health, not in the sense of carrying out a historiographical assessment, but rather to point out the potential of this domain of history in Sergipe, highlighting themes, objects and approaches that have not yet been tried from the point of view of history. This is possible, since regarding health in Sergipe, we have a range of historical sources that have not yet been explored, which constitutes a fertile ground in this historiographical niche for us to uncover nuances and particularities of Sergipe&amp;apos;s past. Therefore, this study was configured on three fronts that will guide our discussion as we understand that they are the pillars of the history of Brazilian health: The cultural heritage of health in Sergipe; The history of the disease in 200 years of independent Sergipe; Scientific productions and subjects from Sergipe in the art of healing. What we intend to highlight is the importance of deepening studies on the history of health in Sergipe in different aspects, immersed in the national historical context, highlighting our particularities and historical agents.</dcterms:abstract>
   <dcterms:subject language="pt-BR">História</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Sergipe</dcterms:subject>
   <dcterms:subject language="pt-BR">Bicentenário</dcterms:subject>
   <dcterms:subject language="pt-BR">Historiografia</dcterms:subject>
   <dcterms:subject language="pt-BR">Doença</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/61791</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Santos, Barbara Barbosa dos</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/78696</identifier><datestamp>2026-10-20T13:40:40Z</datestamp><setSpec>com_icict_8556</setSpec><setSpec>com_icict_8555</setSpec><setSpec>col_icict_8557</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Atenção psicossocial e questão racial: práticas antirracistas de cuidado na zona oeste da cidade do Rio de Janeiro</dcterms:title>
   <dcterms:abstract language="pt-BR">Esta dissertação analisa a atenção psicossocial no Brasil em articulação com a questão racial, discutindo os atravessamentos históricos, ideológicos e sociais que estruturam o racismo e suas implicações no cuidado em saúde mental. A partir de revisão crítica de literatura e do relato de experiência da autora em Centros de Atenção Psicossocial (CAPS) da Zona Oeste do Rio de Janeiro, busca-se compreender como as desigualdades raciais, forjadas no processo de colonização, escravização e constituição do capitalismo dependente, atravessam o cotidiano dos serviços da Rede de Atenção Psicossocial (RAPS). Parte-se do entendimento de que o racismo é um determinante social em saúde e um fenômeno estrutural que organiza o acesso a direitos, condiciona possibilidades de cuidado e impacta a saúde mental da população negra. O estudo percorre a construção ideológica do conceito de “raça”, desde sua apropriação pela ciência moderna até as formas atuais de racismo cordial e institucional, evidenciando como a colonialidade do poder e a ideologia do branqueamento sustentam hierarquias de cor e naturalizam desigualdades. Analisa-se a Reforma Psiquiátrica Brasileira, a Luta Antimanicomial, o Sistema Único de Saúde (SUS) e a Política Nacional de Saúde Integral da População Negra (PNSIPN), destacando avanços e desafios para garantir cuidado integral e equânime. Apesar dos princípios do SUS, o racismo institucional permanece como barreira ao acesso e à qualidade do cuidado. Com base na experiência profissional da autora, relatos evidenciam o predomínio de usuários pretos e pardos em territórios periféricos marcados por pobreza e violência, onde o sofrimento psíquico é frequentemente medicalizado e descontextualizado de raça, classe e gênero. A pesquisa defende a necessidade de racializar o debate em saúde mental, fortalecendo práticas de cuidado antirracistas e decoloniais que valorizem cultura, espiritualidade e saberes da população negra, articulando luta antimanicomial e antirracista para a construção de um SUS democrático e comprometido com a vida.</dcterms:abstract>
   <dcterms:abstract language="en">This dissertation analyzes psychosocial care in Brazil in connection with racial issues, examining the historical, ideological, and social dynamics that structure racism and their implications for mental health care. Based on a critical literature review and the author’s professional experience in Psychosocial Care Centers (CAPS) in the West Zone of Rio de Janeiro, the study investigates how racial inequalities-shaped by colonization, enslavement, and dependent capitalism—permeate the daily practices of the Psychosocial Care Network (RAPS). Racism is understood as a social determinant of health and a structural phenomenon that organizes access to rights, shapes care possibilities, and impacts the mental health of the Black population. The dissertation traces the ideological construction of “race,” from its appropriation by modern science to current forms of cordial and institutional racism, showing how the coloniality of power and the ideology of whitening sustain color hierarchies and normalize inequalities. It examines the Brazilian Psychiatric Reform, the Anti-Asylum Movement, the Unified Health System (SUS), and the National Policy for the Comprehensive Health of the Black Population (PNSIPN), highlighting advances and challenges for equitable care. Despite SUS principles, institutional racism remains a barrier to access and quality. Drawing on professional practice, the study presents narratives that reveal the predominance of Black and Brown users in peripheral areas marked by poverty and violence, where mental suffering is often medicalized and detached from racial, class, and gender determinants. The research argues for racializing mental health debates and strengthening antiracist and decolonial care practices that value Black culture, spirituality, and knowledge, articulating anti-asylum and antiracist struggles to build a democratic and life-affirming Unified Health System.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Atenção Psicossocial</dcterms:subject>
   <dcterms:subject language="pt-BR">Racismo Institucional</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde Mental</dcterms:subject>
   <dcterms:subject language="pt-BR">Práticas Antirracistas</dcterms:subject>
   <dcterms:subject language="pt-BR">População Negra</dcterms:subject>
   <dcterms:subject language="en">Psychosocial Care</dcterms:subject>
   <dcterms:subject language="en">Institutional Racism</dcterms:subject>
   <dcterms:subject language="en">Mental Health</dcterms:subject>
   <dcterms:subject language="en">Antiracist Practices</dcterms:subject>
   <dcterms:subject language="en">Black Population</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde das Minorias Étnicas</dcterms:subject>
   <dcterms:subject language="pt-BR">Reabilitação Psiquiátrica</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/78696</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Educação Profissional em Saúde</capes:hasProgram>
   <capes:programCode>31010016020P4</capes:programCode>
   <bibo:numPages>89</bibo:numPages>
   <capes:defenseDate>2025-10-08</capes:defenseDate>
   <creator>
      <dcterms:creator>Oliveira, Beatriz Moreira de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Silva, Letícia Batista da</capes:advisor>
   </advisor>
   <coAdvisor>
      <capes:coAdvisor>Rodrigues, Rafael Coelho</capes:coAdvisor>
   </coAdvisor>
   <committeeMember>
      <capes:committeeMember>Silva, Letícia Batista da</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Rodrigues, Rafael Coelho</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Mendes, Gianne Cristina dos Reis Ferreira</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Rosa, Roberta Pereira Furtado da</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/3650</identifier><datestamp>2026-10-20T13:45:48Z</datestamp><setSpec>com_icict_74505</setSpec><setSpec>com_123456789_2</setSpec><setSpec>col_icict_74506</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">A enfermidade na infância: um estudo sobre a doença em crianças hospitalizadas</dcterms:title>
   <dcterms:abstract language="pt-BR">Um leve passar de olhos pelas estatísticas mundiais de mortalidade infantil nos leva rapidamente a concluir que, sem dúvida, a necessidade mais urgente para as crianças é a sobrevivência. Analisando, agora atentamente, as causas mais prevalentes de morte, observamos que säo, em grande maioria, passíveis de controle, principalmente se comparados os países desenolvidos e subdesenvolvidos entre si. Neste sentido, é inquestionável a eficácia do tratamento médico tradicional, intervindo tecnicamente em condiçoes predominantemente biológicas - ainda que sua efetividade nem sempre seja um fato, dadas outras condiçoes intervenientes. A hospitalizaçäo da criança surge neste contexto de maior efetividade do ato médico, na medida em que se diminuem os efeitos contrários das condiçoes de moradia, da estrutura familiar, da situaçäo econômica e mesmo da administraçäo dos cuidados médicos propriamente ditos. Mas a criança näo é só corpo, e apesar dos distúrbios emocionais näo agirem com grande impacto na mortalidade infantil, estima-se que ao redor de quatro milhoes de crianças no mundo inteiro sofram seriamente destas afecçoes (STETWART, 1977). Sabe-se, além disso, que há uma interaçäo muito íntima entre a mente e o corpo da criança, e que a dor física é percebida simultaneamente como afecçäo psicológica. Além deste fato estudos nas áreas antropológica e social, como o de MICELA (1984), têm reiteradamente mostrado que através das consciências psicológicas individuais pode-se compreender näo só o individual de cada um, mas todo um complexo de forças e de consciência coletiva que ali transparecem - e que säo o fundamento de sua constituiçäo enquanto individual. Os estudos interdisciplinares têm procurado colocar a criança como um sujeito e uma unidade e, como tal, sua resposta emocional a enfermidade e a hospitalizaçäo é um fato incontestável. Outros têm procurado demosntrar que representaçoes platônicas, agostinianas e cartesianas da infância permaneceram inalteradas ao longo dos séculos como um fundo ideológico, obscurecendo nossa visäo da criança como um todo - apesar de estarmos vivendo o &amp;quot;século da criança&amp;quot;. Partimos do pressuposto de que existe uma dimensäo vivencial da enfermidade na infância, sobre a qual a criança doente é capaz de saber e dizer. Nosso objetivo é conhecer suas representaçoes a respeito da enfermidade, dos procedimentos técnicos, da hospitalizaçäo e daqueles que dela cuidam. Mais especificamente e através do que vimos, ouvimos e sentimos - nós aventuramos a dizer algo sobre a singularidade da criança, e sobre esta criança que habita em todos nós. Enfim, um outro olhar e novas questões.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Doença</dcterms:subject>
   <dcterms:subject language="pt-BR">Hospitalização</dcterms:subject>
   <dcterms:subject language="pt-BR">Mortalidade Infantil</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/3650</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde da Criança e da Mulher</capes:hasProgram>
   <capes:programCode>31010016005P5</capes:programCode>
   <bibo:numPages>161</bibo:numPages>
   <capes:defenseDate>1991-05-14</capes:defenseDate>
   <creator>
      <dcterms:creator>Oliveira, Helena de</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Lima, Elvira Souza</capes:advisor>
   </advisor>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/14531</identifier><datestamp>2026-10-20T14:13:26Z</datestamp><setSpec>com_icict_22901</setSpec><setSpec>com_icict_3802</setSpec><setSpec>col_icict_22902</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>master thesis</dcterms:type>
   <dcterms:title language="pt-BR">Efeito do tratamento em massa com dietilcarbamazina na microfilaremia, antigenemia e anticorpos antifilariais em uma área endêmica do município de Olinda - PE</dcterms:title>
   <dcterms:alternative language="en">The effect of mass drug administration with single doses of diethylcarbamazine in microfilaremia, antigenemia e antifilarial antibodys in a endemic area in Olinda - PE</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Este trabalho analisou o efeito do tratamento em massa com doses únicas anuais de Dietilcarbamazina (DEC), no período de 2007 a 2012, em indivíduos infectados por Wuchereria bancrofti, residentes em Olinda - PE. Para essa análise foram utilizadas as técnicas de filtração em membrana, na detecção da microfilaremia, o teste do cartão ICT e o Og4C3-ELISA, na detecção do antígeno circulante filarial, e o teste BM14 na avaliação dos níveis de anticorpos antifilariais. Os resultados obtidos indicam redução nas características avaliadas: após a quarta dose de DEC, a microfilaremia reduziu 100 por cento e a antigenemia pelo cartão ICT atingiu 78,1 por cento de redução após a quinta dose. A mediana do Og4C3 caiu significativamente de 7117 ua, para 1715 ua após a terceira dose, último ano que o teste foi realizado. Observou-se curva de redução também nos níveis de Bm14, com mediana da densidade ótica caindo de 2,1 para 0,1 após a quinta dose. A diminuição nas taxas das características estudadas indica que o tempo preconizado pela Organização Mundial de Saúde para a eliminação da transmissão da FL na área é suficiente para a negativação das microfilárias. Os resultados desse estudo mostram a elevada eficácia do esquema terapêutico utilizado no clareamento da microfilaremia e tratamento dos infectados, e sugerem que a utilização desse esquema na população possivelmente tenha levado a interrupção da transmissão na área. Sugere-se que haja um acompanhamento maior que cinco anos da população submetida ao tratamento para uma melhor avaliação dos níveis de anticorpos e de antigenemia filarial circulante</dcterms:abstract>
   <dcterms:subject language="pt-BR">Filariose Linfática</dcterms:subject>
   <dcterms:subject language="pt-BR">Dietilcarbamazina</dcterms:subject>
   <dcterms:subject language="pt-BR">Wuchereria bancrofti</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/14531</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Saúde Pública</capes:hasProgram>
   <capes:programCode>25007017001P5</capes:programCode>
   <bibo:numPages>70</bibo:numPages>
   <capes:defenseDate>2014-04-16</capes:defenseDate>
   <creator>
      <dcterms:creator>Pereira, Jennifer Sabrina Ferreira da Silva</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Braga, Maria Cynthia</capes:advisor>
   </advisor>
   <advisor>
      <capes:advisor>Rocha, Abraham Cezar de Brito</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Braga, Maria Cynthia</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Bonfim, Cristine</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Schindler, Haiana Charifker</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/74638</identifier><datestamp>2026-10-21T00:06:04Z</datestamp><setSpec>com_icict_64191</setSpec><setSpec>com_icict_54117</setSpec><setSpec>com_icict_3805</setSpec><setSpec>col_icict_64192</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>book review</dcterms:type>
   <dcterms:title language="es">José Carlos Mariátegui a la luz del prisma de la historia de la discapacidad</dcterms:title>
   <dcterms:abstract language="pt-BR">Resenha do livro, &amp;quot; José Carlos Mariátegui o el “cojito genial”: historia y discapacidad en el Perú&amp;quot;, de Paulo Drinot.</dcterms:abstract>
   <dcterms:language>spa</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/74638</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Ferrante, Carolina</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/75137</identifier><datestamp>2026-10-19T21:52:29Z</datestamp><setSpec>com_icict_3805</setSpec><setSpec>col_icict_11238</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>conference output</dcterms:type>
   <dcterms:title language="pt-BR">Investigação qualitativa em museus de ciências: a produção de sentidos por alunos de licenciatura em visita a exposições</dcterms:title>
   <dcterms:abstract language="pt-BR">Trata-se de recorte de pesquisa que investigou como estudantes de licenciatura se apropriam do discurso expositivo e produzem sentidos por meio de objetos nas exposições de museus de ciências, considerando as práticas educativas que ocorrem na interface entre o Museu, a Universidade e a formação de professores. O trabalho tem como objetivo refletir sobre a utilização de metodologias qualitativas para a produção de dados no espaço/tempo em que se realizam as visitas, e, para isso, busca discorrer sobre as etapas de construção metodológica, tomando como referência a proposta intitulada thinking aloud (pensando em voz alta). A análise baseou-se nos estudos de linguagem, com foco nos enunciados dos sujeitos, e permitiu identificar sete núcleos de sentidos. A adoção de uma perspectiva discursiva, aliada à habilidade de descrever, refletir e atribuir valores, trazem importantes elementos para se pensar a formação docente em espaços de cultura científica como os museus.</dcterms:abstract>
   <dcterms:abstract language="en">This is a research study that investigated how undergraduate students appropriate the exhibition discourse and produce meanings through the objects available in science museums’ exhibitions, considering the educational practices that happen among Museum, University and teacher training. The aim of this presentation is to reflect on the use of qualitative methodologies for the data production in the space/time in which the visits are carried out. It seeks to discuss the steps of methodological building, taking as reference the proposal entitled Thinking Aloud. The analysis was based on language studies, focusing on the subjects&amp;apos; statements, and allowed the identification of seven meaning cores. The assumption of a discursive perspective, combined with the ability to describe, reflect and attribute values, bring important elements to think about teacher education in places of scientific culture such as museums.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Museus de Ciência</dcterms:subject>
   <dcterms:subject language="pt-BR">Formação de Professores</dcterms:subject>
   <dcterms:subject language="pt-BR">Investigação Qualitativa</dcterms:subject>
   <dcterms:subject language="pt-BR">Estudos da Linguagem</dcterms:subject>
   <dcterms:subject language="pt-BR">Produção de Sentidos</dcterms:subject>
   <dcterms:subject language="en">Science Museums</dcterms:subject>
   <dcterms:subject language="en">Teacher Education</dcterms:subject>
   <dcterms:subject language="en">Qualitative Research</dcterms:subject>
   <dcterms:subject language="en">Languages Studies</dcterms:subject>
   <dcterms:subject language="en">Meaning Production</dcterms:subject>
   <dcterms:subject language="pt-BR">Museus</dcterms:subject>
   <dcterms:subject language="pt-BR">Educação</dcterms:subject>
   <dcterms:subject language="pt-BR">Capacitação de Professores</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/75137</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Gruzman, Carla</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gonzalez, Ana Carolina de Souza</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Soares, Ozias de Jesus</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Amaral, Marise Basso</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rocha Salomão, Simone</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Reis, Bianca Santos Silva</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/17880</identifier><datestamp>2026-10-20T21:43:07Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Abordagens alternativas para a vigilância da leishmaniose tegumentar em áreas indígenas – estudo de caso entre os Wajãpi do Amapá</dcterms:title>
   <dcterms:alternative language="en">Alternative approaches for cutaneous leishmaniasis surveillance in indigenous areas - case study among the Amapá Wajãpi people</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Este artigo tem por objetivo apresentar limitações do sistema de vigilância da Leishmaniose Tegumentar Americana (LTA) executado no âmbito do Ministério da Saúde em áreas indígenas, a partir do relato de experiência de técnicos e colaboradores que atuaram na vigilância da doença na Terra Indígena Wajãpi entre 2012 e 2015. O estudo compara as abordagens padrão preconizadas pelo Ministério da Saúde com abordagens alternativas entre três componentes principais: captação de casos e diagnóstico, tratamento e análise epidemiológica. Neste último componente, foram comparados métodos que se relacionam a análise de locais prováveis de infecção, entomologia e estudo de hospedeiros vertebrados. A comparação demonstrou que abordagens de cunho qualitativo e o conhecimento sobre padrões e espeficidades culturais do grupo indígena incrementaram a aceitabilidade do serviço de saúde. Abordagens integrativas como oficinas comunitárias, e, participativas que envolviam membros da comunidade como agentes de notificação e ação dentro do serviço, mostraram-se importantes alternaticas para aperfeiçoamento da sensibilidade e representatividade do sistema de vigilância da LTA em áreas indígenas. Espera-se que as abordagens comparadas neste estudo possam servir de base para aperfeiçoamento de sistemas de vigilância em saúde, principalmente para doenças transmitidas por vetores em áreas indígenas.</dcterms:abstract>
   <dcterms:abstract language="en">Evaluation This paper aims to present the limitations of the surveillance system for cutaneous leishmaniasis (CL) overseen by the Ministry of Health in Brazil in indigenous areas, based on the accounts of technical experts and collaborators who worked on the surveillance of the disease among the Wajãpi indigenous people between 2012 and 2015. The study compares the standard approaches recommended by the Ministry of Health with alternative approaches in three main areas: case detection and diagnosis, treatment, and epidemiological analysis. In the latter area, methods that relate to risk analysis, entomology and the study of vertebrate hosts were compared. The comparison showed that approaches based on qualitative methods and knowledge about cultural patterns and specificities of the indigenous group increased the acceptability of the health service. Integrative approaches such as participatory community workshops involving community members acting as reporting agents working within the health service proved to be important alternatives for improving the sensitivity and representativeness of the CL monitoring system in indigenous areas. It is expected that the approaches compared in this study can form the basis for improvement in health surveillance systems, particularly for vector-borne diseases in indigenous areas.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Amazônia</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmaniose</dcterms:subject>
   <dcterms:subject language="pt-BR">Pesquisa Interdisciplinar</dcterms:subject>
   <dcterms:subject language="pt-BR">Saúde de Populações Indígenas</dcterms:subject>
   <dcterms:subject language="pt-BR">Avaliação em Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Ecossistema Amazônico</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/17880</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Moreno, Eduardo Stramandinoli</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cabral, Joana Oliveira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Freire, Maira Posteraro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Costa, Alline da Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Costa, Tiago da Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Souto, Raimundo Nonato Picanço</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Castro, Isai Jorge</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Nascimento, Luis Otavio Cordeiro</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Zanini, Volmir</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Shimabukuro, Paloma Helena Fernandes</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/17774</identifier><datestamp>2026-10-20T21:43:07Z</datestamp><setSpec>com_icict_32465</setSpec><setSpec>com_icict_3244</setSpec><setSpec>col_icict_32469</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>doctoral thesis</dcterms:type>
   <dcterms:title language="pt-BR">O sistema imune inato na patogênese da malária</dcterms:title>
   <dcterms:abstract language="pt-BR">Por muitas décadas de estudo sobre a patogênese da malária, tem-se estabelecido que as manifestações clínicas são frequentemente uma consequência da inflamação sistêmica provocada pelo parasito. Os imunocomplexos (ICs) são encontrados na circulação de pacientes com inflamação, seja ela estéril ou causada por infecções. O presente trabalho demonstra que pacientes com malária apresentam elevados níveis de anticorpos circulantes anti-DNA, bem como ICs contendo DNA do parasito. A ativação de monócitos por ICs resultou na formação de specks de inflamassomas contendo NLRP3, NLRP12 ou AIM2, ativação de caspase 1 e liberação de IL-1β ativa. As células monocucleares do sangue periférico estimuladas com ICs produzem grandes quantidades de IL-1β e TNFα e, no entanto, baixos níveis de IL-10. A principal fonte de citocinas pró-inflamatórias em pacientes de fase aguda da malária é a subpopulação de monócitos CD14+, que expressa o receptor FcRIIIA (CD16). Os monócitos de pacientes em fase de convalescência apresentam um fenótipo anti-inflamatório e, quando estimulados com ICs, produzem elevados níveis de IL -10 e baixos níveis de TNF α e IL-1β. Portanto, dependendo do Status de ativação do monócito,os ICs podem estimular ou modular a produção de citocinas pró-inflamatórias, atuando como um importante imunoregulador durante a malária. Os monócitos (MOs), macrófagos e células dendríticas (DCs) são populações de células heterogêneas que têm papel crucial na reparação de tecidos, detecção de presença de microrganismos invasivos, iniciando respostas imunitárias protetoras. Estudos recentes definiram novos marcadores que permitem a distinção entre monócitos inflamatórios de células dendríticas derivadas de monócitos (MO-DCs), no entanto, a contribuição destas células para neuroinflamação durante a MCE não foi avaliada. Neste trabalho, observamos que a infecção por Plasmodium berghei ANKA (PbA) promove a diferenciação de monócitos inflamatórios esplênicos e DCs convencionais por células dendríticas derivadas de monócitos (MO-DCs), que são CD11c + CD11b + F4/80 + DC-SIGN + Ly6C +. Estas células respondem a IFNy sendo a principal fonte de CXCL9 e CXCL10. Além disso, células MO-DCs expressando CXCL9/10 emergem no cérebro via CCR5 dependente, coincidindo com o influxo de células T CD8+ e o desenvolvimento da síndrome neuropatológica letal. Assim, nossos dados fornecem evidências de que as MO-DCs induzidas pela infecção com PbA desempenham um papel central nas respostas imunes, mediando o desenvolvimento de MCE. De acordo com nossos resultados, após a diferenciação, MO-DCs, que expressam CXCL9 e CXCL10, tem um papel importante na ativação de células T CD4+ e T CD8+ no baço e também migram para o SNC dependente de CCR5, onde atraem e ativam células T CD8+, levando ao desenvolvimento de MCE.</dcterms:abstract>
   <dcterms:abstract language="en">Decades of research on malaria pathogenesis have established that the clinical manifestations are often a consequence of the systemic inflammation elicited by the parasite. Immunocomplexes (ICs) are found in the circulation of patients undergoing either infectious or sterile systemic inflammation. Here, we report that malaria patients display high levels of circulating anti-DNA antibodies, as well as ICs containing parasite DNA. Monocyte activation with malaria-induced ICs resulted in formation of NLRP3-, NLRP12- or AIM2-inflammasome specks, caspase-1 activation, and release of IL-1β. Upon stimulation with ICs malaria-primed peripheral blood mononuclear cells secrete bulk amounts of IL-1β and TNFα, but low IL-10 levels. The main source of pro-inflammatory cytokines in acutely infected malaria patients is a subset of CD14+ monocytes that express the FcγRIIIA receptor (CD16). Intriguingly, in convalescent malaria patients, monocytes shifted back to an anti-inflammatory phenotype, and upon IC stimulation produced high levels of IL-10, but low levels of TNFα and IL-1β. Hence, depending on the status of monocyte activation, ICs may promote or dampen the production of pro-inflammatory cytokines, and thus act as important immune-regulators during malaria. Monocytes (MOs), macrophages and dendritic cells (DCs) are heterogeneous cell populations that have critical role in tissue repair, sensing presence of invasive microorganisms and initiating protective immune responses. Recent studies have defined new markers that allows the distinction of inflammatory monocytes from monocyte derived dendritic cells (MO-DCs), however the contribution of these cells to neuroinflammation during ECM have not been explored. Here we show that infection with Plasmodium berghei ANKA (PbA) promotes replacement of splenic inflammatory.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Malária</dcterms:subject>
   <dcterms:subject language="pt-BR">Plasmodium</dcterms:subject>
   <dcterms:subject language="pt-BR">Imunidade Inata</dcterms:subject>
   <dcterms:subject language="pt-BR">Imunologia</dcterms:subject>
   <dcterms:subject language="pt-BR">Genética</dcterms:subject>
   <dcterms:subject language="pt-BR">Alergia e Imunologia</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/17774</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <capes:hasProgram>Programa de Pós-Graduação em Ciências da Saúde</capes:hasProgram>
   <capes:programCode>32067011001P6</capes:programCode>
   <bibo:numPages>127</bibo:numPages>
   <capes:defenseDate>2016-05-18</capes:defenseDate>
   <creator>
      <dcterms:creator>Hirako, Isabella Cristina</dcterms:creator>
   </creator>
   <advisor>
      <capes:advisor>Hirako, Isabella Cristina</capes:advisor>
   </advisor>
   <committeeMember>
      <capes:committeeMember>Gazzinelli, Ricardo Tostes</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Carvalho, Andrea Teixeira de</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Campos, Marco Antônio Silva</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Bortoluci, Karina Ramalho</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Fujiwara, Ricardo Toshio</capes:committeeMember>
   </committeeMember>
   <committeeMember>
      <capes:committeeMember>Machado, Alexandre de Magalhães Vieira</capes:committeeMember>
   </committeeMember>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/46999</identifier><datestamp>2026-10-20T21:43:08Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Graphene quantum dots decorated with imatinib for leukemia treatment</dcterms:title>
   <dcterms:abstract language="en">The use of graphene quantum dots as biomedical device and drug delivery system has been increasing. This nano platform of pure carbon has showed unique properties and showed to be safe for human use. The imatinib is a molecule designed to specifically inhibit the tyrosine kinase, used for leukemia treatment. In this study, we successfully decorated the graphene quantum dots (GQDs@imatinb) by a carbodiimide crosslinking reaction. The GQDs@imatinb were characterized by FTIR and AFM. The nanoparticles&amp;apos; in vitro behaviors were evaluated by cellular trafficking (internalization) assay and cell viability and apoptosis assays in various cancer cell lines, including suspension (leukemia) cells and adherent cancer cells. The results showed that the incorporation of the imatinib on the surface of the graphene quantum dots did not change the nanoparticles&amp;apos; morphology and properties. The GQDs@imatinb could be efficiently internalized and kill cancer cells via the induction of apoptosis. The data indicated that the prepared GQDs@imatinb might be a great drug nano-platform for cancer, particularly leukemia treatments.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Entrega de medicamentos</dcterms:subject>
   <dcterms:subject language="pt-BR">Ponto quântico de grafeno</dcterms:subject>
   <dcterms:subject language="pt-BR">Dispositivo biomédico</dcterms:subject>
   <dcterms:subject language="pt-BR">Material inteligente</dcterms:subject>
   <dcterms:subject language="pt-BR">Nano-partícula</dcterms:subject>
   <dcterms:subject language="pt-BR">Materiais Inteligentes</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/46999</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Felix, Daniele Mendes</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alencar, Luciana Magalhães Rebelo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Menezes, Frederico Duarte de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Midlej, Victor do Valle Pereira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Aguiar, Lorayne</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Piperni, Sara Gemini</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Zhang, Jian</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Liu, Yin</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ricci Junior, Eduardo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alexis, Frank</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Alves Junior, Severino</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Zhu, Lin</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, Ràlph Santos</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/68263</identifier><datestamp>2026-10-19T21:52:29Z</datestamp><setSpec>com_icict_3805</setSpec><setSpec>col_icict_7519</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Psicanálise Modernista no Brasil: um Recorte Histórico</dcterms:title>
   <dcterms:abstract language="pt-BR">O presente artigo partiu do pressuposto de que o discurso psicanalítico é sempre apropriado por um intérprete que se filia a uma tradição histórica e cultural. Nesta perspectiva, a produção de subjetividade, que tem lugar na clínica psicanalítica, será marcada por essa tradição privilegiada pelo analista. Assim, julgou-se de grande relevância a investigação das vias discursivas de entrada da psicanálise no Brasil, indicando os pontos de ancoragem da mesma na cultura e na história locais. Com este intuito, traçou-se o processo de urbanização e modernização do Brasil no início do século XX e a entrada da psicanálise em um campo de forças divergentes. Encontrou-se um embate pela hegemonia discursiva entre duas leituras que se constituíram como antagônicas e inconciliáveis, e que levaram a dois modos distintos de uso instrumental da psicanálise: de um lado, o discurso psiquiátrico-higienista, com sua leitura reformista e universalizante da psicanálise; de outro, o discurso da vanguarda modernista, com a leitura da subversão dos códigos estabelecidos e da busca de singularidade. Ambos se constituíram no rastro da busca de forjar o brasileiro que se desejava. Este trabalho percorre o viés da psicanálise modernista, com sua utilização singular para a análise da cultura e das subjetividades, bem como sua função de construção de novos mundos.</dcterms:abstract>
   <dcterms:abstract language="en">The current article&amp;apos;s basic premise is that psychoanalytic discourse is always appropriated by an interpreter thereof who belongs to a historical and cultural tradition. From this perspective, the production of subjectivity in psychoanalytic practice is marked by the analyst&amp;apos;s prime tradition. Thus the major relevance of investigating the discursive routes by which psychoanalysis entered Brazil, identifying its anchoring points in local culture and history. The article thus outlines the urbanization and modernization process in early 20th-century Brazil, together with the entry of psychoanalysis in a field of divergent forces. What occurred was a struggle for discursive hegemony between two antagonistic and irreconcilable readings: on the one hand, psychiatric-hygienist discourse with its reformist and universalizing reading of psychoanalysis; on the other, that of the modernist vanguard, with a reading that subverted established codes in the pursuit of singularity. Both were constituted in the wake of a quest to forge what was viewed as the desired Brazilian. This study covers the modernist psychoanalytic bias, with its unique utilization in the analysis of culture and subjectivities, as well as its role in the construction of new worlds.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">História</dcterms:subject>
   <dcterms:subject language="pt-BR">Psicanálise</dcterms:subject>
   <dcterms:subject language="pt-BR">Modernismo</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/68263</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Facchinetti, Cristiana</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/47694</identifier><datestamp>2026-10-20T05:45:24Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Contribuição ao estudo experimental da physiologia pathologica do &amp;quot;mal de engasgo&amp;quot;</dcterms:title>
   <dcterms:subject language="pt-BR">Mal do engasgo</dcterms:subject>
   <dcterms:subject language="pt-BR">Estudo experimental</dcterms:subject>
   <dcterms:subject language="pt-BR">Fisiologia patológica</dcterms:subject>
   <dcterms:subject language="pt-BR">Coleção PROMAN</dcterms:subject>
   <dcterms:subject language="pt-BR">Esôfago</dcterms:subject>
   <dcterms:subject language="pt-BR">Patologia</dcterms:subject>
   <dcterms:subject language="pt-BR">Cães</dcterms:subject>
   <dcterms:subject language="pt-BR">Fisiologia</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/47694</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Almeida, Miguel Ozório de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/65513</identifier><datestamp>2026-10-19T21:52:29Z</datestamp><setSpec>com_icict_60019</setSpec><setSpec>com_icict_59936</setSpec><setSpec>com_icict_8555</setSpec><setSpec>col_icict_60020</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Incorporações e usos do conceito de recovery no contexto da Reforma Psiquiátrica Brasileira: uma revisão da literatura</dcterms:title>
   <dcterms:alternative language="es">Incorporaciones y usos del concepto de recovery en el contexto de la Reforma Psiquiátrica Brasileña: una revisión de la literatura</dcterms:alternative>
   <dcterms:alternative language="en">Incorporations and uses of the concept of recovery in the context of the Brazilian Psychiatric Reform: a literature review</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O conceito de recovery no campo da saúde mental, oriundo do movimento de pacientes e familiares nos países anglo- axões, tornou-se relevante para a compreensão de práticas de cuidado, valorizando aquelas que incorporem o protagonismo dos usuários e uma dimensão crítica dos métodos de tratamento. Tendo como objetivo investigar as diferentes perspectivas nas quais o conceito vem sendo compreendido e experimentado no contexto da Reforma Psiquiátrica Brasileira, realizou-se uma revisão integrativa da literatura publicada no país sobre o recovery, tomando como critério de inclusão textos que relatam ou analisam experiências concretas de cuidado e que se definam como sendo &amp;apos;baseadas no recovery&amp;apos;. Após ampla busca, foram analisados 32 trabalhos, entre artigos, dissertações e teses. O termo recovery aparece na bibliografia brasileira de saúde mental a partir de 2011, e os trabalhos concentram-se notavelmente nos estados de São Paulo e Rio de Janeiro, ligados a instituições de ensino superior e pesquisa. Grande parte da produção não incorpora elementos-chave do conceito estudado, como o protagonismo de usuários, além de por vezes tomar recovery como sinônimo de reabilitação psicossocial. Apesar do avanço e da consolidação do campo da atenção psicossocial no país, a dimensão do protagonismo de usuários ainda é incipiente na experiência brasileira.</dcterms:abstract>
   <dcterms:abstract language="en">The concept of recovery in the field of mental health, originating from the movement of patients and families in Anglo-Saxon countries, has become relevant for the understanding of care practices, valuing those that incorporate the protagonism of users and a critical dimension of treatment methods. Aiming to investigate the different perspectives in which the concept has been understood and experienced in the context of the Brazilian Psychiatric Reform, an integrative review of the published literature in the country regarding recovery was carried out, taking as inclusion criteria texts that report or analyze concrete experiences of care and define themselves as &amp;apos;recovery based&amp;apos;. After an extensive search, 32 works were analyzed, including articles, dissertations and theses. The term recovery appears in the Brazilian mental health bibliography from 2011 onwards, and the works are notably concentrated in the states of São Paulo and Rio de Janeiro, linked to higher education and research institutions. Much of the production does not incorporate key elements of the concept studied, such as the role of users, in addition to sometimes taking recovery as a synonym for psychosocial rehabilitation. Despite the advancement and consolidation of the field of psychosocial care in the country, the dimension of the role of users is still incipient in the Brazilian experience.</dcterms:abstract>
   <dcterms:abstract language="es">El concepto de recovery en el campo de la salud mental, originario del movimiento de pacientes y familiares en los países anglosajones, se volvió relevante para la comprensión de las prácticas de cuidado, valorando aquellas que incorporan el protagonismo de los usuarios y una dimensión crítica de los métodos de tratamiento. Con el objetivo de investigar las diferentes perspectivas en que el concepto ha sido entendido y vivido en el contexto de la Reforma Psiquiátrica Brasileña, se realizó una revisión integradora de la literatura publicada en el país sobre el recovery, tomando como criterio de inclusión textos que informen o analicen experiencias concretas de cuidado y que se definen a sí mismas como &amp;apos;basadas en el recovery&amp;apos;. Luego de una extensa búsqueda, se analizaron 32 trabajos, entre artículos, disertaciones y tesis. El término recovery aparece en la bibliografía brasileña de salud mental a partir de 2011, y los trabajos se concentran notablemente en los estados de São Paulo y Rio de Janeiro, vinculados a instituciones de enseñanza superior y de investigación. Gran parte de la producción no incorpora elementos clave del concepto estudiado, como el protagonismo de los usuarios, además de tomar, en ocasiones, recovery como sinónimo de rehabilitación psicosocial. A pesar del avance y consolidación del campo de la atención psicosocial en el país, la dimensión del protagonismo de los usuarios aún es incipiente en la experiencia brasileña.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Recovery e saúde mental</dcterms:subject>
   <dcterms:subject language="pt-BR">Reforma psiquiátrica brasileira</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção psicossocial</dcterms:subject>
   <dcterms:subject language="pt-BR">Recovery</dcterms:subject>
   <dcterms:subject language="es">Recovery y salud mental</dcterms:subject>
   <dcterms:subject language="es">Reforma psiquiátrica brasileña</dcterms:subject>
   <dcterms:subject language="es">Atención psicosocial</dcterms:subject>
   <dcterms:subject language="pt-BR">Recuperação da Saúde Mental</dcterms:subject>
   <dcterms:subject language="pt-BR">Reforma Psiquiátrica</dcterms:subject>
   <dcterms:subject language="pt-BR">Reabilitação Psiquiátrica</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/65513</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Brandão, Alice Daudt de Lima</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Figueiredo, Angela Pereira</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Delgado, Pedro Gabriel Godinho</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/29232</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_18318</setSpec><setSpec>com_icict_13554</setSpec><setSpec>col_icict_18319</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Cooperação internacional em saúde do Brasil na era do SUS</dcterms:title>
   <dcterms:alternative language="en">Brazilian international cooperation in health in the era of SUS</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O artigo aborda a presença da saúde na diplomacia da saúde e na cooperação internacional do Brasil, desde o surgimento do Sistema Único de Saúde (SUS), com ênfase na cooperação Sul-Sul e em linha com as prioridades da cooperação técnica internacional do país desde então, que enfatiza as relações com países da América Latina e Caribe (ALC) e da Comunidade de Países de Língua Portuguesa (CPLP), particularmente com os Países Africanos de Língua Oficial Portuguesa (PALOP) e Timor Leste. Ressalta os papéis do Ministério da Saúde, por meio da Assessoria Internacional em Saúde (AISA) e da Fundação Oswaldo Cruz (Fiocruz), além da Agência Brasileira de Cooperação (ABC), do Ministério das Relações Exteriores, e da Organização Pan-Americana da Saúde (OPAS). Aponta o papel do Termo de Cooperação TC-41 como um dos principais instrumentos da viabilização da cooperação. Apresenta os casos das redes estruturantes dos sistemas de saúde, assim como as negociações paradigmáticas da Convenção-Quadro sobre Controle do Tabaco, do Acordo TRIPS e da criação da UNAIDS, nos quais o papel da diplomacia brasileira foi preponderante.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Sistema Único de Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Cooperação Internacional</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/29232</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Buss, Paulo Marchiori</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/27832</identifier><datestamp>2026-10-19T21:52:29Z</datestamp><setSpec>com_icict_1707</setSpec><setSpec>com_icict_7119</setSpec><setSpec>col_icict_6664</setSpec><setSpec>col_icict_9216</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil</dcterms:title>
   <dcterms:alternative language="pt-BR">A produção pública de medicamentos frente à Política Nacional de Medicamentos e à carga de doenças no Brasil</dcterms:alternative>
   <dcterms:alternative language="es">La producción pública de medicamentos frente a la Política Nacional de Medicamentos y a la carga de enfermedades en Brasil</dcterms:alternative>
   <dcterms:abstract language="pt-BR">A produção pública de medicamentos no Brasil pelos Laboratórios Farmacêuticos Oficiais (LFO) retornou a ser alvo de incentivo e as Parcerias de Desenvolvimento Produtivo são um dos instrumentos adotados para a produção de medicamentos estratégicos para o Sistema Único de Saúde (SUS). Tendo em vista que os estudos de carga de doença vêm sendo utilizados como ferramenta para definição de medicamentos prioritários e essenciais, este artigo relaciona os portfólios dos LFO e a lista de medicamentos estratégicos para o SUS com a carga de doença no Brasil 2008. Dos 205 medicamentos estratégicos para o SUS e 111 dos portfolios, 73% e 89% estão na RENAME 2014. Alguns medicamentos estratégicos para o SUS já são produzidos pelos LFO e destaca-se a seleção de medicamentos para câncer e oriundos de rota biológica. O presente estudo contribui para a discussão da produção pública de medicamentos frente a atual política industrial e destaca a necessária definição de medicamentos prioritários e o papel dos laboratórios farmacêuticos oficiais na garantia de seu acesso.</dcterms:abstract>
   <dcterms:abstract language="en">The public production of medicines in Brazil by Government Pharmaceutical Laboratories has once again become the object of incentives, and Industrial Development Partnerships are one of the mechanisms adopted for the production of strategic medicines for the Brazilian Unified National Health System (SUS). Considering that burden-of-disease studies have been used as a tool to define priority and essential medicines, the article compares the product portfolios of the country&amp;apos;s Official Pharmaceutical Laboratories (OPL) and the list of strategic medicines for the SUS and burden of disease in Brazil in 2008. Of the 205 strategic medicines for the SUS and 111 from the portfolios, 73% and 89%, respectively, are on the National List of Essential Medicines (RENAME 2014). Some strategic medicines for the SUS are already produced by OPL and feature the selection of cancer drugs and biologicals. The current study contributes to the discussion on the public production of medicines in light of the country&amp;apos;s current industrial policy and highlights the need to define priority drugs and the role of OPL in guaranteeing access to them.</dcterms:abstract>
   <dcterms:abstract language="es">La producción pública de medicamentos en Brasil por los Laboratorios Farmacéuticos Oficiales (LFO) volvió a ser objetivo de incentivos, así como las Colaboraciones de Desarrollo Productivo que son uno de los instrumentos adoptados para la producción de medicamentos estratégicos para el Sistema Único de Salud (SUS). Teniendo en vista que los estudios de carga de enfermedad está siendo utilizados como herramienta para la definición de medicamentos prioritarios y esenciales, este artículo relaciona los portafolios de los LFO y la lista de medicamentos estratégicos para el SUS con la carga de enfermedad en Brasil 2008. De los 205 medicamentos estratégicos para el SUS y 111 de los portafolios, 73% y 89% están en la RENAME 2014. Algunos medicamentos estratégicos para el SUS ya son producidos por los LFO y se destaca la selección de medicamentos para cáncer y los provenientes de ruta biológica. El presente estudio contribuye a la discusión de la producción pública de medicamentos, frente a la actual política industrial, y destaca la necesaria definición de medicamentos prioritarios y el papel de los laboratorios farmacéuticos oficiales en la garantía a su acceso.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Carga da Doença</dcterms:subject>
   <dcterms:subject language="pt-BR">Anos de Vida Perdidos por Incapacidade</dcterms:subject>
   <dcterms:subject language="pt-BR">Indústria Farmacêutica</dcterms:subject>
   <dcterms:subject language="pt-BR">Assistência Farmacêutica</dcterms:subject>
   <dcterms:subject language="es">Carga de la Enfermedad</dcterms:subject>
   <dcterms:subject language="es">Años de Vida Perdidos por Incapacidad</dcterms:subject>
   <dcterms:subject language="es">Industria Farmacéutica</dcterms:subject>
   <dcterms:subject language="es">Servicios Farmacéuticos</dcterms:subject>
   <dcterms:subject language="pt-BR">Efeitos Psicossociais da Doença</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/27832</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Figueiredo, Tatiana Aragão</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Schramm, Joyce Mendes de Andrade</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pepe, Vera Lúcia Edais</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/39379</identifier><datestamp>2026-10-20T21:43:16Z</datestamp><setSpec>com_icict_35901</setSpec><setSpec>com_123456789_1</setSpec><setSpec>col_icict_35903</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>video</dcterms:type>
   <dcterms:title language="pt-BR">Webinar Proqualis Outubro 2017: Prevenção de tromboembolismo venoso</dcterms:title>
   <dcterms:abstract language="pt-BR">Webinar sobre Prevenção de Tromboembolismo Venoso realizado no dia 30 de outubro de 2017, com o Dr. Marcelo Basso Gazzana, Chefe do Serviço de Pneumologia e Cirurgia Torácica do Hospital Moinhos de Vento (POA).</dcterms:abstract>
   <dcterms:subject language="pt-BR">Webinar</dcterms:subject>
   <dcterms:subject language="pt-BR">Proqualis</dcterms:subject>
   <dcterms:subject language="pt-BR">Tromboembolismo</dcterms:subject>
   <dcterms:subject language="pt-BR">Venoso</dcterms:subject>
   <dcterms:subject language="pt-BR">Tromboembolia</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/39379</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Regadas, Claudia</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/57305</identifier><datestamp>2026-10-21T00:16:53Z</datestamp><setSpec>com_icict_1707</setSpec><setSpec>col_icict_6664</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Descentralização do financiamento e gestão da assistência à saúde no Brasil: a implementação do sistema único de saúde - retrospectiva 1990/1995</dcterms:title>
   <dcterms:abstract language="pt-BR">Este artigo analisa a estratégia de descentralização da assistência ambulatorial e hospitalar, adotada pelo Ministério da Saúde na condução do processo de implementação do Sistema Único de Saúde (SUS) nos anos 90, em especial no período 1993/1995. Para tanto, discorre sobre as principais inovações constitutivas do projeto de reforma setorial consagrado na constituição federal de 1988, e sua implantação no que diz respeito ao financiamento e gestão da assistência à saúde. Por fim, faz uma apreciação das inici- ativas desenvolvidas em 1995 para o fortalecimento da capacidade de gestão pública do sistema de saúde nas três esferas de governo, e apresenta as perspectivas de trabalho para 1996, além de alguns dos principais desafios a superar.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Financiamento</dcterms:subject>
   <dcterms:subject language="pt-BR">Descentralização</dcterms:subject>
   <dcterms:subject language="pt-BR">Assistência à Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">SUS</dcterms:subject>
   <dcterms:subject language="pt-BR">Financiamento de Capital</dcterms:subject>
   <dcterms:subject language="pt-BR">Política</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção à Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Sistema Único de Saúde</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/57305</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Lucchese, Patrícia T. R.</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/68385</identifier><datestamp>2026-07-24T18:51:00Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Variety is the spice: the role of morphological variation of Triatoma infestans (Hemiptera, Reduviidae) at a macro-scale</dcterms:title>
   <dcterms:abstract language="en">Chagas disease is caused by the protozoan parasite Trypanosoma cruzi (Chagas, 1909). One of the primary vectors of T. cruzi in South America is Triatoma infestans (Klug, 1834). This triatomine species is distributed across a huge latitudinal gradient, inhabiting domiciliary, peridomiciliary, and wild environments. Its wide geographic distribution provides an excellent opportunity to study the relationships between environmental gradients and intraspecific morphological variation. In this study, we investigated variations in wing size and shape in T. infestans across six ecoregions. We aimed to address the following questions: How do wing size and shape vary on a regional scale, does morphological variation follow specific patterns along an environmental or latitudinal gradient, and what environmental factors might contribute to wing variation? Geometric morphometric methods were applied to the wings of 162 females belonging to 21 T. infestans populations, 13 from Argentina (n = 105), 5 from Bolivia (n = 42), and 3 from Paraguay (n = 15). A comparison of wing centroid size across the 21 populations showed significant differences. Canonical Variate Analysis (CVA) revealed significant differences in wing shape between the populations from Argentina, Bolivia, and Paraguay, although there was a considerable overlap, especially among the Argentinian populations. Well-structured populations were observed for the Bolivian and Paraguayan groups. Two analyses were performed to assess the association between wing size and shape, geographic and climatic variables: multiple linear regression analysis (MRA) for size and Partial Least Squares (PLS) regression for shape. The MRA showed a significant general model fit. Six temperature-related variables, one precipitation-related variable, and the latitude showed significant associations with wing size. The PLS analysis revealed a significant correlation between wing shape with latitude, longitude, temperature-related, and rainfall-related variables. Wing size and shape in T. infestans populations varied across geographic distribution. Our findings demonstrate that geographic and climatic variables significantly influence T. infestans wing morphology.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/68385</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Carbajal de la Fuente, Ana Laura</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Piccinali, Romina V.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Porcasi, Ximena</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Aníbal Marti, Gerardo</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rojas de Arias, Antonieta</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Abrahan, Luciana</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cano Suárez, Florencia</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Lobbia, Patricia</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Medina, Gabriela</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Provecho, Yael</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rojas Cortez, Mirko</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Soria, Nicolás</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gonçalves, Teresa Cristina Monte</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Nattero, Julieta</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/3864</identifier><datestamp>2026-10-19T21:52:30Z</datestamp><setSpec>com_icict_1707</setSpec><setSpec>com_123456789_1</setSpec><setSpec>col_icict_6664</setSpec><setSpec>col_icict_840</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Hospital deaths and adverse events in Brazil</dcterms:title>
   <dcterms:abstract language="en">Background: Adverse events are considered a major international problem related to the performance of health systems. Evaluating the occurrence of adverse events involves, as any other outcome measure, determining the extent to which the observed differences can be attributed to the patient&amp;apos;s risk factors or to variations in the treatment process, and this in turn highlights the importance of measuring differences in the severity of the cases. The current study aims to evaluate the association between deaths and adverse events, adjusted according to patient risk factors. Methods: The study is based on a random sample of 1103 patient charts from hospitalizations in the year 2003 in 3 teaching hospitals in the state of Rio de Janeiro, Brazil. The methodology involved a retrospective review of patient charts in two stages - screening phase and evaluation phase. Logistic regression was used to evaluate the relationship between hospital deaths and adverse events. Results: The overall mortality rate was 8.5%, while the rate related to the occurrence of an adverse event was 2.9% (32/1103) and that related to preventable adverse events was 2.3% (25/1103). Among the 94 deaths analyzed, 34% were related to cases involving adverse events, and 26.6% of deaths occurred in cases whose adverse events were considered preventable. The models tested showed good discriminatory capacity. The unadjusted odds ratio (OR 11.43) and the odds ratio adjusted for patient risk factors (OR 8.23) between death and preventable adverse event were high. Conclusions: Despite discussions in the literature regarding the limitations of evaluating preventable adverse events based on peer review, the results presented here emphasize that adverse events are not only prevalent, but are associated with serious harm and even death. These results also highlight the importance of risk adjustment and multivariate models in the study of adverse events.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Eventos Adversos</dcterms:subject>
   <dcterms:subject language="pt-BR">Mortalidade Hospitalar</dcterms:subject>
   <dcterms:subject language="pt-BR">Brasil</dcterms:subject>
   <dcterms:subject language="pt-BR">Sistemas de Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Pacientes</dcterms:subject>
   <dcterms:subject language="pt-BR">Fatores de Risco</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/3864</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Martins, Mônica Silva</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Travassos, Claudia Maria de Rezende</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Mendes, Walter</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pavão, Ana Luiza Braz</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/23482</identifier><datestamp>2026-10-20T21:43:17Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Multilocus sequence typing of Salmonella Typhimurium reveals the presence of the highly invasive ST313 in Brazil</dcterms:title>
   <dcterms:subject language="pt-BR">Salmonella Typhimurium</dcterms:subject>
   <dcterms:subject language="pt-BR">Virulência</dcterms:subject>
   <dcterms:subject language="pt-BR">Tipagem de Sequências Multilocus</dcterms:subject>
   <dcterms:subject language="pt-BR">Aumento da sobrevivência intramacrófica</dcterms:subject>
   <dcterms:subject language="pt-BR">Primeiro relatório no Brasil</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/23482</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Almeida, Fernanda</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Seribelli, Amanda Aparecida</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Silva, Patrick da</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Medeiros, Marta Inês Cazentini</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rodrigues, Dália dos Prazeres</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Moreira, Cristiano Gallina</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Allard, Marc W.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Falcão, Juliana Pfrimer</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/39664</identifier><datestamp>2026-10-19T21:52:30Z</datestamp><setSpec>com_icict_1707</setSpec><setSpec>col_icict_6664</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">A utilização de serviços de saúde por sistema de financiamento</dcterms:title>
   <dcterms:alternative language="en">An analysis of health services utilisation, by financing system</dcterms:alternative>
   <dcterms:abstract language="pt-BR">Este artigo analisa, a partir de microdados de 1998 e 2003 da PNAD/IBGE, a utilização de serviços de saúde sob a perspectiva de seu financiamento ou, em outras palavras, sob o prisma do sistema de proteção à saúde pelo qual o serviço foi utilizado: se pelo Sistema Único de Saúde (SUS), ou seja, pelo sistema público financiado por meio de tributos; se por planos e seguros de saúde privados e financiados por prêmios pagos por beneficiários e/ou seus empregadores; ou, finalmente, se mediante a compra direta de serviços (pagamento direto no ato da utilização de serviços). Entre os principais resultados da análise, destacam-se os seguintes: 1) o SUS financia a maioria dos atendimentos e das internações realizados no País, participação que aumentou significativamente entre 1998 e 2003; 2) embora o número absoluto de atendimentos realizados pelos três sistemas de financiamento tenha aumentado, a expansão do SUS foi muito mais significativa e a ela correspondeu uma desaceleração do crescimento do gasto privado direto; 3) o SUS é o principal financiador dos dois níveis extremos de complexidade da atenção à saúde: o de atenção básica e o da alta complexidade.</dcterms:abstract>
   <dcterms:abstract language="en">This article analyses, from micro-data of the National Sample Household Survey (PNAD/IBGE) from 1998 and 2003, the utilisation of health services according to different financing systems. In other words, it analyses if this utilisation has been done through the National Health System SUS (public and universal health insurance, financed by taxes), through private health insurance (premiums paid by the insured population and/or their employers) or through out-of-pocket payments. The main results are: 1) SUS finances most of inpatient and outpatient utilisation and its participation has strongly increased from 1998 to 2003; 2) although the absolute number of outpatient utilisation made through the three systems has increased, SUS expansion has been much stronger (it increased 44%) and it corresponded to a slower increase (6,2%) of out-of-pocket utilisation and 3) SUS is the main financing system of the two extremes of complexity of health care: primary care and high complexity services.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Financiamento</dcterms:subject>
   <dcterms:subject language="pt-BR">Utilização de Serviços de Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Financiamento da Assistência à Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Serviços de Saúde</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/39664</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Porto, Silvia Marta</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Santos, Isabela Soares</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Ugá, Maria Alicia Dominguez</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/19665</identifier><datestamp>2026-10-20T21:43:18Z</datestamp><setSpec>com_icict_3790</setSpec><setSpec>com_icict_1956</setSpec><setSpec>col_icict_9624</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">AIM2 inflammasome is associated with disease severity in tegumentary leishmaniasis caused by Leishmania (V.) braziliensis</dcterms:title>
   <dcterms:abstract language="en">The inflammasome is a multiprotein signalling platform involved in the pathogenesis of various inflammatory skin diseases. Herein, we investigated gene and protein expression of the inflammasome molecules AIM2 and NLRP3 in active lesions from patients with L. (V.) braziliensis-associated tegumentary leishmaniasis (TL) and correlated these findings with the clinical presentations and responses to therapy. Real-time PCR assays showed a significantly higher AIM2 gene expression in mucosal leishmaniasis (ML) compared with that in cutaneous leishmaniasis (CL). Additionally, AIM2 mRNA expression was significantly higher in lesions from poor responders than in lesions from good responders. In situ protein quantification analyses revealed greater AIM2 expression in ML lesions than in CL lesions. The percentage of AIM2-producing cells was higher in poor responders than in good responders. Although not quite significant, IL-1β+ cells were slightly more prominent in poor responders than in good responders. Similar results were observed when patients were evaluated according to clinical form. GP63 immunostaining was identified in all samples, but no significant variation between mucosal and cutaneous lesions was observed. GP63 could be associated with reduced NLRP3 inflammasome expression in CL and ML patients. Taken together, these data demonstrate that AIM2 is an important component of the inflammasome in TL patients and is directly associated with the severity of lesions.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Inflamassomos</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmania braziliensis</dcterms:subject>
   <dcterms:subject language="pt-BR">Leishmaniose</dcterms:subject>
   <dcterms:subject language="pt-BR">Resposta terapêutica</dcterms:subject>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/19665</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Moreira, R. B.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pirmez, C.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira Neto, M. P. de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Aguiar, L. S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Gonçalves, A. J. S.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Pereira, L. O. R.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Abreu, L.</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Oliveira, M. P. de</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/59900</identifier><datestamp>2026-07-24T18:51:01Z</datestamp><setSpec>com_icict_3244</setSpec><setSpec>col_icict_3245</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="en">Exploring health care for transgender people in the Brazilian health system: Qualitative descriptive-interpretative study</dcterms:title>
   <dcterms:abstract language="en">The guarantee of rights in Brazil is legitimized through its Constitution of the Republic and its national health system needs to follow a list of prerogatives that include, also, transgender people. Currently there are situations in which the expectation of rights is broken and the free exercise of life of this population is prevented. This article analyzes access to health services by trans people in the health system in Brazil. The investigation was carried out in cities in the metropolitan region of a municipality in southeastern Brazil, through qualitative, exploratory and descriptive-interpretive research. The trans population faces many difficulties in accessing the services that make up the Brazilian Health System, such as the lack of qualification of health professionals, barriers to the use of the social name and structural prejudices in society.</dcterms:abstract>
   <dcterms:language>eng</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/59900</capes:outputUri>
   <dcterms:rights>Acesso restrito</dcterms:rights>
   <creator>
      <dcterms:creator>Faria, Mateus Aparecido de</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Paiva, Tiago Sousa</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Cornelli, Andressa Marques</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Voigt, Carolina Feijó Bitencourt</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Rocha, Cristianne Maria Famer</dcterms:creator>
   </creator>
   <creator>
      <dcterms:creator>Modena, Celina Maria</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/43331</identifier><datestamp>2026-10-20T21:43:09Z</datestamp><setSpec>com_icict_1956</setSpec><setSpec>col_icict_1957</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Cestóides Proteocefalídeos de &amp;quot;Cachara&amp;quot;, Pseudoplatystoma Fasciatus (L.) (Pisces, Pimelodidae) de Mato Grosso</dcterms:title>
   <dcterms:abstract language="en">The author describes three species of protcocephalid cestodes from the Pimelodid fish, Pseudoplatystoma fasciatus (L.) from rivers of Mato Grosso, Brazil: Nomimoscolex lopesi sp. n., Peltidocotyle rugosa Diesing, 1850 and Spatulifer rugosa (Woodland, 1935). P. rugosa is for the first time referred in this fish species. One hyperparasite nematode specimen was found in a strobila of S. rugosa.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Cachara</dcterms:subject>
   <dcterms:subject language="pt-BR">Pseudoplatystoma fasciatus</dcterms:subject>
   <dcterms:subject language="pt-BR">Parasitos de peixes</dcterms:subject>
   <dcterms:subject language="pt-BR">Cestódeos</dcterms:subject>
   <dcterms:subject language="pt-BR">mato Grosso</dcterms:subject>
   <dcterms:subject language="pt-BR">Proteocefálida</dcterms:subject>
   <dcterms:subject language="pt-BR">Cestoides</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/43331</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Rego, Amilcar Arandas</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/60931</identifier><datestamp>2026-10-19T21:52:30Z</datestamp><setSpec>com_icict_58710</setSpec><setSpec>com_icict_58640</setSpec><setSpec>com_icict_13663</setSpec><setSpec>col_icict_60769</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">O direito transindividual à saúde e as falsas aporias da liberdade individual</dcterms:title>
   <dcterms:alternative language="es">El derecho transindividual a la salud y los falsos dilemas de la libertad individual</dcterms:alternative>
   <dcterms:alternative language="en">The transindividual right to health and the false dilemmas of individual freedom</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O presente texto pretende responder à pergunta: a obrigatoriedade de vacinação imposta pelo Estado é conflitante com a liberdade individual? Diante do recente cenário de caos sanitário resultante da pandemia de COVID-19, a dimensão pública, transindividual, da saúde foi posta em dúvida por discursos pautados na ideia de que as pessoas teriam o direito a não serem vacinadas. Em que pesem a legislação brasileira e a jurisprudência do Supremo Tribunal Federal terem pacificado o tema em favor da obrigatoriedade da vacina, busca-se apresentar o problema a partir de sua perspectiva epistemológica ou hermenêutica. Nesse sentido, mostra-se que, a menos que a comunidade jurídica reveja seu discurso acerca dos princípios constitucionais e direitos fundamentais, ou seja, a sua compreensão e metodologia de aplicação, tais dicotomias que surgem no debate público e nos tribunais persistirão como obstáculos à plena efetivação do Estado democrático de direito e, particularmente, do direito à saúde.</dcterms:abstract>
   <dcterms:abstract language="en">This text aims to answer the question: is the mandatory vaccination imposed by the State in conflict with individual freedom? Given the recent scenario of health chaos resulting from the COVID-19 pandemic, the public, transindividual dimension of health was questioned by discourses based on the idea that people would have the right not to be vaccinated. Although the Brazilian legislation and the jurisprudence of the Supreme Court have settled the issue in favor of the mandatory vaccine, we seek to present the problem from an epistemological or hermeneutic perspective. In this sense, it is shown that, unless the legal community reviews its discourse about constitutional principles and fundamental rights, in other words, its understanding and methodology of application, such dichotomies that arise in the public debate and in the courts will persist as obstacles to the full realization of the democratic State of law and, particularly, the right to health.</dcterms:abstract>
   <dcterms:abstract language="es">El presente texto pretende responder a la pregunta: ¿la obligación de vacunación impuesta por el Estado es contraria a la libertad individual? Frente al reciente escenario de caos sanitario resultante de la pandemia de COVID-19, la dimensión pública, transindividual, de la salud fue puesta en duda por discursos basados en la idea de que las personas tendrían el derecho a no ser vacunadas. Aunque la legislación brasileña y la jurisprudencia del Supremo Tribunal Federal hayan pacificado el tema en favor de la obligatoriedad de la vacuna, se busca presentar el problema desde una perspectiva epistemológica o hermenéutica. En este sentido, se muestra que, a menos que la comunidad jurídica revise su discurso sobre los principios constitucionales y derechos fundamentales, es decir, su comprensión y metodología de aplicación, tales dicotomías que surgen en el debate público y en los tribunales persistirán como obstáculos a la plena realización del Estado democrático de derecho y, particularmente, del derecho a la salud.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Hermenêutica</dcterms:subject>
   <dcterms:subject language="pt-BR">Liberdade</dcterms:subject>
   <dcterms:subject language="pt-BR">Direito à saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Vacinação obrigatória</dcterms:subject>
   <dcterms:subject language="es">Derecho a la salud</dcterms:subject>
   <dcterms:subject language="es">Vacunación obligatoria</dcterms:subject>
   <dcterms:subject language="es">Hermenéutica</dcterms:subject>
   <dcterms:subject language="es">Libertad</dcterms:subject>
   <dcterms:subject language="pt-BR">Vacinação Compulsória</dcterms:subject>
   <dcterms:subject language="pt-BR">COVID-19</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/60931</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Streck, Lenio Luiz</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><record><header><identifier>oai:arca.fiocruz.br:icict/68963</identifier><datestamp>2026-10-19T21:52:30Z</datestamp><setSpec>com_icict_59956</setSpec><setSpec>com_icict_59936</setSpec><setSpec>com_icict_8555</setSpec><setSpec>col_icict_59959</setSpec></header><metadata><oai_capes xmlns="http://capes.gov.br/schema/oai_capes/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:capes="http://capes.gov.br/schema/oai_capes/1.0" xmlns:vivo="http://vivoweb.org/ontology/core#" xmlns:schema="http://schema.org/" xmlns:bibo="http://purl.org/ontology/bibo/">
   <dcterms:type>journal article</dcterms:type>
   <dcterms:title language="pt-BR">Financiamento da saúde: impasses ainda não resolvidos</dcterms:title>
   <dcterms:alternative language="en">Funding health: unsolved impasses</dcterms:alternative>
   <dcterms:abstract language="pt-BR">O trabalho procura dialogar com os achados apresentados por Luciana Dias de Lima em seu texto sobre federalismo fiscal e financiamento descentralizado da saúde no Brasil, mediante a apresentação de resultados parciais e inéditos de um estudo, realizado no período 2006-2008, sobre estratégias de financiamento da atenção básica em municípios com mais de 100 mil habitantes do estado de São Paulo. O estudo envolveu a execução de dois módulos relacionados entre si: coleta e análise de dados secundários, buscando relacionar indicadores de financiamento da saúde no plano local com níveis de desempenho da atenção básica, e entrevistas semi-estruturadas com gestores de saúde de municípios selecionados. Os resultados mostram, de um lado, que os diferentes modelos de atenção básica existentes nos municípios, assim como os níveis diferenciados de eficácia e efetividade dos sistemas municipais de saúde, estão relacionados com o padrão de financiamento e gasto com saúde nesses municípios; de outro lado, que existem diversos aspectos que tendem a jogar papel decisivo na disponibilidade de recursos financeiros para o desenvolvimento da atenção básica, incluindo o comprometimento de recursos com serviços de média e alta complexidade e o alinhamento político do município com as demais esferas de governo.</dcterms:abstract>
   <dcterms:abstract language="en">The article seeks to dialogue with the discoveries presented by Luciana Dias de Lima in her article about fiscal federalism and decentralized funding of health in Brazil by presenting partial, unpublished results of a study carried out between 2006 and 2008 regarding basic care funding strategies in cities with more than 100,000 inhabitants in the State of São Paulo. The study involved two interrelated modules: secondary data collection and analysis, seeking to relate health funding indices on the local plan to basic care performance levels, and semi-structured interviews with health managers of selected cities. The results show, on one token, that the different basic care models that exist in the cities, as well as the differentiated levels of efficacy and effectiveness of the municipal health systems, are related to the health funding and expenditure standard in these cities; and, on the other, that there are several aspects that tend to play decisive roles in the availability of financial resources for the development of basic care, including committing resources with medium-complexity and high-complexity services and the city&amp;apos;s political alignment with the remaining spheres of government.</dcterms:abstract>
   <dcterms:subject language="pt-BR">Sistema Único de Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Federalismo fiscal</dcterms:subject>
   <dcterms:subject language="pt-BR">Financiamento</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção básica</dcterms:subject>
   <dcterms:subject language="pt-BR">Federalismo</dcterms:subject>
   <dcterms:subject language="pt-BR">Financiamento da Assistência à Saúde</dcterms:subject>
   <dcterms:subject language="pt-BR">Atenção Primária à Saúde</dcterms:subject>
   <dcterms:language>por</dcterms:language>
   <capes:outputUri>https://arca.fiocruz.br/handle/icict/68963</capes:outputUri>
   <dcterms:rights>Acesso aberto</dcterms:rights>
   <creator>
      <dcterms:creator>Viana, Ana Luiza D&amp;apos;Ávila</dcterms:creator>
   </creator>
</oai_capes>
</metadata></record><resumptionToken completeListSize="69423" cursor="0">oai_capes////100</resumptionToken></ListRecords></OAI-PMH>